"AHC","PY","nTotDoc","meanAUPerArt","meanAU_IN_PerArt","meanArtWith_AU_IN_FIRST","meanArtWith_AU_IN_LAST","meanArtWith_AU_IN_CORR","mean_articles_per_internal_author","mean_articles_per_internal_first_author","mean_articles_per_internal_last_author","mean_articles_per_internal_corresponding_author","ArtOA","singleAuArt","Q1_nSJR","Q2_nSJR","Q3_nSJR","Q4_nSJR","Q1_percSJR","Q2_percSJR","Q3_percSJR","Q4_percSJR","meanTCperArt","mean_NTC","meanCitationTrend","InternCoauthorship","AffCoauthorship","GC_AUIN_wFractional","GC_AUIN_FIRSTname","GC_AUIN_LASTname","GC_AUIN_CORRESP","top_AU","top_AU_freq","top_AU_wFract","top_AU_freq_wFract","top_AUIN","top_AUIN_freq","top_AUIN_wFract","top_AUIN_freq_wFract","topAUbyCit","topAUbyCit_TC","topAUINbyCit","topAUINbyCit_TC","topAUINbyCit_norm_byYear","topAUINbyCit_TC_norm_byYear","topConcept_L0","topFreq_L0","topConcept_L1","topFreq_L1","topConcept_L2","topFreq_L2","topConcept_L3","topFreq_L3","topConcept_L4","topFreq_L4","topMESH","topMESH_n","topprimary_topic.display_name","topprimary_topic.display_name_n","topDE","topDE_n","topTI_TM","topTI_TM_n","topAB_TM","topAB_TM_n","nDoc_wALTM","percDoc_wALTM","altmetric_score_thirdQu","cited_by_accounts_count_thirdQu","cited_by_fbwalls_count_thirdQu","cited_by_feeds_count_thirdQu","cited_by_gplus_count_thirdQu","cited_by_msm_count_thirdQu","cited_by_patents_count_thirdQu","cited_by_peer_review_sites_count_thirdQu","cited_by_policies_count_thirdQu","cited_by_posts_count_thirdQu","cited_by_rdts_count_thirdQu","cited_by_rh_count_thirdQu","cited_by_tweeters_count_thirdQu","cited_by_videos_count_thirdQu","cited_by_wikipedia_count_thirdQu","cohorts.com_thirdQu","cohorts.doc_thirdQu","cohorts.pub_thirdQu","cohorts.sci_thirdQu","readers.citeulike_thirdQu","readers.connotea_thirdQu","readers.mendeley_thirdQu","readers_count_thirdQu","n_patentsDistinct","nPatentStatus_Abandoned","nPatentStatus_Granted","nPatentStatus_N/A","nPatentStatus_Pending","nPatentStatus_Active","nPatentStatus_Not-in-force","nPatentStatus_Expired - Fee Related","nPatentStatus_Withdrawn","nPatentStatus_Ceased","nPatentStatus_Revoked","nPatentStatus_Expired - Lifetime","nPatentPubType_Application","nPatentPubType_Grant","nPatentPubType_N/A","avg_citations_Patent","avg_Inventors_Patent","inventor_per_AUIN_100","avg_InstitutesInvolved_Patent","nPatent_singleInventor","n_Patents_CoAff","n_Jurisdiction_distinct","nJurisd_AU","nJurisd_CA","nJurisd_EP","nJurisd_IN","nJurisd_CN","nJurisd_US","nJurisd_DE","nJurisd_ES","nJurisd_IT","nJurisd_AT","nJurisd_BR","nJurisd_WO","nJurisd_JP","nJurisd_DK","nJurisd_IL","nJurisd_PT","nJurisd_PL","nJurisd_FR","nJurisd_SA","nJurisd_MY","nJurisd_KR","nJurisd_NL","nJurisd_CO","nJurisd_SM","nJurisd_SI","nJurisd_HR","nJurisd_RU","nJurisd_EA","nJurisd_MX","nJurisd_HK","nPatentKC_A1","nPatentKC_A","nPatentKC_A2","nPatentKC_B1","nPatentKC_D1","nPatentKC_T3","nPatentKC_B2","nPatentKC_T1","nPatentKC_A3","nPatentKC_C","nPatentKC_B","nPatentKC_C2","nPatentKC_C0","nPatentKC_A8","nPatentKC_E","nPatentKC_T4","nPatentKC_D0","nPatentKC_T2","nPatentKC_A0","nPatentKC_B8","nPatentKC_A4","nPatentKC_T8","nPatentKC_C1","nPatentKC_U1","nPatentKC_T5","nPatentKC_B3","nPatentKC_T7","nPatentKC_A9","top_Inventor names_Patent","top_Inventor names_Patent_n","top_Original assignee names_Patent","top_Original assignee names_Patent_n","top_Fields of Research (ANZSRC 2020)_Patent","top_Fields of Research (ANZSRC 2020)_Patent_n","top_RCDC Categories_Patent","top_RCDC Categories_Patent_n","top_HRCS RAC Categories_Patent","top_HRCS RAC Categories_Patent_n","top_IPCR_Patent","top_IPCR_Patent_n","top_CPC_Patent","top_CPC_Patent_n","n_clTrial","avg_durationYear_clTrial","avg_participants_clTrial","clTrial_perAUIN_100","nClTrial_w_AltmScore","cl_AltmS_rel","avg_sponsor_clTrial","nclTrialPhase_Phase 1","nclTrialPhase_Phase 1/2","nclTrialPhase_Phase 2","nclTrialPhase_Phase 2/3","nclTrialPhase_Phase 3","nclTrialPhase_Phase 3/4","nclTrialPhase_Phase 4","nclTrialPhase_N/A","nclTrialPhase_Post Authorisation Studies","nclTrial_StudyType_Interventional","nclTrial_StudyType_Observational","nclTrial_StudyType_Other","nclTrial_StudyType_Expanded access","nclTrial_StudyType_Active surveillance","nclTrial_StudyType_Non-interventional","nclTrial_StudyType_RCT","nclTrial_StudyType_CCT","nclTrial_Gender_All","nclTrial_Gender_Female","nclTrial_Gender_Male","nclTrial_Registry_ClinicalTrials.gov","nclTrial_Registry_EU-CTR","nclTrial_Registry_ENCePP","nclTrial_Registry_ISRCTN","nclTrial_Registry_ANZCTR","nclTrial_Registry_GCTR","nclTrial_Registry_PACTR","nclTrial_Registry_CTRI","nclTrial_Registry_ReBEC","nclTrial_Registry_UMIN-CTR","top_funder_country","top_funder_country_n","top_Fields of Research (ANZSRC 2020)_clTrial","top_Fields of Research (ANZSRC 2020)_clTrial_n","top_RCDC Categories_clTrial","top_RCDC Categories_clTrial_n","top_HRCS HC Categories_clTrial","top_HRCS HC Categories_clTrial_n","top_HRCS RAC Categories_clTrial","top_HRCS RAC Categories_clTrial_n","top_Cancer Types_clTrial","top_Cancer Types_clTrial_n","top_CSO Categories_clTrial","top_CSO Categories_clTrial_n","n_grants","avg_funding_EUR","avg_funding_EUR_perOrganization","avg_durationYear_grant","avg_Organization_per_grant","avg_countries_per_grant","perc_grant_internationalColl","avg_ResultingPublications_per_grant","totFundingOrgbyActivedGrant","avgPubByActivedFundingGrant_1000","top_Research Organization - standardized_Grants","top_Research Organization - standardized_n_Grants","top_Funder_Grants","top_Funder_n_Grants","top_Funder Group_Grants","top_Funder Group_n_Grants","top_Program_Grants","top_Program_n_Grants","top_Fields of Research (ANZSRC 2020)_Grants","top_Fields of Research (ANZSRC 2020)_n_Grants","top_RCDC Categories_Grants","top_RCDC Categories_n_Grants","top_HRCS HC Categories_Grants","top_HRCS HC Categories_n_Grants","top_HRCS RAC Categories_Grants","top_HRCS RAC Categories_n_Grants","top_Cancer Types_Grants","top_Cancer Types_n_Grants","top_CSO Categories_Grants","top_CSO Categories_n_Grants","top_Units of Assessment_Grants","top_Units of Assessment_n_Grants","top_Sustainable Development Goals_Grants","top_Sustainable Development Goals_n_Grants","n_dataset","top_Repository_Dataset","top_Repository_Dataset_n","top_Fields of Research (ANZSRC 2020)_Dataset","top_Fields of Research (ANZSRC 2020)_Dataset_n","top_RCDC Categories_Dataset","top_RCDC Categories_Dataset_n","top_HRCS HC Categories_Dataset","top_HRCS HC Categories_Dataset_n","top_HRCS RAC Categories_Dataset","top_HRCS RAC Categories_Dataset_n","top_Health Research Areas_Dataset","top_Health Research Areas_Dataset_n","top_Broad Research Areas_Dataset","top_Broad Research Areas_Dataset_n","top_Cancer Types_Dataset","top_Cancer Types_Dataset_n","top_Sustainable Development Goals_Dataset","top_Sustainable Development Goals_Dataset_n"
"AOU_TORVERGATA",2000,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,"0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_TORVERGATA",2001,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,"0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0","0",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,0,31546,0,0,0,660,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,"Germany","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES","1;1","AGING;CARDIOVASCULAR;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;HEART DISEASE;HEART DISEASE - CORONARY HEART DISEASE","1;1;1;1;1;1","CARDIOVASCULAR","1","6.1 PHARMACEUTICALS","1",NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_TORVERGATA",2002,9,6.11111111111111,1.66666666666667,0.777777777777778,0.222222222222222,0.666666666666667,1.07142857142857,0.875,0.666666666666667,0.857142857142857,0.333333333333333,0,3,1,1,3,0.33,0.11,0.11,0.33,25.78,0.467253585164927,NA,0.222222222222222,0.666666666666667,0.437,0.159,0.167,0.167,"TOMMASO CLAUDIO MINEO;EUGENIO POMPEO;SILVIA MINELLI;GABRIELE SERAFINI;ANNA MARIA NARDONE;MARIA RITA TALAMO;COMES MS;FEDERICA SANGIUOLO;ALBERTO NISINI;E FANUCCI;CHRISTIAN P. JONESCU-CUYPERS;EMANUELA M. BRUSCIA;CARLA FONTANA;CARTESIO FAVALLI;MONICA RAPINO;SALVATORE MASALA;MARIANGELA PIERANTOZZI;PAOLO MARIA ROSSINI;R. MIGLIARDI;ANTONELLA PEPPE","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","TOMMASO CLAUDIO MINEO;EUGENIO POMPEO;GABRIELE SERAFINI;MARIA RITA TALAMO;COMES MS;ALBERTO NISINI;E FANUCCI;SALVATORE MASALA;ETTORE SQUILLACI;ELSA COSSU;FIASCHETTI;MARCO TOMASSINI;GIOVANNI SIMONETTI;G SIMONETTI;SILVIA MINELLI;CHRISTIAN P. JONESCU-CUYPERS;CARLA FONTANA;CARTESIO FAVALLI;R. MIGLIARDI;A. YEE","1;1;0.17;0.17;0.17;0.17;0.17;0.17;0.17;0.17;0.17;0.17;0.17;0.17;0.14;0.14;0.14;0.14;0.14;0.14","TOMMASO CLAUDIO MINEO;EUGENIO POMPEO;SILVIA MINELLI;ANNA MARIA NARDONE;CARLA FONTANA;CARTESIO FAVALLI;MARIANGELA PIERANTOZZI;R. MIGLIARDI;ETTORE SQUILLACI;FRANCESCO GARACI;ELSA COSSU;MARIA GRAZIA MARCIANI;ANNA ANGELA CRISCUOLO;MARIA GIUSEPPINA PALMIERI","2;2;1;1;1;1;1;1;1;1;1;1;1;1","TOMMASO CLAUDIO MINEO;EUGENIO POMPEO;ETTORE SQUILLACI;ELSA COSSU;SILVIA MINELLI;CARLA FONTANA;CARTESIO FAVALLI;R. MIGLIARDI;ANNA ANGELA CRISCUOLO;ANNA MARIA NARDONE;FRANCESCO GARACI;MARIANGELA PIERANTOZZI;MARIA GRAZIA MARCIANI;MARIA GIUSEPPINA PALMIERI","1;1;0.17;0.17;0.14;0.14;0.14;0.14;0.14;0.12;0.12;0.11;0.11;0.11","ALBERTO GALANTE;ANNA ANGELA CRISCUOLO;ANTONIO PIETROIUSTI;CARLA FONTANA;CARTESIO FAVALLI;MARCO FAVARO;SILVIA MINELLI;ALESSANDRO STEFANI;ANTONELLA PEPPE;MARIA GIUSEPPINA PALMIERI;MARIA GRAZIA MARCIANI;MARIANGELA PIERANTOZZI;P. MAZZONE;PAOLO MARIA ROSSINI;PAOLO STANZIONE;PATRIZIA GIACOMINI;ANNA MARIA NARDONE;ANNALUCIA SERAFINO;DIETER C. GRUENERT;E. BONIFAZI","81;81;81;81;81;81;81;74;74;74;74;74;74;74;74;74;41;41;41;41","ANNA ANGELA CRISCUOLO;CARLA FONTANA;CARTESIO FAVALLI;SILVIA MINELLI;MARIA GIUSEPPINA PALMIERI;MARIA GRAZIA MARCIANI;MARIANGELA PIERANTOZZI;ANNA MARIA NARDONE;TOMMASO CLAUDIO MINEO;EUGENIO POMPEO;FRANCESCO GARACI;ETTORE SQUILLACI;ELSA COSSU;R. MIGLIARDI","81;81;81;81;74;74;74;41;20;19;11;5;0;0","TOMMASO CLAUDIO MINEO;ANNA ANGELA CRISCUOLO;ANNA MARIA NARDONE;CARLA FONTANA;CARTESIO FAVALLI;ETTORE SQUILLACI;EUGENIO POMPEO;FRANCESCO GARACI;MARIA GIUSEPPINA PALMIERI;MARIA GRAZIA MARCIANI;MARIANGELA PIERANTOZZI;SILVIA MINELLI;ELSA COSSU;R. MIGLIARDI","2;1;1;1;1;1;1;1;1;1;1;1;0;0","MEDICINE;BIOLOGY;MATHEMATICS;PHYSICS;CHEMISTRY;ECONOMICS;GEOLOGY;PSYCHOLOGY","6;4;3;3;1;1;1;1","GENETICS;INTERNAL MEDICINE;SURGERY;CELL BIOLOGY;GEOMETRY;MOLECULAR BIOLOGY;ANESTHESIA;BIOCHEMISTRY;CANCER RESEARCH;ECOLOGY;INTENSIVE CARE MEDICINE;MATHEMATICAL ECONOMICS;MICROBIOLOGY;NEUROSCIENCE;NUCLEAR MEDICINE;NUCLEAR PHYSICS;NURSING;ONCOLOGY;OPHTHALMOLOGY;OPTICS;OPTOMETRY;PALEONTOLOGY;PHYSICAL THERAPY;PSYCHIATRY;QUANTUM MECHANICS;RADIOLOGY;STATISTICS","3;3;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","GENE;REDUCTION (MATHEMATICS);ABDOMEN;ANTIBIOTICS;AORTA;APOPTOSIS;BLOOD FLOW;CANCER;CELL CULTURE;CENTRAL NERVOUS SYSTEM;CONTRAST MEDIUM;DISEASE;DNA;DOPAMINE;FUNDUS (UTERUS);HELICOBACTER PYLORI;IRRADIATION;KINASE;LASER;LUNG;NEUROLOGY;OUTCOME (GAME THEORY);PULMONARY FUNCTION TESTING;QUALITY OF LIFE (HEALTHCARE);RANDOMIZED CONTROLLED TRIAL;REHABILITATION;REPRODUCIBILITY;SIGNAL TRANSDUCTION;STAGE (STRATIGRAPHY);STIMULATION;TERM (TIME);TRUNK","3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ABDOMINAL AORTA;AORTIC BIFURCATION;BASAL GANGLIA;BREAST CANCER;CHROMOSOMAL TRANSLOCATION;CLARITHROMYCIN;CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;DOPAMINERGIC;GENE ISOFORM;IONIZING RADIATION;LASER THERAPY;LUNG VOLUMES;MINIMUM INHIBITORY CONCENTRATION;MUTATION;NEURORADIOLOGY;PARKINSON'S DISEASE;PNEUMONECTOMY;PROTEIN KINASE C;PULMONARY REHABILITATION;RADIORESISTANCE;RIBOSOMAL RNA;RNA;TRANSCRANIAL MAGNETIC STIMULATION;TRANSFECTION","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","AGAR DILUTION;APOMORPHINE;DEEP BRAIN STIMULATION;GLOBUS PALLIDUS;LEVODOPA;LUNG VOLUME REDUCTION SURGERY;MAMMOGRAPHY;RIBOSOME","1;1;1;1;1;1;1;1","PULMONARY EMPHYSEMA;HUMANS;HELICOBACTER PYLORI;LUNG;PARKINSON DISEASE;BREAST NEOPLASMS;FORCED EXPIRATORY VOLUME;LEUKEMIA, ERYTHROBLASTIC, ACUTE;MAGNETIC RESONANCE IMAGING;MIDDLE AGED;PNEUMONECTOMY;PULMONARY SURGICAL PROCEDURES;RNA, RIBOSOMAL, 23S;;ABDOMEN;ANTIPARKINSON AGENTS;AORTA, ABDOMINAL;APOMORPHINE;BASAL GANGLIA;BREAST","7;6;4;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2","DIAGNOSIS AND MANAGEMENT OF PLEURAL DISEASES;BREAST MAGNETIC RESONANCE IMAGING IN ONCOLOGY;DEEP BRAIN STIMULATION FOR NEUROLOGICAL DISORDERS;EFFECTS OF LASER RADIATION ON OCULAR HEALTH;HELICOBACTER PYLORI INFECTION AND GASTRIC CANCER;MAGNETIC RESONANCE IMAGING APPLICATIONS IN MEDICINE;MECHANISMS AND APPLICATIONS OF RNA INTERFERENCE;MOLECULAR MECHANISMS OF APOPTOSIS AND CELL DEATH","2;1;1;1;1;1;1;1","DYNAMIC CONTRAST-ENHANCED MRI;PERFUSION IMAGING;23S RIBOSOMAL RNA;ABDOMINAL AORTA;AGAR DILUTION;AORTIC BIFURCATION;APOMORPHINE;BREAST MRI;CALCIUM SIGNALING;CARDIOVASCULAR MRI;CELL MIGRATION;CELL REGULATION;DEEP BRAIN STIMULATION;DIAGNOSTIC ACCURACY;EMPHYSEMA;FUNCTIONAL MRI;FUNDUS (UTERUS);GENE THERAPY;HELICOBACTER PYLORI;NEUROMODULATION","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","REDUCTION PNEUMOPLASTY;ABDOMINAL VASCULAR;APOMORPHINE EFFECTS;BILATERAL THORACOSCOPIC;BRAIN STIMULATION;BREAST MRI;CELL LINES;CLARITHROMYCIN RESISTANCE;CLINICAL ISOLATES;CONTRAST MEDIA;CYSTIC FIBROSIS;DEBATE AWAIT;DEEP BRAIN;DIGITAL FUNDUS;DISEASE PARALLELING;EPITHELIAL CELL;ERYTHROLEUKEMIA CELLS;FIBROSIS EPITHELIAL;FRAGMENT HOMOLOGOUS;FRIEND ERYTHROLEUKEMIA;FUNDUS OXYMETER;GLOBUS PALLIDUS;HOMOLOGOUS REPLACEMENT;IHELICOBACTER PYLORII;INTERNAL GLOBUS;INTRACORTICAL INHIBITION;LONG-TERM OUTCOME;MAGNETIC STIMULATION;MULTIDETECTOR CT;NEAT SENTENCE","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","REDUCTION PNEUMOPLASTY;ONE-STAGE BILATERAL;BILATERAL REDUCTION;BIOPSY SPECIMENS;GENE TARGETING;PCR PRODUCT;PEAK IMPROVEMENTS;RRNA GENE;SFHR-MEDIATED GENE;UNILATERAL REDUCTION;ABSTRACT RESISTANCE;AGAR DILUTION;AIRWAY EPITHELIAL;ASYMMETRIC EMPHYSEMA;AVERAGED MONTHS;BASELINE DATA;BILATERAL THORACOSCOPIC;BILATERAL TREATMENT;BILATERAL TREATMENTFIFTY-NINE;BP PCR;CAPACITY FVC;CATIONIC LIPID-FACILITATED;CELL LINE;CELL LINES;CELLULAR DNA;CELLULAR FACTORS;CELLULAR PROCESSING;CF TRANSMEMBRANE;CFTR DNA;CHARACTERIZE GENE","6;4;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,6.5,486,14.29,0,0,56,0,0,0,0,2,0,0,0,0,2,0,0,0,0,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,0,"Belgium;Israel","1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS","2;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;HEMATOLOGY;CANCER;INFECTIOUS DISEASES;ORPHAN DRUG;PATIENT SAFETY;RARE DISEASES;SEPSIS","2;2;2;1;1;1;1;1;1","CANCER;INFECTION;INFLAMMATORY AND IMMUNE SYSTEM","1;1;1","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS","2;1","LEUKEMIA / LEUKAEMIA","1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_TORVERGATA",2003,11,5.90909090909091,3.54545454545455,0.818181818181818,0.636363636363636,0.818181818181818,1.14705882352941,1,1,1,0.363636363636364,0,4,2,2,3,0.36,0.18,0.18,0.27,31.36,0.592572827341254,NA,0.181818181818182,0.636363636363636,0.269,0.15,0.119,0.15,"VINCENZO AMBROGI;TOMMASO LUPATTELLI;FRANCESCO GARACI;TOMMASO CLAUDIO MINEO;STEFANO ELIA;EUGENIO POMPEO;D BACARO;G. SIMONETTI;LUCA BIANCHI;CESARE CATANANTI;MARIA CRISTINA GAGLIARDI;GUGLIELMO MANENTI;FRANCESCA IZZI;ELENA GALLI;NADIA SABATINI;ANDREA ROMIGI;UGO LUIGI APARO;MARIA SOLE CHIMENTI;E BOLLERO;CARLA FONTANA","2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","TOMMASO LUPATTELLI;VINCENZO AMBROGI;TOMMASO CLAUDIO MINEO;STEFANO ELIA;EUGENIO POMPEO;FRANCESCO GARACI;D BACARO;G. SIMONETTI;F. M. SOLIVETTI;CHELSEA HOPKINS;A. DI LUCA SIDOZZI;FRANCESCO GARACI;PIETRO CECCONI;CESARE CATANANTI;GUGLIELMO MANENTI;UGO LUIGI APARO;E BOLLERO;ARMANDO MUZZI;AUGUSTO PANÀ;G. R. PISTOLESE","0.45;0.37;0.37;0.37;0.37;0.34;0.25;0.25;0.25;0.25;0.25;0.25;0.25;0.2;0.2;0.2;0.2;0.2;0.2;0.2","VINCENZO AMBROGI;TOMMASO LUPATTELLI;FRANCESCO GARACI;TOMMASO CLAUDIO MINEO;STEFANO ELIA;EUGENIO POMPEO;G. SIMONETTI;MARIA CRISTINA GAGLIARDI;GUGLIELMO MANENTI;FRANCESCA IZZI;ELENA GALLI;ANDREA ROMIGI;E BOLLERO;CARLA FONTANA;CARTESIO FAVALLI;CRISTOFORO SILVESTRI;E DE DOMINICIS;F. M. SOLIVETTI;DAVIDE MINEO;MARIA GRAZIA MARCIANI","2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","TOMMASO LUPATTELLI;VINCENZO AMBROGI;TOMMASO CLAUDIO MINEO;STEFANO ELIA;EUGENIO POMPEO;FRANCESCO GARACI;G. SIMONETTI;F. M. SOLIVETTI;FRANCESCO GARACI;GUGLIELMO MANENTI;E BOLLERO;GIOVANNI SIMONETTI;CARLA FONTANA;CARTESIO FAVALLI;E DE DOMINICIS;DAVIDE MINEO;ELENA CAMPIONE;MARIA CRISTINA GAGLIARDI;ELENA GALLI;PAOLO ROSSI","0.45;0.37;0.37;0.37;0.37;0.34;0.25;0.25;0.25;0.2;0.2;0.2;0.17;0.17;0.17;0.17;0.17;0.14;0.14;0.14","EUGENIO POMPEO;STEFANO ELIA;TOMMASO CLAUDIO MINEO;VINCENZO AMBROGI;G. R. PISTOLESE;ANNA MARIA CARROZZO;ANTONIO COSTANZO;ELENA CAMPIONE;GEORGIANA CLARE MARULLI;LUCA BIANCHI;MARIA SOLE CHIMENTI;FRANCESCO GARACI;ALBERTO GALANTE;ANTONIO PIETROIUSTI;CARLA FONTANA;CARTESIO FAVALLI;ENRICO SALVATORE PISTOIA;MARCO FAVARO;TOMMASO LUPATTELLI;DAVIDE MINEO","123;123;123;123;89;79;79;79;79;79;79;70;50;50;50;50;50;50;45;34","EUGENIO POMPEO;STEFANO ELIA;TOMMASO CLAUDIO MINEO;ELENA CAMPIONE;FRANCESCO GARACI;CARLA FONTANA;CARTESIO FAVALLI;TOMMASO LUPATTELLI;DAVIDE MINEO;E DE DOMINICIS;VINCENZO AMBROGI;GIOVANNI SIMONETTI;GUGLIELMO MANENTI;F. M. SOLIVETTI;G. SIMONETTI;CARLO DI STANISLAO;CIRA FUNDARÒ;ELENA GALLI;F ANGÉLINI;L. DI BERNARDINO","123;123;123;79;70;50;50;45;34;34;34;32;32;21;13;2;2;2;2;2","FRANCESCO GARACI;EUGENIO POMPEO;STEFANO ELIA;TOMMASO CLAUDIO MINEO;TOMMASO LUPATTELLI;CARLA FONTANA;CARLO DI STANISLAO;CARTESIO FAVALLI;CIRA FUNDARÒ;DAVIDE MINEO;E DE DOMINICIS;ELENA CAMPIONE;ELENA GALLI;F ANGÉLINI;F. M. SOLIVETTI;G. SIMONETTI;GIOVANNI SIMONETTI;GUGLIELMO MANENTI;L. DI BERNARDINO;MARIA CRISTINA GAGLIARDI","3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;COMPUTER SCIENCE;PHYSICS;PSYCHOLOGY","9;4;2;2;2;1","INTERNAL MEDICINE;SURGERY;IMMUNOLOGY;RADIOLOGY;BIOCHEMISTRY;CARDIOLOGY;PALEONTOLOGY;PATHOLOGY;ARTIFICIAL INTELLIGENCE;AUDIOLOGY;CANCER RESEARCH;CELL BIOLOGY;DERMATOLOGY;ENVIRONMENTAL HEALTH;GENETICS;MICROBIOLOGY;NEUROSCIENCE;NUCLEAR PHYSICS;NURSING;PHARMACOLOGY;PROGRAMMING LANGUAGE;QUANTUM MECHANICS","5;4;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ANEURYSM;GENE;IMMUNE SYSTEM;LUNG CANCER;STAGE (STRATIGRAPHY);ADIPOSE TISSUE;ANGIOGRAPHY;ANTIBIOTICS;ANTIBODY;APOPTOSIS;ARTERIOVENOUS FISTULA;ATROPHY;BETA (PROGRAMMING LANGUAGE);BIOPSY;CARDIAC SURGERY;CARDIOTHORACIC SURGERY;CAROTID ARTERIES;COMORBIDITY;CONTRAST (VISION);CORONARY ARTERY DISEASE;DOSE;DRUG;DYSPLASIA;ELECTROENCEPHALOGRAPHY;EMBOLIZATION;ENZYME;EPIDEMIOLOGY;EPILEPSY;FISTULA;HELICOBACTER PYLORI;INTERNAL CAROTID ARTERY;IRRADIATION;KIDNEY;KINASE;LUNG;MALIGNANCY;PERCUTANEOUS;PULMONARY FUNCTION TESTING;QUALITY OF LIFE (HEALTHCARE);RESECTION;SIGNAL TRANSDUCTION;SOFT TISSUE;STENT;TERM (TIME);TOXIC EPIDERMAL NECROLYSIS;TOXICITY;ULTRASOUND","2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ABDOMINAL AORTIC ANEURYSM;ANTIBIOTIC RESISTANCE;CLARITHROMYCIN;CORTICAL DYSPLASIA;DIGITAL SUBTRACTION ANGIOGRAPHY;ENDOVASCULAR TREATMENT;GENE EXPRESSION;GLUCURONIDASE;IMMUNOTHERAPY;INTRAVENOUS IMMUNOGLOBULIN THERAPY;IONIZING RADIATION;K562 CELLS;LUNG VOLUMES;MUTATION;NEPHRECTOMY;PARTIAL EPILEPSY;PARTIAL SEIZURES;PNEUMONECTOMY;PROGRAMMED CELL DEATH;PROTEIN KINASE C;PSEUDOANEURYSM;RNA;T CELL;VASCULAR SURGERY;WEDGE RESECTION","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","BETA-GLUCURONIDASE;CASPASE;JURKAT CELLS;LUNG VOLUME REDUCTION SURGERY;POINT MUTATION;RIBOSOME","1;1;1;1;1;1","HUMANS;CARCINOMA, NON-SMALL-CELL LUNG;LUNG NEOPLASMS;MALE;ADULT;FEMALE;MEDICAL ERRORS;PULMONARY EMPHYSEMA;ARTERIOVENOUS FISTULA;EPILEPSIES, PARTIAL;FIBROMA;INTELLECTUAL DISABILITY;STEVENS-JOHNSON SYNDROME;AGED;APOPTOSIS;CAROTID-CAVERNOUS SINUS FISTULA;CASPASES;CELL NUCLEUS;CELL SURVIVAL;CONJUNCTIVITIS, ALLERGIC","10;8;8;6;5;5;5;5;4;4;4;4;4;3;3;3;3;3;3;3","DIAGNOSIS AND TREATMENT OF LUNG CANCER;CLINICOPATHOLOGY OF FIBROUS TUMORS AND TREATMENT STRATEGIES;DIAGNOSIS AND MANAGEMENT OF HEREDITARY HEMORRHAGIC TELANGIECTASIA;EPIDEMIOLOGY AND MANAGEMENT OF CYTOMEGALOVIRUS INFECTION;HELICOBACTER PYLORI INFECTION AND GASTRIC CANCER;HYPERSENSITIVITY REACTIONS TO DRUGS AND MEDICATIONS;MAGNETIC RESONANCE IMAGING APPLICATIONS IN MEDICINE;MEDICAL EQUIPMENT MAINTENANCE AND MANAGEMENT;NF-?B SIGNALING IN INFLAMMATION AND CANCER;PATHOPHYSIOLOGY AND MANAGEMENT OF CEREBRAL ANEURYSMS","2;1;1;1;1;1;1;1;1;1","NON-SMALL CELL LUNG CANCER;23S RIBOSOMAL RNA;ANEURYSM SCREENING;ANTIBIOTIC RESISTANCE;ANTIGEN PRESENTATION;APOPTOSIS;BETA (PROGRAMMING LANGUAGE);BETA-GLUCURONIDASE;CARDIAC IMAGING;CARDIAC MYXOMAS;CARDIOTHORACIC SURGERY;CAROTID ARTERY STENOSIS;CLINICAL PRACTICE GUIDELINES;CORTICAL PARCELLATION;DIGITAL SUBTRACTION ANGIOGRAPHY;DOSE;EMBOLIZATION;GLUCURONIDASE;INCIDENCE OF ADVERSE EVENTS;INTRACRANIAL ANEURYSMS","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","LUNG CANCER;ACTIVATION PLAYS;ANTIAPOPTOTIC ROLE;ARTERIOVENOUS FISTULA;ARTERY PSEUDOANEURYSM;ATROPHY MENTAL;BETA GLUCURONIDASE;CARDIOVASCULAR COMORBIDITY;CAROTID ARTERY;CELLS EXPOSED;CLARITHROMYCIN-RESISTANT IHELICOBACTER;COMBINED SURGERY;CONTRAST DSC;CORTICAL DYSPLASIA;COVERED STENT;DORSI ULTRASOUND;DRUG REACTIONS;DSC MRI;DYNAMIC SUSCEPTIBILITY;DYSMORPHIC FACIES;DYSPLASIA TEMPORAL;ELASTOFIBROMA DORSI;EPIDERMAL NECROLYSIS;FISTULA TREATED;GENETIC SYNDROME;GIANT HIGH-FLOW;GLUCURONIDASE SHORTTERM;HIGH-DOSE INTRAVENOUS;HIGH-FLOW RENAL;HUMAN LEUKEMIC","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","LUNG CANCER;CARDIOVASCULAR DISEASE;CLARITHROMYCIN RESISTANCE;CARDIOVASCULAR COMORBIDITY;VASCULAR DISEASE;CANCER NSCLC;COMBINED SURGERY;GIANT RENAL;LONG-TERM QUALITY;MAJOR RESECTIONS;MBO II;MEDIAN INTERVAL;MULTIFOCAL VASCULAR;MULTIVARIATE ANALYSIS;PATIENTS UNDERGONE;PCR PRODUCTS;RENAL ARTERIOVENOUS;SEVERE EMPHYSEMA;STOOL SAMPLES;TAILORED COMBINED;THORACIC PROCEDURE;UNDERGONE SURGERY;VASCULAR SURGERY;ABDOMINAL AORTIC;ACTUARIAL -YEAR;ADVISABLE PREVIOUS;ADVOCATED THERAPY;AFFECT SURVIVAL;AG MBO;ALLOWING SCREENING","6;5;4;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1",1,0.09,9,3,0,0,0,0,3,0,0,3,0,0,0,0,0,0,0,0,0,0,0,27,27,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_TORVERGATA",2004,26,6.5,3.5,0.692307692307692,0.423076923076923,0.692307692307692,1.26388888888889,1.2,1,1.2,0.384615384615385,2,13,2,6,4,0.5,0.08,0.23,0.15,42,0.892598830872881,NA,0.115384615384615,0.692307692307692,0.414,0.31,0.167,0.307,"TOMMASO CLAUDIO MINEO;MARCO CIOTTI;PIERPAOLO PABA;G SPLENDIANI;EUGENIO POMPEO;VINCENZO AMBROGI;CLAUDIO CORTESE;ANTONIO ORLACCHIO;GIORGIO BERNARDI;MARIA SOLE CHIMENTI;SARA DOMINIJANNI;CARTESIO FAVALLI;MARIANGELA PIERANTOZZI;KARÍ SYRJÄNEN;SILVIA CIPRIANI;AUGUSTO ORLANDI;ANTONIO COSTANZO;PAOLA ROGLIANI;PAOLO STANZIONE;DAVIDE MINEO","5;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","TOMMASO CLAUDIO MINEO;ANTONIO ORLACCHIO;SABRINA FERRI;EUGENIO POMPEO;VINCENZO AMBROGI;DANIELE BOVA;ISABELLA MASTROBUONO;MARIA SOLE CHIMENTI;ANTONIO COSTANZO;PAOLA ROGLIANI;DAVIDE MINEO;CLAUDIA GRAGNOLI;GUIDO MENZINGER VON PREUSSENTHAL;JOEL F. HABENER;GIUSEPPE NOVELLI;GIOVANNI SIMONETTI;G SPLENDIANI;MARCO CIOTTI;PIERPAOLO PABA;ROSITA SARACENO","1.51;1.12;1;0.87;0.64;0.5;0.5;0.39;0.39;0.37;0.37;0.33;0.33;0.33;0.32;0.32;0.32;0.29;0.29;0.25","TOMMASO CLAUDIO MINEO;MARCO CIOTTI;PIERPAOLO PABA;G SPLENDIANI;EUGENIO POMPEO;VINCENZO AMBROGI;CLAUDIO CORTESE;ANTONIO ORLACCHIO;GIORGIO BERNARDI;MARIA SOLE CHIMENTI;CARTESIO FAVALLI;MARIANGELA PIERANTOZZI;AUGUSTO ORLANDI;ANTONIO COSTANZO;PAOLA ROGLIANI;PAOLO STANZIONE;DAVIDE MINEO;MARIA GRAZIA MARCIANI;GIORGIO FEDERICI;GIUSEPPE NOVELLI","5;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","TOMMASO CLAUDIO MINEO;ANTONIO ORLACCHIO;SABRINA FERRI;EUGENIO POMPEO;VINCENZO AMBROGI;ISABELLA MASTROBUONO;MARIA SOLE CHIMENTI;ANTONIO COSTANZO;PAOLA ROGLIANI;DAVIDE MINEO;CLAUDIA GRAGNOLI;GUIDO MENZINGER VON PREUSSENTHAL;GIUSEPPE NOVELLI;GIOVANNI SIMONETTI;G SPLENDIANI;MARCO CIOTTI;PIERPAOLO PABA;ROSITA SARACENO;S. NISTICÒ;GIORGIO BERNARDI","1.51;1.12;1;0.87;0.64;0.5;0.39;0.39;0.37;0.37;0.33;0.33;0.32;0.32;0.32;0.29;0.29;0.25;0.25;0.24","TOMMASO CLAUDIO MINEO;EUGENIO POMPEO;DAVIDE MINEO;PAOLA ROGLIANI;ALESSANDRO SABATO;VINCENZO AMBROGI;ALFONSO BALDI;BRUNO VINCENZI;CARLA RABITTI;GIUSEPPE TONINI;PATRIZIO BOLLERO;ANTONIO COSTANZO;MARIA SOLE CHIMENTI;MARIA GRAZIA MARCIANI;MARIANGELA PIERANTOZZI;PAOLO STANZIONE;AUGUSTO ORLANDI;GIORGIO BERNARDI;B DE VIVO;CATERINA EXACUSTOS","558;336;261;261;247;222;189;189;189;189;189;120;120;99;99;99;97;97;96;96","TOMMASO CLAUDIO MINEO;DAVIDE MINEO;PAOLA ROGLIANI;ALESSANDRO SABATO;VINCENZO AMBROGI;PATRIZIO BOLLERO;ANTONIO COSTANZO;MARIA SOLE CHIMENTI;MARIA GRAZIA MARCIANI;MARIANGELA PIERANTOZZI;PAOLO STANZIONE;AUGUSTO ORLANDI;GIORGIO BERNARDI;G SORRENTI;MARCO CIOTTI;EUGENIO POMPEO;ALESSANDRO STEFANI;ALESSIO GIORDANO;MARIA GIUSEPPINA PALMIERI;PIERPAOLO PABA","311;261;261;247;222;189;120;120;99;99;99;97;97;96;90;89;84;84;84;75","TOMMASO CLAUDIO MINEO;ANTONIO ORLACCHIO;GIORGIO BERNARDI;MARCO CIOTTI;ANTONIO COSTANZO;AUGUSTO ORLANDI;DAVIDE MINEO;EUGENIO POMPEO;GIUSEPPE NOVELLI;MARIA GRAZIA MARCIANI;MARIA SOLE CHIMENTI;MARIANGELA PIERANTOZZI;PAOLA ROGLIANI;PAOLO STANZIONE;PIERPAOLO PABA;VINCENZO AMBROGI;A. BENEDETTO;A. VEGA;ALESSANDRO MARTORANA;ALESSANDRO SABATO","4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1","MEDICINE;BIOLOGY;PHYSICS;BUSINESS;CHEMISTRY;PSYCHOLOGY;ECONOMICS;GEOGRAPHY;MATERIALS SCIENCE;POLITICAL SCIENCE","21;12;3;2;2;2;1;1;1;1","INTERNAL MEDICINE;GENETICS;SURGERY;PATHOLOGY;CANCER RESEARCH;NURSING;BIOCHEMISTRY;PALEONTOLOGY;CARDIOLOGY;DERMATOLOGY;ENDOCRINOLOGY;ENVIRONMENTAL HEALTH;IMMUNOLOGY;ONCOLOGY;PSYCHIATRY;RADIOLOGY;ANATOMY;ANESTHESIA;ASTROPHYSICS;AUDIOLOGY;BIOTECHNOLOGY;CELL BIOLOGY;CHROMATOGRAPHY;ECONOMIC GROWTH;FAMILY MEDICINE;GASTROENTEROLOGY;GYNECOLOGY;INTENSIVE CARE MEDICINE;LAW;METALLURGY;MOLECULAR BIOLOGY;NEUROSCIENCE;NUCLEAR MEDICINE;NUCLEAR PHYSICS;OBSTETRICS;OPTICS;ORGANIC CHEMISTRY;PHYSICAL THERAPY;RISK ANALYSIS (ENGINEERING);VIROLOGY","16;9;7;5;4;4;3;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","GENE;DISEASE;CANCER;QUALITY OF LIFE (HEALTHCARE);ADVERSE EFFECT;STAGE (STRATIGRAPHY);APOPTOSIS;DIABETES MELLITUS;DYSPHAGIA;ESOPHAGUS;HUMAN PAPILLOMAVIRUS;KIDNEY;REGURGITATION (CIRCULATION);TRANSPLANTATION;VIRUS;ACNE;ANGIOGENESIS;ANGIOGRAPHY;AORTA;APNEA;BASAL CELL;BIOPSY;CARTRIDGE;CHARCOAL;CHEMOTHERAPY;COGNITION;COMPUTED TOMOGRAPHY;CREATININE;CYSTIC FIBROSIS;DISCONTINUATION;DNA;DONATION;DOPAMINE;ENDOMETRIOSIS;EPIDEMIOLOGY;HEALTH CARE;HOMOCYSTEINE;HORMONE;IMMUNE SYSTEM;IMMUNOHISTOCHEMISTRY;IN VIVO;INFERIOR VENA CAVA;INSOMNIA;INTRACELLULAR;IRRADIATION;KINASE;LASER;LESION;LUNG;LUNG CANCER;LYMPHOMA;MODAFINIL;MONOCHROMATIC COLOR;MULTIVARIATE ANALYSIS;MYOTONIC DYSTROPHY;NEUROLOGY;ODDS RATIO;PELVIC PAIN;POPULATION;PSORIASIS;PULMONARY EMBOLISM;RADIATION THERAPY;REFERRAL;RENAL FUNCTION;RESECTION;STEM CELL;STIMULATION;THORACOSCOPY;THORAX (INSECT ANATOMY);TREADMILL;VARIATION (ASTRONOMY);VEGF RECEPTORS;VISUAL ANALOGUE SCALE;VITAMIN;VITAMIN B12","8;5;4;4;3;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","GENOTYPE;ALLELE;ALZHEIMER'S DISEASE;GENE EXPRESSION;ACHALASIA;CERVICAL CANCER;KIDNEY TRANSPLANTATION;BASAL CELL CARCINOMA;CD31;CD34;CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;DEMENTIA;DIGITAL SUBTRACTION ANGIOGRAPHY;DNA DAMAGE;DOPAMINERGIC;EPIDEMIOLOGICAL TRANSITION;ESCHERICHIA COLI;ESOPHAGEAL CANCER;ETOPOSIDE;EXCIMER;EXON;GENETIC VARIATION;HUMAN GENETICS;INTRON;IONIZING RADIATION;ISOTRETINOIN;LIVER TRANSPLANTATION;LUNG FUNCTION;LUNG VOLUMES;MAPK/ERK PATHWAY;MEGAESOPHAGUS;METHYLATION;MUTATION;MYCOSIS FUNGOIDES;NEPHROPATHY;NEUROPSYCHOLOGY;NEURORADIOLOGY;ORGAN DONATION;ORGAN TRANSPLANTATION;PARKINSON'S DISEASE;PHENOTYPE;PNEUMONECTOMY;POLYSOMNOGRAPHY;PROGRAMMED CELL DEATH;PROLACTIN;PROSTATE;PROSTATE CANCER;REFLUX;RETINOIC ACID;SLEEP DISORDER;SOLITARY PULMONARY NODULE;SOMNOLENCE;T CELL;TAZAROTENE;THORACIC AORTA;TOLERABILITY;TRANSCRANIAL MAGNETIC STIMULATION;TYPE 2 DIABETES MELLITUS;UNIVARIATE ANALYSIS;VASCULAR ENDOTHELIAL GROWTH FACTOR;VIREMIA","4;3;3;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","SINGLE-NUCLEOTIDE POLYMORPHISM;HAPLOTYPE;MYOTOMY;PRESENILIN;PROMOTER;BK VIRUS;CABERGOLINE;CASPASE;CERVICAL INTRAEPITHELIAL NEOPLASIA;COLPOSCOPY;DIFFUSING CAPACITY;DNA METHYLATION;DONEPEZIL;DOPAMINE AGONIST;ENDOGLIN;EPWORTH SLEEPINESS SCALE;ESOPHAGECTOMY;EXCESSIVE DAYTIME SLEEPINESS;FRONTOTEMPORAL DEMENTIA;GENETIC HETEROGENEITY;GSTP1;HFR CELL;JURKAT CELLS;KIDNEY DONATION;LUNG VOLUME REDUCTION SURGERY;MISSENSE MUTATION;PAPANICOLAOU STAIN;PCA3;PRAMIPEXOLE;RESTRICTION FRAGMENT LENGTH POLYMORPHISM;RETINOID;UNITED NETWORK FOR ORGAN SHARING","3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MIDDLE AGED;FEMALE;MALE;ADULT;AGED;TREATMENT OUTCOME;UTERINE CERVICAL NEOPLASMS;ESOPHAGEAL ACHALASIA;ITALY;PAPILLOMAVIRUS INFECTIONS;SKIN NEOPLASMS;THORACIC SURGERY, VIDEO-ASSISTED;TUMOR VIRUS INFECTIONS;BIOMARKERS, TUMOR;DNA;ENDOMETRIOSIS;MUTATION, MISSENSE;PNEUMONECTOMY;POSTOPERATIVE COMPLICATIONS","24;16;15;14;13;12;9;8;6;6;6;6;6;6;5;5;5;5;5;5","DIAGNOSIS AND MANAGEMENT OF GASTROESOPHAGEAL REFLUX DISEASE;HUMAN PAPILLOMAVIRUS AND CERVICAL CANCER EPIDEMIOLOGY;ANALYSIS OF GENE INTERACTION NETWORKS;CLASSIFICATION AND TREATMENT OF CUTANEOUS LYMPHOMAS;DIAGNOSIS AND MANAGEMENT OF ENDOMETRIOSIS;EFFECTS OF BRAIN STIMULATION ON MOTOR CORTEX;EPIDEMIOLOGY AND MANAGEMENT OF CONGENITAL HEART DISEASE;EPIDEMIOLOGY AND MANAGEMENT OF SKIN CANCER;EPIDEMIOLOGY AND PREVENTION OF CARDIOVASCULAR DISEASES IN RUSSIA;ETHICAL AND MEDICAL ASPECTS OF ORGAN DONATION;HEALTH SURVEYS IN GERMANY AND PUBLIC HEALTH RESEARCH;MANAGEMENT OF DIFFICULT AIRWAY IN ANESTHESIA PRACTICE;MOLECULAR MECHANISMS OF ANGIOGENESIS AND VASCULAR FUNCTION;MOLECULAR MECHANISMS OF APOPTOSIS AND CELL DEATH;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;PANCREATIC ISLET DYSFUNCTION AND REGENERATION;POLYOMAVIRUS-ASSOCIATED CARCINOGENESIS AND CLINICAL MANIFESTATIONS;PREDICTION OF PROTEIN SUBCELLULAR LOCALIZATION;ROLE OF GLUTATHIONE IN OXIDATIVE STRESS RESPONSE;ROLE OF HOMOCYSTEINE IN HEALTH AND DISEASE","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","GENETIC ASSOCIATION;NICASTRIN;SNP;ANTIFUNGAL THERAPY;APOPTOSIS;BASAL CELL CARCINOMA;BEXAROTENE TREATMENT;CABERGOLINE;CANCER CELL METABOLISM;CARTRIDGE;CD31;CFTR;CHARCOAL;CORTICAL EXCITABILITY;CPG SITE;CYSTIC FIBROSIS;CYTOLOGY SCREENING;DIGITAL SUBTRACTION ANGIOGRAPHY;DISCONTINUATION;DNA METHYLATION","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","PROMOTER REGION;ALZHEIMERS DISEASE;HUMAN PAPILLOMAVIRUS;NICASTRIN GENE;REGION POLYMORPHISMS;ABNORMAL PAP;ACHALASIC SIGMOID;ADD-BACK THERAPY;AFFECTED POPULATION;ALZHEIMER DEMENTIA;APOPTOGENIC FACTORS;AWAKE THORACOSCOPIC;BASAL CELL;CD CD;CD EXPRESSION;CELL CARCINOMA;CELL LUNG;CELLS EXPOSED;CENTRAL ITALY;CERVICAL CANCER;CERVICAL INTRAEPITHELIAL;CLINICOPATHOLOGICAL STUDY;COLPOSCOPY REFERRAL;COMBINED TREATMENT;COSTS CONSIDERATIONS;CPG ISLANDS;CYSTIC FIBROSIS;DAYTIME SOMNOLENCE;DETECTION RATE;DIABETES MELLITUS","3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","GNRH ANALOGUE;LUNG VOLUME;VOLUME REDUCTION;ADD-BACK THERAPY;EXPIRATORY VOLUME;FORCED EXPIRATORY;UNILATERAL LUNG;DISTINCT HETEROGENEITY;DOMAIN SCORE;FORM- QUALITY;FUNCTIONING DOMAIN;INCREMENTAL TREADMILL;MAXIMAL INCREMENTAL;NURSING CARE;PHYSICAL FUNCTIONING;RESIDUAL VOLUME;SHORT FORM-;TEST SCORE;TREADMILL TEST;LIFE QUESTIONNAIRE;MM HG;PATIENTS TREATED;ADVERSE EFFECTS;ARM ENTAILING;ASYMMETRIC RATIO;AWAKE THORACOSCOPIC;DENSITY LOSS;EPIDURAL ANESTHESIA;HOSPITAL STAY;HR HPV","14;10;10;9;8;8;8;6;6;6;6;6;6;6;6;6;6;6;6;5;5;5;4;4;4;4;4;4;4;4",6,0.23,3,2,0,0,0,0,5.75,0,2,2,0,0,0,0,2,0,0,0,0,0,0,36.25,36.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,2,213,4.41,1,0.33,24,1,0,0,1,0,0,1,0,0,3,0,0,0,0,0,0,0,3,0,0,3,0,0,0,0,0,0,0,0,0,"Italy;Belgium","2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3202 CLINICAL SCIENCES;3204 IMMUNOLOGY","3;2;1;1","CANCER;CLINICAL RESEARCH;ATHEROSCLEROSIS;BIOMEDICAL IMAGING;BIOTECHNOLOGY;CARDIOVASCULAR;CHILDHOOD LEUKEMIA;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;HEART DISEASE;HEART DISEASE - CORONARY HEART DISEASE;HEMATOLOGY;IMMUNIZATION;PEDIATRIC;PEDIATRIC CANCER;RARE DISEASES;VACCINE RELATED","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;CARDIOVASCULAR","2;1","6.1 PHARMACEUTICALS;3.4 VACCINES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS","2;1;1;1","LEUKEMIA / LEUKAEMIA;MELANOMA","1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT","2;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_TORVERGATA",2005,30,7.53333333333333,3.7,0.6,0.7,0.633333333333333,1.33734939759036,1.125,1.23529411764706,1.1875,0.533333333333333,0,18,4,4,2,0.6,0.13,0.13,0.07,49.23,0.929918133882968,NA,0.166666666666667,0.666666666666667,0.292,0.304,0.348,0.304,"CARTESIO FAVALLI;TOMMASO CLAUDIO MINEO;DAVIDE MINEO;GIORGIO FEDERICI;MARCO CIOTTI;LUIGI DI BONITO;ALESSANDRO STEFANI;A. BENEDETTO;ANTONINO BIROCCIO;VINCENZO AMBROGI;SERGIO BERNARDINI;D BONIFACIO;LUISA ACCARDI;ANTONIO ORLACCHIO;GIORGIO BERNARDI;CARLA FONTANA;STINA SYRJÄNEN;GIANLUCA VANNI;PAOLA DI BONITO;ENRICO SALVATORE PISTOIA","5;5;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2","TOMMASO CLAUDIO MINEO;DAVIDE MINEO;CARTESIO FAVALLI;EUGENIO POMPEO;GIORGIO FEDERICI;VINCENZO AMBROGI;CARLA FONTANA;GIANLUCA VANNI;ENRICO SALVATORE PISTOIA;MARCO FAVARO;ROBERTO FLORIS;FEDERICO TACCONI;ALESSANDRO STEFANI;MARCO CIOTTI;LUIGI DI BONITO;A. BENEDETTO;STEFANO FORLANI;RUGGERO DE PAULIS;MARIO FRANCESCO FRAIOLI;CHIARA FRAIOLI","1.03;0.7;0.65;0.5;0.4;0.37;0.37;0.37;0.37;0.37;0.35;0.33;0.33;0.28;0.28;0.28;0.25;0.25;0.25;0.25","CARTESIO FAVALLI;TOMMASO CLAUDIO MINEO;DAVIDE MINEO;GIORGIO FEDERICI;MARCO CIOTTI;ALESSANDRO STEFANI;A. BENEDETTO;ANTONINO BIROCCIO;VINCENZO AMBROGI;SERGIO BERNARDINI;ANTONIO ORLACCHIO;GIORGIO BERNARDI;CARLA FONTANA;GIANLUCA VANNI;ROBERTO FLORIS;EUGENIO POMPEO;SILVIA MINELLI;CLAUDIA GRAGNOLI;MARCO ANDREANI;M. SBRACIA","5;5;4;4;3;3;3;2;2;2;2;2;2;2;2;2;1;1;1;1","TOMMASO CLAUDIO MINEO;DAVIDE MINEO;CARTESIO FAVALLI;EUGENIO POMPEO;GIORGIO FEDERICI;VINCENZO AMBROGI;CARLA FONTANA;GIANLUCA VANNI;ROBERTO FLORIS;FEDERICO TACCONI;ALESSANDRO STEFANI;MARCO CIOTTI;A. BENEDETTO;STEFANO FORLANI;RUGGERO DE PAULIS;CHIARA FRAIOLI;LUIGI CHIARIELLO;RAFFAELE SCAFFA;ANTONINO BIROCCIO;SERGIO BERNARDINI","1.03;0.7;0.65;0.5;0.4;0.37;0.37;0.37;0.35;0.33;0.33;0.28;0.28;0.25;0.25;0.25;0.25;0.25;0.21;0.21","ALESSANDRO STEFANI;ANDRÉS M. LOZANO;ANTONELLA PEPPE;EUGENIO SCARNATI;PAOLO MAZZONE;PAOLO STANZIONE;SALVATORE GALATI;TOMMASO CLAUDIO MINEO;DAVIDE MINEO;CARTESIO FAVALLI;GIORGIO FEDERICI;ANDREA URBANI;SERGIO BERNARDINI;EUGENIO POMPEO;CARLA FONTANA;ENRICO SALVATORE PISTOIA;GUIDO LUCARELLI;JAVID GAZIEV;MARCO ANDREANI;MARCO FAVARO","502;411;411;411;411;411;411;258;252;180;168;145;112;104;101;101;101;101;101;101","ALESSANDRO STEFANI;TOMMASO CLAUDIO MINEO;DAVIDE MINEO;CARTESIO FAVALLI;GIORGIO FEDERICI;SERGIO BERNARDINI;EUGENIO POMPEO;CARLA FONTANA;GUIDO LUCARELLI;JAVID GAZIEV;MARCO ANDREANI;PAOLA POLCHI;PIETRO SODANI;ALESSANDRO SABATO;FREDERICO TACCONI;MARIO MARINO;ALESSANDRO MAURIELLO;DAVIDE LAURO;GIANLUCA GUGGINO;GIANLUCA VANNI","502;258;252;180;168;112;104;101;101;101;101;101;101;98;98;98;97;97;97;97","CARTESIO FAVALLI;TOMMASO CLAUDIO MINEO;DAVIDE MINEO;GIORGIO FEDERICI;ALESSANDRO STEFANI;A. BENEDETTO;MARCO CIOTTI;ANTONIO ORLACCHIO;CARLA FONTANA;EUGENIO POMPEO;GIAMPIERO PALMIERI;GIANLUCA GUGGINO;GIANLUCA VANNI;GIORGIO BERNARDI;ROBERTO FLORIS;SERGIO BERNARDINI;VINCENZO AMBROGI;ALESSANDRO MARTORANA;ALESSANDRO MAURIELLO;ALESSANDRO SABATO","5;5;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;PSYCHOLOGY;COMPUTER SCIENCE;ENGINEERING;MATERIALS SCIENCE;MATHEMATICS;PHYSICS","24;16;6;2;1;1;1;1;1","INTERNAL MEDICINE;GENETICS;SURGERY;PATHOLOGY;CANCER RESEARCH;BIOCHEMISTRY;ONCOLOGY;ENDOCRINOLOGY;MOLECULAR BIOLOGY;CHROMATOGRAPHY;GASTROENTEROLOGY;GYNECOLOGY;IMMUNOLOGY;RADIOLOGY;ANATOMY;ANESTHESIA;BOTANY;COMPUTATIONAL BIOLOGY;MICROBIOLOGY;NURSING;PEDIATRICS;UROLOGY","21;11;9;8;6;5;5;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2","GENE;CANCER;ENZYME;LUNG;CARDIOTHORACIC SURGERY;CEREBROSPINAL FLUID;CHEMOTHERAPY;DIABETES MELLITUS;DISEASE;IMMUNOHISTOCHEMISTRY;OSTEOPOROSIS;PNEUMOTHORAX;PREGNANCY;QUALITY OF LIFE (HEALTHCARE);ADIPOSE TISSUE;ADVERSE EFFECT;ALTERNATIVE MEDICINE;ANTIBODY;AORTA;AORTIC VALVE;APOPTOSIS;ATOPIC DERMATITIS;CARCINOMA;CARTRIDGE;CATALYSIS;CELL CULTURE;CEREBELLUM;CHLAMYDIA TRACHOMATIS;CLINICAL CHEMISTRY;CLINICAL MICROBIOLOGY;COPD;CORONAL PLANE;DEFORMITY;DIALYSIS;DIFFERENTIAL DIAGNOSIS;DISCONTINUATION;DNA;DOUBLE BOND;ENDOMETRIOSIS;ENDOMETRIUM;ETIOLOGY;FAMILY HISTORY;FATTY ACID;FIBRIN GLUE;FISTULA;FOLIC ACID;FRONTAL SINUS;GENUS;HEMODIALYSIS;HOMOCYSTEINE;HUMAN PAPILLOMAVIRUS;HYPERHIDROSIS;HYSTERECTOMY;IDENTIFICATION (BIOLOGY);IN VITRO;INFLAMMATION;IRRADIATION;LEUKEMIA;LYMPH NODE;MAGNETIC RESONANCE IMAGING;MASS SPECTROMETRY;MEMBRANE;MULTIVARIATE ANALYSIS;MYELOID LEUKEMIA;MYOTONIC DYSTROPHY;NEISSERIA GONORRHOEAE;NUCLEUS;OUTPATIENT CLINIC;PATHOGENESIS;PATIENT SATISFACTION;PELVIC PAIN;PERCUTANEOUS;PERIOPERATIVE;PHOSPHORYLATION;PRESENTATION (OBSTETRICS);PROPORTIONAL HAZARDS MODEL;PROTEOME;PULMONARY FUNCTION TESTING;RADIOGRAPHY;RECEPTOR;REDUCTION (MATHEMATICS);REGIMEN;REPRODUCIBILITY;SARCOMA;SKULL;SPASTICITY;STAGE (STRATIGRAPHY);STIMULATION;SYMPATHECTOMY;SYMPATHETIC TRUNK;THALASSEMIA;THORACOSCOPY;TIBIA;TRANSPLANTATION;TRUNK;UTERUS;VENTILATION (ARCHITECTURE);VIDEO-ASSISTED THORACOSCOPIC SURGERY;VIRUS;VISUAL ANALOGUE SCALE;VITAMIN;VITAMIN B12","9;7;3;3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CERVICAL CANCER;LUNG VOLUMES;ALLELE;BONE MINERAL;ETOPOSIDE;EXON;GENOTYPE;PROSTATE CANCER;SURVIVIN;16S RIBOSOMAL RNA;ADIPOGENESIS;ADJUVANT THERAPY;ALKALINE PHOSPHATASE;AORTIC ROOT;ARACHIDONIC ACID;BONE DENSITY;BREAST CANCER;CANCER CELL;CARCINOGENESIS;CELL CYCLE;CEREBROSPINAL FLUID LEAK;CHLAMYDIACEAE;CHROMOSOME;COGNITIVE IMPAIRMENT;CYTOKERATIN;DEMENTIA;DENTATE NUCLEUS;DNA SEQUENCING;ENDOMETRIAL CANCER;ENDOMETRIAL STROMAL SARCOMA;ESCHERICHIA COLI;FEMORAL NECK;FETUS;FIBULA;GENE EXPRESSION;GENE ISOFORM;GESTATION;HCCS;HEPATITIS B VIRUS;IMMUNOASSAY;INTRON;IONIZING RADIATION;ISOMERIZATION;K562 CELLS;LYMPHADENECTOMY;MASS SPECTROMETRY IMAGING;MEMBRANE FLUIDITY;MEMBRANE LIPIDS;MESSENGER RNA;METASTASIS;MUTATION;NEUROBLASTOMA;NUCLEOPHOSMIN;OCCULT;PARKINSON'S DISEASE;PEDUNCULOPONTINE TEGMENTAL NUCLEUS;PERIPHERAL NEUROPATHY;PHENOTYPE;PHYSIS;PLASMID;PNEUMONECTOMY;PROGRAMMED CELL DEATH;PROSTATE;PROTEIN KINASE B;PROTEOMICS;RIBOSOMAL RNA;RNA;SEROTONIN;SINUS (BOTANY);SYNGENIC;THORACOSTOMY;TOPOISOMERASE;TYPE 2 DIABETES;UNIVARIATE ANALYSIS;UNSATURATED FATTY ACID;WHITE MATTER","3;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","LUNG VOLUME REDUCTION SURGERY;CERVICAL INTRAEPITHELIAL NEOPLASIA;ALTERNATIVE SPLICING;BENTALL PROCEDURE;CERVICAL CARCINOMA;DEEP BRAIN STIMULATION;FUNCTIONAL RESIDUAL CAPACITY;GENETIC HETEROGENEITY;GESTATIONAL DIABETES;HEPADNAVIRIDAE;HEREDITARY SPASTIC PARAPLEGIA;HFR CELL;HPV INFECTION;INTRAEPITHELIAL NEOPLASIA;KARYOTYPE;MATURITY ONSET DIABETES OF THE YOUNG;MICROMETASTASIS;MISSENSE MUTATION;ONCOGENE;OSTEOCALCIN;PAPILLOMAVIRIDAE;PROBAND;PROSTATE DISEASE;PROSTATE-SPECIFIC ANTIGEN;RNA SPLICING;SEROTONERGIC;SINGLE-NUCLEOTIDE POLYMORPHISM;SUBSTANTIA NIGRA;TAMOXIFEN;TRINUCLEOTIDE REPEAT EXPANSION;UNTRANSLATED REGION;VASCULAR DEMENTIA","3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;MIDDLE AGED;ADULT;PNEUMONECTOMY;AGED;CELL DEATH;POSTOPERATIVE COMPLICATIONS;PULMONARY EMPHYSEMA;THALASSEMIA;;PROSTATIC NEOPLASMS;PROTEOME;TREATMENT OUTCOME;ALZHEIMER DISEASE;ANTINEOPLASTIC AGENTS, PHYTOGENIC;BONE MARROW TRANSPLANTATION;CARCINOMA, SQUAMOUS CELL;CEREBROSPINAL FLUID RHINORRHEA","23;14;14;9;8;7;6;6;6;6;6;5;5;5;5;4;4;4;4;4","HUMAN PAPILLOMAVIRUS AND CERVICAL CANCER EPIDEMIOLOGY;ACUTE MYELOID LEUKEMIA;CHOLANGIOCARCINOMA;DEEP BRAIN STIMULATION FOR NEUROLOGICAL DISORDERS;DIAGNOSIS AND MANAGEMENT OF AORTIC DISEASES;DIAGNOSIS AND MANAGEMENT OF ENDOMETRIOSIS;DIAGNOSIS AND MANAGEMENT OF PLEURAL DISEASES;ENDOSCOPIC SKULL BASE SURGERY TECHNIQUES;EPIDEMIOLOGY AND MANAGEMENT OF NEUROENDOCRINE TUMORS;ETIOLOGY AND MANAGEMENT OF ABDOMINAL WALL DEFECTS;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;GENETIC BASIS OF NEUROPATHIES AND RELATED DISORDERS;HUMAN T-CELL LEUKEMIA VIRUS TYPE 1 INFECTION;MASS SPECTROMETRY TECHNIQUES;MECHANICAL VENTILATION IN RESPIRATORY FAILURE AND ARDS;MECHANISMS OF ALZHEIMER'S DISEASE;MICROBIAL IDENTIFICATION AND DIAGNOSIS;MOLECULAR MECHANISMS OF APOPTOSIS AND CELL DEATH;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;NEUROBLASTOMA RESEARCH AND TREATMENT","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CARDIOTHORACIC SURGERY;PULMONARY DISEASE;SURVIVIN;ABDOMINAL WALL DEFECTS;ACUTE MYELOID LEUKEMIA;ADJUVANT THERAPY;AORTIC ROOT REPLACEMENT;BACTERIAL IDENTIFICATION;BENTALL PROCEDURE;CANCER;CANCER THERAPY;CARTRIDGE;CELL DEATH;CEREBROSPINAL FLUID LEAK;CEREBROSPINAL FLUID LEAKS;CERVICAL CANCER;CLINICAL MICROBIOLOGY;CYTOLOGY SCREENING;DEEP BRAIN STIMULATION;DENTATE NUCLEUS","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CERVICAL CANCER;CERVICAL INTRAEPITHELIAL;HIGH-RISK HUMAN;HUMAN PAPILLOMAVIRUS;INTRAEPITHELIAL NEOPLASIA;ITALIAN FAMILY;LUNG VOLUME;REDUCTION SURGERY;VIRUS CLEARANCE;VOLUME REDUCTION;ACTIVATED N-MYC;ACUTE MYELOID;ADD-BACK THERAPY;ADIPOSE TISSUE;ADIPOSE TISSUERELATED;AKT INCREASES;AMPLIFICATION ASSAY;ANALYTICAL ASSESSMENT;AORTIC VALVE;ATOPIC ECZEMADERMATITIS;AUTOMATED SYSTEMS;AWAKE NONRESECTIONAL;BACTERIAL ISOLATES;BILATERAL THORACOSCOPIC;BONE MARROW;BONE MINERAL;BREAST CANCER;CANCER CELLS;CANCER SCREENING;CARCINOID TUMORS","2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","GNRH ANALOGUE;ADD-BACK THERAPY;VOLUME-REDUCTION SURGERY;LUNG VOLUME;LUNG VOLUME-REDUCTION;REDUCTION SURGERY;VOLUME REDUCTION;ADVERSE EFFECTS;BMD LUMBAR;DENSITY LOSS;FAT-FREE MASS;ORAL CONTRACEPTIVE;ORAL STEROIDS;PATIENTS TREATED;RESPIRATORY REHABILITATION;SURVIVIN EXPRESSION;T-SCORE LUMBAR;BONE MINERAL;MINERAL DENSITY;OCCULT PNEUMOTHORAX;AWAKE VIDEO-ASSISTED;CERVICAL CANCER;CYANOACRYLATE GLUE;LATE COMPLICATIONS;LUMBAR FEMORAL;NUTRITIONAL STATUS;PATIENTS UNDERGOING;RESPIRATORY FUNCTION;SEVERE EMPHYSEMA;SIGNIFICANT IMPROVEMENT","18;13;10;9;9;9;9;6;6;6;6;6;6;6;6;6;6;5;5;5;4;4;4;4;4;4;4;4;4;4",9,0.3,3,2,0,0,0,0,12.25,1,0,3,0,0,1.5,1,2,0,1,1,1,0,0,42,42,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,8,1100,1.2,1,1,107,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,"Italy;United States","1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES","1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PATIENT SAFETY","1;1;1","CANCER","1","6.1 PHARMACEUTICALS","1","STOMACH CANCER","1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_TORVERGATA",2006,39,10.9230769230769,4.76923076923077,0.435897435897436,0.512820512820513,0.666666666666667,1.57627118644068,1.21428571428571,1.25,1.04,0.41025641025641,0,22,10,4,1,0.56,0.26,0.1,0.03,26.56,0.520067246492605,NA,0.333333333333333,0.846153846153846,0.394,0.431,0.256,0.381,"MARCO CIOTTI;LUISA ACCARDI;CARTESIO FAVALLI;PAOLA DI BONITO;LUIGI DI BONITO;A. BENEDETTO;COLOMBA GIORGI;KARÍ SYRJÄNEN;DONATELLA SANTINI;D BONIFACIO;LUCIANO MARIANI;M BRANCA;S COSTA;FRANCESCO BUCCISANO;STINA SYRJÄNEN;PIERPAOLO PABA;FRANCESCO LO‐COCO;MERJA RUUTU;EUGENIO POMPEO;PIERLUIGI PABA","11;8;8;8;8;8;8;7;7;6;6;5;5;4;4;4;4;4;4;4","MARCO CIOTTI;EUGENIO POMPEO;GIOVANNI SIMONETTI;CARTESIO FAVALLI;LUIGI DI BONITO;A. BENEDETTO;LUISA ACCARDI;PAOLA DI BONITO;COLOMBA GIORGI;TOMMASO CLAUDIO MINEO;KARÍ SYRJÄNEN;DONATELLA SANTINI;PIERPAOLO PABA;D BONIFACIO;ANTONIO ORLACCHIO;E FANUCCI;VALERIA FIASCHETTI;LUCIANO MARIANI;M BRANCA;S COSTA","0.95;0.77;0.77;0.63;0.63;0.63;0.55;0.55;0.55;0.52;0.49;0.47;0.44;0.4;0.4;0.4;0.4;0.4;0.34;0.34","MARCO CIOTTI;LUISA ACCARDI;CARTESIO FAVALLI;PAOLA DI BONITO;LUIGI DI BONITO;A. BENEDETTO;COLOMBA GIORGI;KARÍ SYRJÄNEN;DONATELLA SANTINI;D BONIFACIO;LUCIANO MARIANI;FRANCESCO BUCCISANO;STINA SYRJÄNEN;PIERPAOLO PABA;FRANCESCO LO‐COCO;MERJA RUUTU;EUGENIO POMPEO;PIERLUIGI PABA;GIOVANNI SIMONETTI;SERGIO BERNARDINI","11;8;8;8;8;8;8;7;7;6;6;4;4;4;4;4;4;4;4;3","MARCO CIOTTI;EUGENIO POMPEO;GIOVANNI SIMONETTI;CARTESIO FAVALLI;LUIGI DI BONITO;A. BENEDETTO;LUISA ACCARDI;PAOLA DI BONITO;COLOMBA GIORGI;TOMMASO CLAUDIO MINEO;KARÍ SYRJÄNEN;DONATELLA SANTINI;PIERPAOLO PABA;D BONIFACIO;ANTONIO ORLACCHIO;E FANUCCI;VALERIA FIASCHETTI;LUCIANO MARIANI;GIORGIO BERNARDI;F. LAVIANI","0.95;0.77;0.77;0.63;0.63;0.63;0.55;0.55;0.55;0.52;0.49;0.47;0.44;0.4;0.4;0.4;0.4;0.4;0.33;0.33","MARCO CIOTTI;COLOMBA GIORGI;LUISA ACCARDI;PAOLA DI BONITO;A. BENEDETTO;CARTESIO FAVALLI;LUIGI DI BONITO;KARÍ SYRJÄNEN;DONATELLA SANTINI;D BONIFACIO;M BRANCA;S COSTA;GIOVANNI SIMONETTI;SERGIO BERNARDINI;FRANCESCO LO‐COCO;LUCIANO MARIANI;FRANCESCO BUCCISANO;ALESSANDRO MARTORANA;ALESSANDRO STEFANI;MARTA PANELLA","293;235;235;235;212;212;212;211;203;179;172;172;166;153;151;143;131;129;129;129","MARCO CIOTTI;A. BENEDETTO;CARTESIO FAVALLI;GIOVANNI SIMONETTI;SERGIO BERNARDINI;FRANCESCO BUCCISANO;ADRIANO VENDITTI;ANNA TAMBURINI;BRUNO NERI;CARLA MAZZONE;DANIELA FRABONI;FRANCESCO LO‐COCO;GIOVANNI DEL POETA;LICIA OTTAVIANI;LUCA MAURILLO;MARIA CHRISTINA COX;MARIA ILARIA DEL PRINCIPE;MARIA IRNO CONSALVO;PAOLA PANETTA;SERGIO AMADORI","293;203;203;166;153;131;127;127;127;127;127;127;127;127;127;127;127;127;127;127","MARCO CIOTTI;A. BENEDETTO;CARTESIO FAVALLI;FRANCESCO BUCCISANO;GIOVANNI SIMONETTI;PIERLUIGI PABA;FRANCESCO LO‐COCO;LICIA OTTAVIANI;MARIA ILARIA DEL PRINCIPE;MARIA IRNO CONSALVO;PAOLA PANETTA;SERGIO AMADORI;ANTONIO ORLACCHIO;EUGENIO POMPEO;PIERPAOLO PABA;SERGIO BERNARDINI;ADRIANO VENDITTI;ALESSANDRO SABATO;ANTONIO GATTI;COLOMBA GIORGI","11;7;7;4;4;4;3;3;3;3;3;3;3;3;3;3;2;2;2;2","MEDICINE;BIOLOGY;COMPUTER SCIENCE;CHEMISTRY;MATHEMATICS;PSYCHOLOGY;ENGINEERING;GEOLOGY;PHYSICS","34;21;5;4;2;2;1;1;1","INTERNAL MEDICINE;GENETICS;ONCOLOGY;PATHOLOGY;CANCER RESEARCH;IMMUNOLOGY;BIOCHEMISTRY;RADIOLOGY;MOLECULAR BIOLOGY;ENDOCRINOLOGY;NUCLEAR MEDICINE;SURGERY;VIROLOGY;ARTIFICIAL INTELLIGENCE;GASTROENTEROLOGY;PSYCHIATRY;ACOUSTICS;ALGORITHM;ANDROLOGY;ANESTHESIA;CELL BIOLOGY;CLIMATOLOGY;COMPUTER VISION;ENVIRONMENTAL HEALTH;GEOTECHNICAL ENGINEERING;GYNECOLOGY;MATHEMATICAL ECONOMICS;MEDICAL PHYSICS;MICROBIOLOGY;NEUROSCIENCE;OPERATING SYSTEM;PALEONTOLOGY;PHARMACOLOGY;PHYSICAL THERAPY;PROGRAMMING LANGUAGE;STATISTICS;VETERINARY MEDICINE","26;15;10;10;8;7;6;6;5;4;4;4;4;3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","GENE;CANCER;DISEASE;HUMAN PAPILLOMAVIRUS;IMMUNOHISTOCHEMISTRY;MYELOID LEUKEMIA;ALTERNATIVE MEDICINE;LEUKEMIA;MULTIVARIATE ANALYSIS;TRANSPLANTATION;ANGIOGENESIS;ANTIBODY;CALCIUM;CHEMOTHERAPY;HORMONE;IMAGE (MATHEMATICS);LUNG CANCER;MYELOID;MYOTONIC DYSTROPHY;ODDS RATIO;PATHOGENESIS;PREGNANCY;RADIATION DOSE;STEM CELL;THALASSEMIA;VIRUS","16;11;5;4;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","CERVICAL CANCER;PROSTATE;MINIMAL RESIDUAL DISEASE;MUTATION;PHENOTYPE;CARCINOGENESIS;CD34;CHROMOSOME;DOWNREGULATION AND UPREGULATION;GENETIC ENHANCEMENT;GENOTYPE;GLOBIN;HAEMATOPOIESIS;IMAGE QUALITY;MESSENGER RNA;POLYMERASE CHAIN REACTION;PROTOCOL (SCIENCE);RECOMBINANT DNA;RNA;TRANSGENE;UNIVARIATE ANALYSIS","9;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","CERVICAL INTRAEPITHELIAL NEOPLASIA;HPV INFECTION;INTRAEPITHELIAL NEOPLASIA;ALTERNATIVE SPLICING;ACUTE PROMYELOCYTIC LEUKEMIA;CABERGOLINE;CERVICAL CARCINOMA;CONTROLLED OVARIAN HYPERSTIMULATION;FLUORESCENCE IN SITU HYBRIDIZATION;GENOTYPING;GLUTATHIONE PEROXIDASE;GSTP1;HEREDITARY SPASTIC PARAPLEGIA;IMATINIB MESYLATE;IN SITU HYBRIDIZATION;KARYOTYPE;LEVODOPA;MATRIX GLA PROTEIN;MOLECULAR MEDICINE;ONCOGENE;OVARIAN HYPERSTIMULATION SYNDROME;PRENATAL DIAGNOSIS;PRIMARY TUMOR;RNA SPLICING;TELOMERASE REVERSE TRANSCRIPTASE;VIRAL VECTOR","7;5;3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;UTERINE CERVICAL NEOPLASMS;CERVICAL INTRAEPITHELIAL NEOPLASIA;PAPILLOMAVIRUS INFECTIONS;FEMALE;CARCINOMA, SQUAMOUS CELL;AGED;MALE;PAPILLOMAVIRIDAE;ADULT;MIDDLE AGED;BIOMARKERS, TUMOR;ADOLESCENT;;MYOTONIC DYSTROPHY;AGED, 80 AND OVER;PROGNOSIS;CERVIX UTERI;POLYMERASE CHAIN REACTION;ALZHEIMER DISEASE","30;29;25;22;21;19;15;15;15;14;14;11;10;9;9;7;7;6;6;5","HUMAN PAPILLOMAVIRUS AND CERVICAL CANCER EPIDEMIOLOGY;ACUTE MYELOID LEUKEMIA;DIAGNOSIS AND TREATMENT OF LUNG CANCER;MINERAL METABOLISM IN CHRONIC KIDNEY DISEASE;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;CELLULAR SENESCENCE AND AGING-RELATED DISEASES;CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS AND CRISPR-ASSOCIATED PROTEINS;CONE-BEAM COMPUTED TOMOGRAPHY IN DENTISTRY;DIAGNOSIS AND MANAGEMENT OF POLYCYSTIC OVARY SYNDROME;EPIDEMIOLOGY AND MOLECULAR CHARACTERIZATION OF PARASITIC DISEASES;EPIDEMIOLOGY AND PATHOGENESIS OF RESPIRATORY VIRAL INFECTIONS;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;GENETIC BASIS OF NEUROPATHIES AND RELATED DISORDERS;HEALTH RISKS OF MEDICAL IMAGING RADIATION EXPOSURE;HERPESVIRUSES: EPIDEMIOLOGY, PATHOGENESIS, AND MANAGEMENT;HYPEREOSINOPHILIC SYNDROME AND RELATED DISORDERS;INTEGRIN SIGNALING IN INFLAMMATION AND CANCER;MAGNETIC RESONANCE IMAGING APPLICATIONS IN MEDICINE;MECHANISMS OF ALZHEIMER'S DISEASE;MOLECULAR MECHANISMS OF AMYLOIDOSIS","6;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HPV VACCINATION;KOILOCYTE;MINIMAL RESIDUAL DISEASE;ACUTE MYELOID LEUKEMIA;PATHOGENESIS;UNIVARIATE ANALYSIS;ALZHEIMER'S DISEASE;AML;AMYLOID (MYCOLOGY);ARSENIC TRIOXIDE;AUTOSOMAL RECESSIVE INHERITANCE;AVIDITY;BETA (PROGRAMMING LANGUAGE);BONE REMODELING;CABERGOLINE;CANCER;CARCINOMA IN SITU;CENTRAL VENOUS CATHETERIZATION;CERVICAL CANCER;CHRONIC KIDNEY DISEASE","6;4;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CERVICAL CANCER;CERVICAL INTRAEPITHELIAL;INTRAEPITHELIAL NEOPLASIA;HUMAN PAPILLOMAVIRUS;HIGH-RISK HUMAN;ACUTE MYELOID;DISEASE OUTCOME;MINIMAL RESIDUAL;MYELOID LEUKEMIA;NEOPLASIA CIN;PAPILLOMAVIRUS HPV;RESIDUAL DISEASE;FLOW-CYTOMETRY MINIMAL;GENE THERAPY;HPV TYPES;HUMAN CELLS;INDEPENDENT PREDICTOR;LUNG CANCER;MYOTONIC DYSTROPHY;PRECLINICAL STUDIES;ABERRANT EXPRESSION;ACUTE PROMYELOCYTIC;ALZHEIMER DISEASE;ALZHEIMERS DISEASE;ANTIBODY RESPONSE;ANTIGEN PCNA;AUTOSOMAL DOMINANT;BETA THALASSEMIA;BETA-THALASSEMIA PRECLINICAL;BOBINA DI","8;7;7;6;5;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1","PUBMED SCOPUS;FETUIN-A LEVELS;CROSSREF PUBMED;VENA CAVA;SUPERIOR VENA;BONE FORMATION;MGP SERUM;SERUM LEVELS;BIOL CHEM;SERUM FETUIN-A;BONE TURNOVER;TRANSFORMING GROWTH;CHEM -CROSSREF;GLA PROTEIN;MGP LEVELS;RENAL OSTEODYSTROPHY;BONE BIOPSY;CAVA OBSTRUCTION;DEPENDENT VARIABLES;FETUIN-A LEVEL;LUNG CANCER;MATRIX GLA;MORPHOGENETIC PROTEIN;SIGNIFICANT CORRELATION;CERVICAL CANCER;INDEPENDENT VARIABLES;SURG -ABSTRACT;THORAC SURG;ADJUVANT CHEMOTHERAPY;CASR GENE","27;19;18;16;14;13;12;12;11;11;10;10;9;8;8;8;7;7;7;7;7;7;7;7;6;6;6;6;5;5",5,0.13,6,4,0,0,0,0,6,0,1,4,0,0,0,0,2,0,0,0,0,0,0,32,32,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,4,821.8,4.9,2,0.4,139.2,0,0,0,0,2,0,2,1,0,4,1,0,0,0,0,0,0,5,0,0,4,0,0,1,0,0,0,0,0,0,"United States;Germany;Switzerland","2;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","5;2;2;2;2;2","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;BRAIN DISORDERS;CANCER;HEMATOLOGY;LYMPHOMA;NEURODEGENERATIVE;NEUROSCIENCES;RARE DISEASES;AGING;AUTOIMMUNE DISEASE;BEHAVIORAL AND SOCIAL SCIENCE;DEPRESSION;MENTAL HEALTH;MULTIPLE SCLEROSIS;PARKINSON'S DISEASE;PATIENT SAFETY","4;4;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1","CANCER;MENTAL HEALTH;MUSCULOSKELETAL;NEUROLOGICAL","1;1;1;1","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES","5;2","NON-HODGKIN'S LYMPHOMA","2","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","2",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_TORVERGATA",2007,37,8.91891891891892,4.02702702702703,0.594594594594595,0.486486486486487,0.621621621621622,1.31858407079646,1.04761904761905,1.5,1.0952380952381,0.351351351351351,0,22,9,1,3,0.59,0.24,0.03,0.08,37.49,0.710294317905282,NA,0.216216216216216,0.675675675675676,0.369,0.344,0.28,0.35,"LUCA SANTINI;MARK M. GALLAGHER;TOMMASO CLAUDIO MINEO;EUGENIO POMPEO;GIULIA MAGLIANO;PAOLO DE FABRITIIS;ALESSANDRA SPAGNOLI;GIOVANNI SIMONETTI;ADRIANO VENDITTI;MICHELE GRANDE;FRANCESCO BUCCISANO;VINCENZO AMBROGI;FRANCESCO ROMEO;DANIELA FRABONI;CHIARA SARLO;MARIA IRNO CONSALVO;M PADULA;ALESSANDRA PICARDI;GIOVANNI DEL POETA;LUCA MAURILLO","5;5;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2","TOMMASO CLAUDIO MINEO;EUGENIO POMPEO;LUCA SANTINI;MARK M. GALLAGHER;VINCENZO AMBROGI;E POMPEO;TC MINEO;GIOVANNI SIMONETTI;GIULIA MAGLIANO;MICHELE GRANDE;ADRIANO VENDITTI;FEDERICO TACCONI;M PADULA;MARIANNA SGUEGLIA;FRANCESCO ROMEO;GIUSEPPE NOVELLI;FRANCESCO ROMEO;ANTONINO BAGNATO;ALFONSO BALDI;ANDREA ASCOLI MARCHETTI","1.33;1.33;0.64;0.64;0.5;0.5;0.5;0.4;0.39;0.38;0.38;0.33;0.27;0.27;0.27;0.27;0.25;0.25;0.25;0.25","LUCA SANTINI;MARK M. GALLAGHER;TOMMASO CLAUDIO MINEO;EUGENIO POMPEO;GIULIA MAGLIANO;PAOLO DE FABRITIIS;ALESSANDRA SPAGNOLI;GIOVANNI SIMONETTI;ADRIANO VENDITTI;MICHELE GRANDE;FRANCESCO BUCCISANO;VINCENZO AMBROGI;FRANCESCO ROMEO;DANIELA FRABONI;CHIARA SARLO;MARIA IRNO CONSALVO;M PADULA;ALESSANDRA PICARDI;GIOVANNI DEL POETA;LUCA MAURILLO","5;5;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2","TOMMASO CLAUDIO MINEO;EUGENIO POMPEO;LUCA SANTINI;MARK M. GALLAGHER;VINCENZO AMBROGI;TC MINEO;GIOVANNI SIMONETTI;GIULIA MAGLIANO;MICHELE GRANDE;ADRIANO VENDITTI;FEDERICO TACCONI;M PADULA;MARIANNA SGUEGLIA;FRANCESCO ROMEO;FRANCESCO ROMEO;DAVIDE MINEO;S RULLO;GIORGIO FEDERICI;ORAZIO SCHILLACI;PAOLO DE FABRITIIS","1.33;1.33;0.64;0.64;0.5;0.5;0.4;0.39;0.38;0.38;0.33;0.27;0.27;0.27;0.25;0.25;0.25;0.23;0.22;0.22","ARNALDO FIGUEIREDO;CHRISTOPHE BAUDOUIN;GIANLUCA MANNI;N. JAENEN;P. POULIQUEN;THIERRY ZEYEN;ORAZIO SCHILLACI;A. D’AMICO;ANTONELLA MACAGNANO;C ROSCIONI;CORRADO DI NATALE;ENRICO FINAZZI AGRÒ;EUGENIO MARTINELLI;GIORGIO PENNAZZA;GIOVANNI GALLUCCIO;M. BERNABEI;MARCO SANTONICO;R. BONO;ROBERTO PAOLESSE;S. RULLO","392;392;392;392;392;392;176;158;158;158;158;158;158;158;158;158;158;158;158;158","GIANLUCA MANNI;ORAZIO SCHILLACI;ENRICO FINAZZI AGRÒ;EUGENIO POMPEO;TOMMASO CLAUDIO MINEO;ADRIANO VENDITTI;ANNA TAMBURINI;CHIARA SARLO;DANIELA FRABONI;FRANCESCO BUCCISANO;GIOVANNI DEL POETA;LUCA MAURILLO;MARIA ILARIA DEL PRINCIPE;MARIA IRNO CONSALVO;SERGIO AMADORI;GIORGIO FEDERICI;ALESSANDRA SPAGNOLI;BRUNO NERI;CARLA MAZZONE;LETIZIA OTTAVIANI","392;176;158;139;123;91;91;91;91;91;91;91;91;91;91;86;83;83;83;83","LUCA SANTINI;MARK M. GALLAGHER;EUGENIO POMPEO;FRANCESCO ROMEO;GIOVANNI SIMONETTI;TOMMASO CLAUDIO MINEO;ADRIANO VENDITTI;GIULIA MAGLIANO;ALESSANDRA PICARDI;ANNA TAMBURINI;CHIARA SARLO;DANIELA FRABONI;FRANCESCO BUCCISANO;GIORGIO FEDERICI;GIOVANNI DEL POETA;LUCA MAURILLO;M PADULA;MARIA ILARIA DEL PRINCIPE;MARIA IRNO CONSALVO;MARIANNA SGUEGLIA","5;5;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2","MEDICINE;BIOLOGY;PHYSICS;COMPUTER SCIENCE;MATERIALS SCIENCE;PHILOSOPHY;PSYCHOLOGY;ECONOMICS;ENGINEERING;MATHEMATICS","37;10;3;2;2;2;2;1;1;1","INTERNAL MEDICINE;SURGERY;PATHOLOGY;GENETICS;ANESTHESIA;CARDIOLOGY;GASTROENTEROLOGY;ENDOCRINOLOGY;IMMUNOLOGY;NUCLEAR MEDICINE;RADIOLOGY;DERMATOLOGY;ENVIRONMENTAL HEALTH;ONCOLOGY;BIOINFORMATICS;LINGUISTICS;OPHTHALMOLOGY;PROGRAMMING LANGUAGE;PSYCHIATRY;BOTANY;CANCER RESEARCH;COMPUTATIONAL PHYSICS;DATA SCIENCE;ECONOMIC GROWTH;FAMILY MEDICINE;INTENSIVE CARE MEDICINE;MECHANICAL ENGINEERING;MEDICAL PHYSICS;METALLURGY;MICROBIOLOGY;NEUROSCIENCE;NUCLEAR MAGNETIC RESONANCE;NURSING;OPTOMETRY;PALEONTOLOGY;PHARMACOLOGY;PHYSICAL MEDICINE AND REHABILITATION;PHYSICAL THERAPY;RISK ANALYSIS (ENGINEERING);SOCIAL PSYCHOLOGY;STATISTICS;THERMODYNAMICS;VIROLOGY","23;15;9;7;5;5;5;4;4;4;4;3;3;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","BONE MARROW;DISEASE;GENE;LUNG;TRANSPLANTATION;CANCER;POPULATION;PROSPECTIVE COHORT STUDY;ATRIAL FIBRILLATION;CHEMOTHERAPY;COMPLICATION;COMPUTED TOMOGRAPHY;DIABETES MELLITUS;ELECTROCARDIOGRAPHY;LUNG CANCER;MULTIPLE MYELOMA;MYELOID;MYOCARDIAL INFARCTION;PREGNANCY;STEM CELL;THORACOTOMY","4;4;4;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2","HEMATOPOIETIC STEM CELL TRANSPLANTATION;ALLELE;BORTEZOMIB;METASTASIS;MYELODYSPLASTIC SYNDROMES;ACUTE CORONARY SYNDROME;ALLERGIC CONTACT DERMATITIS;AMBULATORY ECG;ANAL CANAL;ANGINA;ANTI-THYMOCYTE GLOBULIN;BREAST CANCER;CANDIDA PARAPSILOSIS;CARDIOVERSION;CD34;CHROMOSOME;CLINICAL NEUROPHYSIOLOGY;COMPUTED TOMOGRAPHY ANGIOGRAPHY;CONTACT DERMATITIS;CORONARY ANGIOGRAPHY;CORONARY ARTERIES;CORONARY ATHEROSCLEROSIS;CUMULATIVE INCIDENCE;CYCLOPHOSPHAMIDE;CYTOKERATIN;CYTOPENIA;DIABETIC FOOT;DIFFUSION MRI;ESCHERICHIA COLI;EXON;FETUS;GENE EXPRESSION;GENETIC DIVERSITY;GENOME;GENOMIC DNA;GENOTYPE;GESTATION;GLAUCOMA MEDICATION;HAZARD RATIO;HOLTER MONITOR;HOUNSFIELD SCALE;HYPERHOMOCYSTEINEMIA;IN VIVO MAGNETIC RESONANCE SPECTROSCOPY;INCISION AND DRAINAGE;L-SELECTIN;LENALIDOMIDE;LIVER TRANSPLANTATION;LUNG VOLUMES;MAINTENANCE THERAPY;MELPHALAN;MIDAZOLAM;MINIMAL RESIDUAL DISEASE;MULTISLICE COMPUTED TOMOGRAPHY;MUTATION;NEURALGIA;OPTIC NEUROPATHY;PERFORATION;PERIPHERAL NEUROPATHY;PLASMA CELL LEUKEMIA;POSTHERPETIC NEURALGIA;PROGENITOR CELL;PROTEASOME INHIBITOR;PROTOCOL (SCIENCE);PSEUDOMONAS AERUGINOSA;RARE DISEASE;SEROMA;SINUS (BOTANY);SINUS RHYTHM;SOLITARY PULMONARY NODULE;SPIRAL COMPUTED TOMOGRAPHY;SUPRAVENTRICULAR TACHYCARDIA;TACROLIMUS;THALIDOMIDE;UNIVARIATE ANALYSIS;VORICONAZOLE;WARFARIN","3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","BUSULFAN;METASTASECTOMY;AMPLIFIED FRAGMENT LENGTH POLYMORPHISM;CASPOFUNGIN;COMPARATIVE GENOMIC HYBRIDIZATION;COMPOUND HETEROZYGOSITY;COPY-NUMBER VARIATION;CYP2C9;ELECTRICAL CARDIOVERSION;FLUDARABINE;FRACTIONAL ANISOTROPY;HAPLOTYPE;INTERNAL ANAL SPHINCTER;KARYOTYPE;KLEBSIELLA PNEUMONIAE;LEBER'S HEREDITARY OPTIC NEUROPATHY;LUNG VOLUME REDUCTION SURGERY;MICROARRAY;MISSENSE MUTATION;PRENATAL DIAGNOSIS;RESIDUAL VOLUME;RIGHT CORONARY ARTERY;SENTINEL NODE;SINGLE-NUCLEOTIDE POLYMORPHISM;SUBTELOMERE;THIOTEPA;THYMOGLOBULIN;UMBILICAL CORD BLOOD TRANSPLANTATION;UTERINE ARTERY","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;LUNG NEOPLASMS;MIDDLE AGED;AGED;ADULT;TREATMENT OUTCOME;;CARCINOMA, NON-SMALL-CELL LUNG;PROSPECTIVE STUDIES;TACHYCARDIA, VENTRICULAR;ELECTROCARDIOGRAPHY, AMBULATORY;ITALY;LEUKEMIA, MYELOID;ADENOCARCINOMA;ADOLESCENT;ANTICOAGULANTS;BREAST NEOPLASMS;CARCINOMA, SQUAMOUS CELL","28;22;22;16;16;13;12;9;8;7;6;6;5;5;5;4;4;4;4;4","ACUTE MYELOID LEUKEMIA;DIAGNOSIS AND TREATMENT OF LUNG CANCER;ANORECTAL SURGICAL PROCEDURES;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;ATRIAL FIBRILLATION;BOTULINUM TOXIN IN NEUROLOGY AND MEDICINE;BREATH ANALYSIS TECHNOLOGY;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;CATHETER ABLATION OF CARDIAC ARRHYTHMIAS;DIAGNOSIS AND MANAGEMENT OF CONGENITAL DIAPHRAGMATIC HERNIA;DIAGNOSIS AND MANAGEMENT OF FUNGAL INFECTIONS;DIAGNOSIS AND MANAGEMENT OF HEREDITARY HEMORRHAGIC TELANGIECTASIA;DIAGNOSIS AND MANAGEMENT OF SYNCOPE;DRUG METABOLISM AND PHARMACOGENOMICS;GENOMIC REARRANGEMENTS AND COPY NUMBER VARIATIONS;GLOBAL CHALLENGE OF ANTIBIOTIC RESISTANCE IN BACTERIA;GLOBAL PREVALENCE AND TREATMENT OF GLAUCOMA;HEMATOPOIETIC STEM CELL BIOLOGY;IMPACT OF CHRONIC STRESS ON CANCER PROGRESSION","3;3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ARRHYTHMIA DETECTION;HEARTBEAT CLASSIFICATION;METASTASECTOMY;MRI IMAGING;NON-SMALL CELL LUNG CANCER;SUPRAVENTRICULAR TACHYCARDIA;THORACOTOMY;ABDOMINAL CAVITY;AMBULATORY ECG;AML;ANAL FISSURE;ANDROGEN RECEPTOR GENE MUTATIONS;ANESTHETIC TECHNIQUE;ANTI-THYMOCYTE GLOBULIN;ANTIFUNGAL RESISTANCE;ANTIFUNGAL THERAPY;ATRIAL FIBRILLATION;AXONAL TRACKING;BETA (PROGRAMMING LANGUAGE);BONE MARROW BIOPSY","2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","BLOOD TRANSPLANTATION;CORD BLOOD;LUNG CANCER;MULTIPLE MYELOMA;MYELODYSPLASTIC SYNDROMES;PATIENTS UNDERGOING;PROSPECTIVE STUDY;ABDOMINAL ENTRY;ACUTE MYELOID;ADULT ACUTE;AFFECTS OUTCOME;ALLELIC VARIANTS;ALLOGENEIC STEM;ALTERNATE VITAMIN;ALTERNATIVE SOURCE;AMPLIFIED LENGTH;ANAL FISSURE;ANDOR SYSTEMIC;ANTI-THYMOCYTE GLOBULIN;ANTICOAGULANT DOSE;ARRAY-BASED COMPARATIVE;ARTERY INJURY;ARTERY THROMBUS;ATOPIC CHILDREN;ATRIAL FIBRILLATION;AWAKE PULMONARY;BASED THERAPY;BETA-EMITTING SOURCES;BONE MARROW;BORTEZOMIB BASED","2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","OPERATIVE TIME;HAND-ASSISTED VIDEOTHORACOSCOPY;PULMONARY METASTASECTOMY;RADIOLOGIC EVIDENCE;SATISFACTION SCORE;TECHNICAL FEASIBILITY;BENIGN NODULES;HOSPITAL STAY;TRANSXIPHOID HAND-ASSISTED;GLOBAL OPERATING;LUNG METASTASECTOMY;LUNG METASTASES;LUNG PALPATION;METASTATIC PATIENTS;PATIENT SATISFACTION;PATIENTS UNDERGOING;PROXIMAL VASCULAR;QS INTERVAL;RESPIRATORY FUNCTION;SHORT FORM-;SOLE THORACIC;SURVIVAL RATE;THORACIC EPIDURAL;TIME MINUTES;AWAKE PULMONARY;DECEMBER PATIENTS;DOUBLING TIME;EPIDURAL ANESTHESIA;HEART DISEASE;LUNG CANCER","7;6;6;6;6;6;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3",8,0.22,6,2,0,0,0,4,12,0,2,3,0,0,1,0,1,0,0,1,0,0,0,117,117.75,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,8,4.86,472.5,7.08,2,0.25,109.38,0,0,1,0,6,0,1,0,0,8,0,0,0,0,0,0,0,8,0,0,8,0,0,0,0,0,0,0,0,0,"Germany;Italy","1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3204 IMMUNOLOGY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING","8;4;3;2;2;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;AGING;BRAIN DISORDERS;HEMATOLOGY;NEURODEGENERATIVE;NEUROSCIENCES;PARKINSON'S DISEASE;RARE DISEASES;ASSISTIVE TECHNOLOGY;ATHEROSCLEROSIS;BIOENGINEERING;BIOTECHNOLOGY;CARDIOVASCULAR;COLO-RECTAL CANCER;DIGESTIVE DISEASES;HEART DISEASE;HEART DISEASE - CORONARY HEART DISEASE;LIVER DISEASE","7;6;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1","CANCER;NEUROLOGICAL","2;2","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES","6;2","LEUKEMIA / LEUKAEMIA;BLOOD CANCER;COLON AND RECTAL CANCER","2;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","3",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_TORVERGATA",2008,73,10.6027397260274,4.45205479452055,0.616438356164384,0.506849315068493,0.657534246575342,1.59313725490196,1.15384615384615,1.68181818181818,1.14285714285714,0.424657534246575,0,45,11,7,3,0.62,0.15,0.1,0.04,48.77,0.888745411378423,NA,0.246575342465753,0.726027397260274,0.392,0.408,0.361,0.391,"GIOVANNI SIMONETTI;MARCO MARZIALI;PIETRO SODANI;GIORGIO FEDERICI;ANTONELLA ISGRÒ;CECILIA ALFIERI;CRISTIANO GALLUCCI;JAVID GAZIEV;KATIA PACIARONI;GUIDO LUCARELLI;PAOLA POLCHI;SERGIO BERNARDINI;ANTONIO ORLACCHIO;FRANCESCA BOLACCHI;CARLA FONTANA;CARLO REALE;ANDREA ROVEDA;MARCO FAVARO;FABIO PLACIDI;GIOIA DE ANGELIS","12;6;6;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4","GIOVANNI SIMONETTI;ANASTASIOS D. ASIMAKOPOULOS;ENRICO FINAZZI AGRÒ;GIORGIO FEDERICI;TOMMASO CLAUDIO MINEO;EUGENIO POMPEO;GIUSEPPE NOVELLI;FRANCESCA BOLACCHI;CARLO REALE;G SIMONETTI;G VIRGILI;GIUSEPPE VESPASIANI;MARCO MARZIALI;PIETRO SODANI;ANTONELLA ISGRÒ;ANTONIO ORLACCHIO;VALERIA COZZOLINO;JAVID GAZIEV;GUIDO LUCARELLI;PAOLA POLCHI","1.48;0.7;0.7;0.62;0.62;0.62;0.61;0.6;0.52;0.51;0.5;0.5;0.48;0.48;0.48;0.45;0.43;0.43;0.42;0.42","GIOVANNI SIMONETTI;MARCO MARZIALI;PIETRO SODANI;GIORGIO FEDERICI;ANTONELLA ISGRÒ;CECILIA ALFIERI;CRISTIANO GALLUCCI;JAVID GAZIEV;KATIA PACIARONI;GUIDO LUCARELLI;PAOLA POLCHI;SERGIO BERNARDINI;ANTONIO ORLACCHIO;FRANCESCA BOLACCHI;CARLA FONTANA;CARLO REALE;ANDREA ROVEDA;MARCO FAVARO;FABIO PLACIDI;GIOIA DE ANGELIS","12;6;6;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4","GIOVANNI SIMONETTI;ANASTASIOS D. ASIMAKOPOULOS;ENRICO FINAZZI AGRÒ;GIORGIO FEDERICI;TOMMASO CLAUDIO MINEO;EUGENIO POMPEO;GIUSEPPE NOVELLI;FRANCESCA BOLACCHI;CARLO REALE;G SIMONETTI;G VIRGILI;GIUSEPPE VESPASIANI;MARCO MARZIALI;PIETRO SODANI;ANTONELLA ISGRÒ;ANTONIO ORLACCHIO;VALERIA COZZOLINO;JAVID GAZIEV;GUIDO LUCARELLI;PAOLA POLCHI","1.48;0.7;0.7;0.62;0.62;0.62;0.61;0.6;0.52;0.51;0.5;0.5;0.48;0.48;0.48;0.45;0.43;0.43;0.42;0.42","ALBERTO PIAGGESI;ALEXANDRA JIRKOVSKÁ;DÍDAC MAURICIO;FRITS VAN MERODE;HEINRICH REIKE;K. BAKKER;K. VAN ACKER;L. PROMPERS;LUIGI UCCIOLI;M. HUIJBERTS;MAXIMILIAN SPRAUL;NICOLAAS C. SCHAPER;P. HOLSTEIN;V. URBANČIČ;EDWARD B. JUDE;JAN APELQVIST;J. VAN BAAL;GUNNEL RAGNARSON-TENNVALL;ISABEL FERREIRA;MICHAEL EDMONDS","1378;1378;1378;1378;1378;1378;1378;1378;1378;1378;1378;1378;1378;1378;1187;1187;1098;907;907;907","LUIGI UCCIOLI;GIOVANNI SIMONETTI;FRANCESCO LO‐COCO;ROBERTO MIANO;GIORGIO FEDERICI;MARIA GIUSEPPINA PALMIERI;ADRIANO VENDITTI;ALESSANDRA SPAGNOLI;BENEDETTA NERI;CHIARA SARLO;DANIELA VENDITTI;EMANUELE AMMATUNA;FRANCESCO BUCCISANO;GIOVANNI DEL POETA;LICIA OTTAVIANI;LUCA MAURILLO;MANUELA RIZZO;MARIA ILARIA DEL PRINCIPE;MICOL QUARESIMA;PAOLA PANETTA","1378;298;237;200;195;180;171;171;171;171;171;171;171;171;171;171;171;171;171;171","GIOVANNI SIMONETTI;MARCO MARZIALI;PIETRO SODANI;GUIDO LUCARELLI;PAOLA POLCHI;ANTONELLA ISGRÒ;CECILIA ALFIERI;CRISTIANO GALLUCCI;KATIA PACIARONI;ANDREA ROVEDA;ANTONIO ORLACCHIO;FRANCESCA BOLACCHI;GIOIA DE ANGELIS;GIORGIO FEDERICI;EUGENIO POMPEO;JAVID GAZIEV;SERGIO BERNARDINI;TOMMASO CLAUDIO MINEO;ANDREA ROMIGI;CARLA FONTANA","10;6;6;5;5;5;5;5;5;4;4;4;4;4;3;3;3;3;3;3","MEDICINE;BIOLOGY;PHYSICS;CHEMISTRY;ENGINEERING;COMPUTER SCIENCE;MATERIALS SCIENCE;PHILOSOPHY;PSYCHOLOGY;BUSINESS;ECONOMICS;MATHEMATICS","63;25;6;3;3;2;2;2;2;1;1;1","INTERNAL MEDICINE;SURGERY;GENETICS;RADIOLOGY;GASTROENTEROLOGY;ENDOCRINOLOGY;CANCER RESEARCH;CARDIOLOGY;IMMUNOLOGY;MICROBIOLOGY;NUCLEAR MEDICINE;PATHOLOGY;ANESTHESIA;ENVIRONMENTAL HEALTH;MOLECULAR BIOLOGY;PSYCHIATRY;BIOCHEMISTRY;MEDICAL PHYSICS;VIROLOGY;ANATOMY;BOTANY;DERMATOLOGY;INTENSIVE CARE MEDICINE;OPTICS;PEDIATRICS;PHYSICAL THERAPY","41;25;16;14;10;7;6;6;6;6;6;6;5;5;5;5;4;4;4;3;3;3;3;3;3;3","GENE;CANCER;DISEASE;TRANSPLANTATION;CHEMOTHERAPY;MAGNETIC RESONANCE IMAGING;POPULATION;THALASSEMIA;ASYMPTOMATIC;BIOPSY;DIABETES MELLITUS;INSULIN;MYELOID LEUKEMIA;MYOCARDIAL INFARCTION;STENOSIS;BACTERIA;BONE MARROW;COHORT;IMMUNE SYSTEM;LEUKEMIA;PROPOFOL;PROSPECTIVE COHORT STUDY;REGIMEN;STENT;VERTEBRAL BODY","14;10;7;7;5;5;5;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3","GENOTYPE;PROSTATE;ALLELE;BREAST CANCER;DIABETIC FOOT;HEMATOPOIETIC STEM CELL TRANSPLANTATION;INSULIN RESISTANCE;MUTATION;PERCUTANEOUS VERTEBROPLASTY;PROSTATE CANCER;REMIFENTANIL;ANGINA;BETA THALASSEMIA;CAROTID ENDARTERECTOMY;COMPLETE REMISSION;CYCLOPHOSPHAMIDE;EXCIMER;EXON;FOCUSED ULTRASOUND;HAEMATOPOIESIS;HIGH-INTENSITY FOCUSED ULTRASOUND;LIVER BIOPSY;POLYSOMNOGRAPHY;RESTENOSIS;T CELL;TRANSCRIPTION FACTOR","4;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","MAMMOGRAPHY;CAROTID STENTING;EPWORTH SLEEPINESS SCALE;SINGLE-NUCLEOTIDE POLYMORPHISM;THIOTEPA;18S RIBOSOMAL RNA;ACINETOBACTER BAUMANNII;ADIPONECTIN;ANNEXIN A2;BREAST CARCINOMA;BUSULFAN;CABERGOLINE;CAROTID ARTERY DISEASE;DACLIZUMAB;DIABETIC FOOT ULCER;DIFFUSION-WEIGHTED MAGNETIC RESONANCE IMAGING;DNA METHYLATION;ESMOLOL;EXCESSIVE DAYTIME SLEEPINESS;GENE MUTATION;HEMATOPOIETIC STEM CELL;HISTOCOMPATIBILITY TESTING;HLA-A;HOMEOSTATIC MODEL ASSESSMENT;IMPAIRED GLUCOSE TOLERANCE;INSULIN RECEPTOR;KARYOTYPE;LOWER URINARY TRACT SYMPTOMS;LUNG VOLUME REDUCTION SURGERY;MATRIX-ASSISTED LASER DESORPTION/IONIZATION;MISSENSE MUTATION;MOLECULAR MEDICINE;MUTATION TESTING;NONALCOHOLIC FATTY LIVER DISEASE;OXYCODONE;PELARGONIDIN;PNEUMOCOCCAL INFECTIONS;PROSTATECTOMY;RIBOSOMAL DNA;RIGHT CORONARY ARTERY;RNA SPLICING;RUNX1;SEMEN ANALYSIS;SEROPREVALENCE;SLEEP STAGES;STREPTOCOCCUS PYOGENES;THROAT CULTURE;TRANSURETHRAL RESECTION OF THE PROSTATE;VARICOCELE;VERBAL FLUENCY TEST","3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;MIDDLE AGED;AGED;ADULT;;TREATMENT OUTCOME;MAGNETIC RESONANCE IMAGING;LIVER CIRRHOSIS;BREAST NEOPLASMS;DIABETIC FOOT;LEUKEMIA, MYELOID, ACUTE;GAMMA-AMINOBUTYRIC ACID;HEPATITIS C, CHRONIC;POLYMERASE CHAIN REACTION;PROSPECTIVE STUDIES;TIME FACTORS;AGED, 80 AND OVER;FATTY LIVER","53;36;35;32;24;18;16;12;11;10;9;9;9;8;8;8;8;8;7;7","BREAST MAGNETIC RESONANCE IMAGING IN ONCOLOGY;ACUTE MYELOID LEUKEMIA;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;MANAGEMENT OF POSTOPERATIVE PAIN AND COMPLICATIONS;PREVENTION AND MANAGEMENT OF DIABETIC FOOT ULCERS;ATOPIC DERMATITIS AND SKIN MICROBIOME;DIAGNOSIS AND TREATMENT OF CAROTID ARTERY DISEASE;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;HUMAN PAPILLOMAVIRUS AND CERVICAL CANCER EPIDEMIOLOGY;PROSTATE CANCER RESEARCH AND TREATMENT;ROLE OF GLUTATHIONE IN OXIDATIVE STRESS RESPONSE;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;ANALYSIS OF ELECTROCARDIOGRAM SIGNALS;ASTHMA;ATRIAL FIBRILLATION;BLOOD RHEOLOGY AND COAGULATION MECHANISMS;BREATH ANALYSIS TECHNOLOGY;CHEMISTRY AND HEALTH EFFECTS OF OLIVE OIL;CLASSIFICATION AND MANAGEMENT OF ODONTOGENIC TUMORS;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION","5;3;3;3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1","BREAST MRI;DIABETES;MAGNETIC RESONANCE IMAGING;ANALGESIA;FOOT ULCERS;PERCUTANEOUS VERTEBROPLASTY;REGIMEN;TREATMENT;ACUTE MYELOID LEUKEMIA;BETA THALASSEMIA;BREAST IMAGING;CANCER IMAGING;CAROTID ARTERY STENOSIS;CAROTID STENTING;CHOLINE;CONTINUOUS INFUSION;DYNAMIC CONTRAST-ENHANCED MRI;EPWORTH SLEEPINESS SCALE;EXCIMER;FOCUSED ULTRASOUND","4;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2","STEM CELL;INTRAOSSEOUS LIDOCAINE;ACUTE MYELOID;EURODIALE STUDY;FOOT ULCERS;MYELOID LEUKEMIA;PERCUTANEOUS VERTEBROPLASTY;PROSTATE CANCER;ARTERY STENTING;BETA THALASSEMIA;CANCER TECHNOLOGY;CAROTID ARTERY;CELL TRANSPLANTATION;CONTINUOUS IV;CORONARY ARTERY;DE NOVO;DIABETIC FOOT;EXCIMER LIGHT;FOCUSED ULTRASOUND;GLUTATHIONE TRANSFERASES;HEMATOPOIETIC STEM;HIGH-INTENSITY FOCUSED;IV REMIFENTANIL;LIDOCAINE PROVIDE;LIGHT NM;LOW DOSES;MAGNETIC RESONANCE;MONOCHROMATIC EXCIMER;OSTEOPOROTIC FRACTURES;REMIFENTANIL INFUSION","5;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","VENA CAVA;SUPERIOR VENA;PUBMED SCOPUS;INSULIN RESISTANCE;CR OXYCODONE;FIBROSING MEDIASTINITIS;BLADDER CANCER;CROSSREF PUBMED;DIABETIC FOOT;GLUTATHIONYLATED HEMOGLOBIN;INSRTACE MICE;ECTODERMAL DYSPLASIA;IMAGE QUALITY;SURG -ABSTRACT;BUTADIENE EXPOSURE;CAROTID ARTERY;CAVA REPLACEMENT;CAVA SYNDROME;CHAIN REACTION;CHEST TUBE;COMBINATION THERAPY;CONTROL SUBJECTS;ECTODERMAL DYSPLASIAS;ENDOVASCULAR TREATMENT;EXTRA-ANATOMIC BYPASS;FATTY LIVER;GST ACTIVITY;IKKΑ EXPRESSION;INFLAMMATION TIMP;INSR TIMP","24;19;11;10;9;7;6;6;6;6;6;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4",12,0.16,7,5.5,0,2,0,2,4,0,2,6.25,0,0,1.5,0,2,1,1,1,0,0,0,89.25,89.25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,11,6.3,863.91,5.76,2,0.18,58.09,0,1,2,0,4,0,2,2,0,9,2,0,0,0,0,0,0,11,0,0,11,0,0,0,0,0,0,0,0,0,"Italy;United States;Belgium;Germany","3;2;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING","10;5;4;3;2;2;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PATIENT SAFETY;RARE DISEASES;CANCER;CARDIOVASCULAR;HEART DISEASE;HEMATOLOGY;PREVENTION;ATHEROSCLEROSIS;BEHAVIORAL AND SOCIAL SCIENCE;DIABETES;HEART DISEASE - CORONARY HEART DISEASE;LYMPHOMA;ORPHAN DRUG;PEDIATRIC;TRANSPLANTATION;ASSISTIVE TECHNOLOGY;AUTOIMMUNE DISEASE;BASIC BEHAVIORAL AND SOCIAL SCIENCE","11;8;7;5;4;4;4;4;4;2;2;2;2;2;2;2;2;1;1;1","CANCER;CARDIOVASCULAR;METABOLIC AND ENDOCRINE;NEUROLOGICAL;RENAL AND UROGENITAL;RESPIRATORY","4;4;1;1;1;1","6.1 PHARMACEUTICALS;7.3 MANAGEMENT AND DECISION MAKING;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;6.4 SURGERY;6.7 PHYSICAL","8;3;1;1;1;1;1","LEUKEMIA / LEUKAEMIA;NON-HODGKIN'S LYMPHOMA;HODGKIN'S DISEASE","2;2;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING","4;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_TORVERGATA",2009,64,9.171875,4.28125,0.65625,0.5625,0.6875,1.50549450549451,1.13513513513514,1.63636363636364,1.1,0.421875,1,33,5,7,11,0.52,0.08,0.11,0.17,59.05,1.27648985743968,NA,0.203125,0.6875,0.358,0.342,0.361,0.338,"EUGENIO POMPEO;TOMMASO CLAUDIO MINEO;GIOVANNI SIMONETTI;GIUSEPPE NOVELLI;ANTONIO ORLACCHIO;CRISTIANO GALLUCCI;CARLA FONTANA;PIETRO SODANI;DAVIDE MINEO;MARCO FAVARO;ORAZIO SCHILLACI;CARLO FEDERICO PERNO;GUIDO LUCARELLI;SILVIA MINELLI;VINCENZO AMBROGI;MARCO ANDREANI;FEDERICO TACCONI;CECILIA ALFIERI;JAVID GAZIEV;FRANCESCA BOLACCHI","7;6;6;5;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3","EUGENIO POMPEO;LAURA CUDILLO;TOMMASO CLAUDIO MINEO;GIOVANNI SIMONETTI;DAVIDE MINEO;FEDERICO TACCONI;GIUSEPPE NOVELLI;CARLA FONTANA;MARCO FAVARO;VINCENZO AMBROGI;PIERPAOLO SILERI;SERGIO CHIMENTI;ORAZIO SCHILLACI;ELEONORA FABBI;CARTESIO FAVALLI;ANTONIO ORLACCHIO;PATRIZIO BOLLERO;L OTTRIA;A BARLATTANI;CARLO FEDERICO PERNO","1.3;1.08;1.05;0.74;0.73;0.67;0.63;0.57;0.57;0.57;0.52;0.5;0.5;0.5;0.49;0.48;0.42;0.42;0.42;0.4","EUGENIO POMPEO;TOMMASO CLAUDIO MINEO;GIOVANNI SIMONETTI;GIUSEPPE NOVELLI;ANTONIO ORLACCHIO;CRISTIANO GALLUCCI;CARLA FONTANA;PIETRO SODANI;DAVIDE MINEO;MARCO FAVARO;ORAZIO SCHILLACI;CARLO FEDERICO PERNO;GUIDO LUCARELLI;SILVIA MINELLI;VINCENZO AMBROGI;MARCO ANDREANI;FEDERICO TACCONI;CECILIA ALFIERI;JAVID GAZIEV;FRANCESCA BOLACCHI","7;6;6;5;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3","EUGENIO POMPEO;LAURA CUDILLO;TOMMASO CLAUDIO MINEO;GIOVANNI SIMONETTI;DAVIDE MINEO;FEDERICO TACCONI;GIUSEPPE NOVELLI;CARLA FONTANA;MARCO FAVARO;VINCENZO AMBROGI;PIERPAOLO SILERI;SERGIO CHIMENTI;ORAZIO SCHILLACI;ELEONORA FABBI;CARTESIO FAVALLI;ANTONIO ORLACCHIO;PATRIZIO BOLLERO;A BARLATTANI;CARLO FEDERICO PERNO;SILVIA MINELLI","1.3;1.08;1.05;0.74;0.73;0.67;0.63;0.57;0.57;0.57;0.52;0.5;0.5;0.5;0.49;0.48;0.42;0.42;0.4;0.37","ALESSANDRA NICOLETTI;ALFREDO PETRONE;ANGELO ANTONINI;ANNA RITA BENTIVOGLIO;ANTONINO CANNAS;ANTONIO PISANI;CARLO COLOSIMO;FABRIZIO STOCCHI;FRANCESCA MORGANTE;FRANCESCO E. PONTIERI;FRANCESCO IEMOLO;G. MECO;GIORGIO TRIANNI;GIULIO CICARELLI;M. MANFREDI;MARIA GABRIELLA CERAVOLO;MASSIMO PEDERZOLI;PAOLO BARONE;PAOLO DEL DOTTO;R. QUATRALE","1453;1453;1453;1453;1453;1453;1453;1453;1453;1453;1453;1453;1453;1453;1453;1453;1453;1453;1453;1453","ANTONIO PISANI;GIOVANNI SIMONETTI;TOMMASO CLAUDIO MINEO;ANTONIO ORLACCHIO;ORAZIO SCHILLACI;EUGENIO POMPEO;CARMELO CICCIÒ;FERDINANDO CALABRIA;FRANCESCO GARACI;GIUSEPPE NOVELLI;ANDREA ROVEDA;ANTONELLA ISGRÒ;CECILIA ALFIERI;CRISTIANO GALLUCCI;GIOIA DE ANGELIS;GUIDO LUCARELLI;JAVID GAZIEV;KATIA PACIARONI;MARCO MARZIALI;MARIA DOMENICA SIMONE","1453;262;261;235;225;221;207;197;196;192;176;176;176;176;176;176;176;176;176;176","EUGENIO POMPEO;TOMMASO CLAUDIO MINEO;CARLO FEDERICO PERNO;CRISTIANO GALLUCCI;GIOVANNI SIMONETTI;GUIDO LUCARELLI;PIETRO SODANI;ANTONIO ORLACCHIO;GIUSEPPE NOVELLI;ORAZIO SCHILLACI;ANDREA ROVEDA;ANTONELLA ISGRÒ;CARLA FONTANA;CARMELO CICCIÒ;CARTESIO FAVALLI;CECILIA ALFIERI;DAVIDE MINEO;FEDERICO TACCONI;GIOIA DE ANGELIS;JAVID GAZIEV","6;6;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3","MEDICINE;BIOLOGY;CHEMISTRY;PSYCHOLOGY;COMPUTER SCIENCE;ENGINEERING;MATERIALS SCIENCE;PHYSICS;ECONOMICS;HISTORY;POLITICAL SCIENCE","59;18;5;4;3;2;2;2;1;1;1","INTERNAL MEDICINE;SURGERY;PATHOLOGY;GENETICS;RADIOLOGY;IMMUNOLOGY;NUCLEAR MEDICINE;ANESTHESIA;PSYCHIATRY;BIOCHEMISTRY;GASTROENTEROLOGY;VIROLOGY;CARDIOLOGY;GENERAL SURGERY;MICROBIOLOGY;NURSING;DERMATOLOGY;ENVIRONMENTAL HEALTH;MOLECULAR BIOLOGY;NEUROSCIENCE;PEDIATRICS;PHYSICAL THERAPY;PROGRAMMING LANGUAGE","44;24;14;12;12;9;8;6;6;5;5;5;4;4;4;4;3;3;3;3;3;3;3","CANCER;GENE;CHEMOTHERAPY;LUNG;MAGNETIC RESONANCE IMAGING;TRANSPLANTATION;DISEASE;THALASSEMIA;VIRUS;ANTIBIOTICS;BONE MARROW;PREGNANCY;QUALITY OF LIFE (HEALTHCARE);ADVERSE EFFECT;BIOPSY;MULTIVARIATE ANALYSIS;OSTEOPOROSIS;POPULATION;POSITRON EMISSION TOMOGRAPHY;RADIATION THERAPY;RETROSPECTIVE COHORT STUDY;STEM CELL","7;7;6;6;6;6;5;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3","CYCLOPHOSPHAMIDE;HEMATOPOIETIC STEM CELL TRANSPLANTATION;CIDOFOVIR;HAEMATOPOIESIS;KIDNEY TRANSPLANTATION;POLYMERASE CHAIN REACTION;UNIVARIATE ANALYSIS;COLORECTAL CANCER;DEMENTIA;FETUS;LAPAROSCOPIC SURGERY;PARKINSON'S DISEASE;PARKINSONISM;PERCUTANEOUS VERTEBROPLASTY;PET-CT;PLEURAL FLUID;PROSTATE;PROSTATE CANCER;RESPIRATORY DISEASE;STANDARDIZED UPTAKE VALUE","4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2","BK VIRUS;HEMORRHAGIC CYSTITIS;THIOTEPA;PLEURAL DISEASE;PRENATAL DIAGNOSIS;AKATHISIA;AMPLICON;ANTIRETROVIRAL THERAPY;BONE MARROW FAILURE;BUSULFAN;CHRONIC HYPERTENSION;CLINICAL GLOBAL IMPRESSION;COGNITIVE DECLINE;COLONOSCOPY;CORTICOBASAL DEGENERATION;CYP2C9;DEEP BRAIN STIMULATION;DEMENTIA WITH LEWY BODIES;DYSKINESIA;EXTRAPLEURAL PNEUMONECTOMY;EXTRAPYRAMIDAL SYMPTOMS;FERROPORTIN;FLUDARABINE;FRACTIONAL ANISOTROPY;GENE DOSAGE;GENOTYPING;GESTATIONAL HYPERTENSION;GROUND-GLASS OPACITY;GSTP1;HAMP;HEMATOPOIETIC CELL;HEPACIVIRUS;HYPERTENSION IN PREGNANCY;IMIPENEM;INTRAEPITHELIAL NEOPLASIA;KARYOTYPE;KLEBSIELLA PNEUMONIAE;LEWY BODY;MEROPENEM;METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS;MORBID OBESITY;MULTIPLEX POLYMERASE CHAIN REACTION;NITROFURANTOIN;OPTIC RADIATION;PALIPERIDONE;PARAPNEUMONIC EFFUSION;PHOSPHATIDYLCHOLINE;PRAMIPEXOLE;PROBAND;PROSTATE BIOPSY;PROSTATE-SPECIFIC ANTIGEN;RECTAL EXAMINATION;STAPHYLOCOCCAL INFECTIONS;STAPHYLOCOCCUS;STAPHYLOCOCCUS EPIDERMIDIS;SYNOVIAL FLUID;TOTAL BODY IRRADIATION;VANCOMYCIN;XERODERMA PIGMENTOSUM","3;3;3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;MIDDLE AGED;;AGED;ADULT;DNA;ITALY;TREATMENT OUTCOME;BETA-THALASSEMIA;CYSTITIS;TOMOGRAPHY, X-RAY COMPUTED;AGED, 80 AND OVER;ANEMIA, SICKLE CELL;CYTOSINE;PAIN;RETROSPECTIVE STUDIES;SPINAL FRACTURES;THALASSEMIA","42;32;32;28;22;20;14;9;9;9;8;8;8;7;7;7;7;7;7;7","POLYOMAVIRUS-ASSOCIATED CARCINOGENESIS AND CLINICAL MANIFESTATIONS;DIAGNOSIS AND MANAGEMENT OF PLEURAL DISEASES;DIAGNOSIS AND TREATMENT OF LUNG CANCER;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;MYASTHENIA GRAVIS AND THYMIC TUMORS RESEARCH;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;RECIPROCAL DEVELOPMENT OF TH17 AND TREG CELLS;;ADVANCEMENTS IN PROSTATE CANCER RESEARCH;AUTOMATED SPINE SEGMENTATION AND IDENTIFICATION;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;BREAST PATHOLOGY AND IMAGING TECHNIQUES;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;CEREBELLAR CONTRIBUTIONS TO NEUROLOGICAL DISORDERS AND FUNCTIONS;COLORECTAL CANCER RESEARCH AND TREATMENT;DEEP BRAIN STIMULATION FOR NEUROLOGICAL DISORDERS;DENTAL IMPLANTOLOGY AND PERI-IMPLANT DISEASES;DEVELOPMENTAL ORIGINS OF ADULT HEALTH AND DISEASE;DIAGNOSIS AND MANAGEMENT OF FOOD ALLERGY;DIAGNOSIS AND TREATMENT OF DIVERTICULITIS","3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","CIDOFOVIR;HEMORRHAGIC CYSTITIS;PARAPNEUMONIC EFFUSIONS;PET/CT;PLEURAL EFFUSION;PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;THIOTEPA;THORACOSCOPY;UNIVARIATE ANALYSIS;CANCER IMAGING;CT SCREENING;DECORTICATION;EMERGENCY THORACOTOMY;HEMATOPOIETIC CELL TRANSPLANTATION;INTERQUARTILE RANGE;NON-MOTOR SYMPTOMS;PERCUTANEOUS VERTEBROPLASTY;PET-CT;PLEURAL DISEASE;PSORIASIS","3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2","CELL TRANSPLANTATION;HEMATOPOIETIC STEM;HEMORRHAGIC CYSTITIS;STEM CELL;AWAKE VIDEO-ASSISTED;BK VIRUS;CELL ANEMIA;COMPUTED TOMOGRAPHY;EMPYEMA THORACIS;LATE-ONSET HEMORRHAGIC;LEFT VENTRICULAR;LONG-TERM OUTCOME;MELPHALAN MGM;PARKINSONS DISEASE;PERCUTANEOUS VERTEBROPLASTY;PLEURAL DECORTICATION;POLYOMA BK;PRIAMO STUDY;PROSPECTIVE EVALUATION;PROSTATE CANCER;SICKLE CELL;VIDEO-ASSISTED PLEURAL;VIRUS INFECTION;ABBOTT REALTIME;ACCURATEZZA DELLA;ACUTE BIVENTRICULAR;ACUTE VESTIBULAR;ACUTELY EXACERBATED;AGTG VARIANT;ALBANIAN POPULATION","4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1","COMPUTED TOMOGRAPHY;BONE MARROW;STEM CELL;HEMATOPOIETIC STEM;COMPLETE RESECTION;MIXED CHIMERISM;N- PUFA;PERIPHERAL BLOOD;PERSISTENT MIXED;PROTEIN EXPRESSION;CELL TRANSPLANTATION;CELL-CYCLE PROTEIN;HCV GENOTYPE;HIGH-RESOLUTION COMPUTED;INTRATHORACIC THYMOMAS;LONG-TERM RESULTS;MULTIVARIATE ANALYSIS;PATIENTS RECEIVED;RECURRENT INTRATHORACIC;GROUND-GLASS OPACITY;INCOMPLETE RESECTION;INFLUENZALIKE ILLNESS;MARROW FAILURE;MYOCARDIAL INFARCTION;POTENTIAL PROGNOSTIC;PROGNOSTIC IMPORTANCE;REDUCED SUSCEPTIBILITY;VOLUMETRIC COMPUTED;ABBOTT REALTIME;BOWEL OBSTRUCTION","12;8;8;7;6;6;6;6;6;6;5;5;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;3;3",10,0.16,5.77,3.5,3.5,1.75,0,2,2,0,1,4.5,0,1,3,3,0,1,1,3.5,1,0,0,109.25,109.25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,9,3.25,202.44,5.26,1,0.11,25.44,0,0,2,0,2,0,1,4,0,7,2,0,0,0,0,0,0,9,0,0,9,0,0,0,0,0,0,0,0,0,"Italy;United States","3;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3204 IMMUNOLOGY;3207 MEDICAL MICROBIOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS","9;5;2;1;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;AUTOIMMUNE DISEASE;BIOENGINEERING;CANCER;CARDIOVASCULAR;HEART DISEASE;LUNG;RARE DISEASES;ARTHRITIS;ASSISTIVE TECHNOLOGY;ATHEROSCLEROSIS;CHRONIC OBSTRUCTIVE PULMONARY DISEASE;CROHN'S DISEASE;DIGESTIVE DISEASES;EMPHYSEMA;HEALTH SERVICES;HEART DISEASE - CORONARY HEART DISEASE;HEMATOLOGY;HIV/AIDS","8;5;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","CARDIOVASCULAR;RESPIRATORY;INFECTION;INFLAMMATORY AND IMMUNE SYSTEM;ORAL AND GASTROINTESTINAL","2;2;1;1;1","6.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS;7.1 INDIVIDUAL CARE NEEDS;7.3 MANAGEMENT AND DECISION MAKING","5;1;1;1;1","NON-HODGKIN'S LYMPHOMA;LUNG CANCER","2;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_TORVERGATA",2010,58,9.82758620689655,4.53448275862069,0.706896551724138,0.568965517241379,0.706896551724138,1.40641711229947,1.20588235294118,1.57142857142857,1.20588235294118,0.5,1,23,17,5,5,0.4,0.29,0.09,0.09,46.1,1.02020010314706,NA,0.224137931034483,0.637931034482759,0.446,0.291,0.367,0.291,"GIOVANNI SIMONETTI;TOMMASO CLAUDIO MINEO;EUGENIO POMPEO;SERGIO BERNARDINI;MARCO CIOTTI;FEDERICO TACCONI;SALVATORE MASALA;MATTEO MAMMUCARI;GIORGIO FEDERICI;PAOLO GRAVINA;DANIELA FRABONI;MARCO ANDREANI;PAOLO NARDI;JAVID GAZIEV;LUIGI CHIARIELLO;PATRIZIO POLISCA;ROBERTO FIORI;PIETRO SODANI;ANTONIO PELLEGRINO;FRANCESCO MASSARI","8;5;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3","GIOVANNI SIMONETTI;TOMMASO CLAUDIO MINEO;EUGENIO POMPEO;CAROLINA SCIOMER;FEDERICO TACCONI;ELEONORA GASPARI;SALVATORE MASALA;MATTEO MAMMUCARI;ROBERTO FIORI;MARCO CIOTTI;CARLO FEDERICO PERNO;MUHAMMED BABAKIR‐MINA;MATTEO BENEDETTI VALENTINI;S. LEZZERINI;V. BONANNI;VITO POTENZA;FRANCESCO MASSARI;MASSIMO CICCOZZI;FRANCESCO SELLITRI;PAOLO NARDI","1.39;1.06;1.06;1;0.92;0.65;0.63;0.63;0.59;0.58;0.51;0.51;0.5;0.5;0.5;0.5;0.47;0.43;0.42;0.41","GIOVANNI SIMONETTI;TOMMASO CLAUDIO MINEO;EUGENIO POMPEO;SERGIO BERNARDINI;MARCO CIOTTI;FEDERICO TACCONI;SALVATORE MASALA;MATTEO MAMMUCARI;GIORGIO FEDERICI;PAOLO GRAVINA;DANIELA FRABONI;MARCO ANDREANI;PAOLO NARDI;JAVID GAZIEV;LUIGI CHIARIELLO;PATRIZIO POLISCA;ROBERTO FIORI;PIETRO SODANI;ANTONIO PELLEGRINO;FRANCESCO MASSARI","8;5;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3","GIOVANNI SIMONETTI;TOMMASO CLAUDIO MINEO;EUGENIO POMPEO;CAROLINA SCIOMER;FEDERICO TACCONI;ELEONORA GASPARI;SALVATORE MASALA;MATTEO MAMMUCARI;ROBERTO FIORI;MARCO CIOTTI;CARLO FEDERICO PERNO;MUHAMMED BABAKIR‐MINA;MATTEO BENEDETTI VALENTINI;S. LEZZERINI;V. BONANNI;FRANCESCO MASSARI;FRANCESCO SELLITRI;PAOLO NARDI;LUIGI CHIARIELLO;PATRIZIO POLISCA","1.39;1.06;1.06;1;0.92;0.65;0.63;0.63;0.59;0.58;0.51;0.51;0.5;0.5;0.5;0.47;0.42;0.41;0.41;0.41","ANDRÉ REIS;ANNE BARTON;ANTHONY W. RYAN;ARIF B. EKICI;BEATE BÖHM;CHRISTIAN GIEGER;CHRISTINE HEROLD;ELEANOR KORENDOWYCH;EMILIANO GIARDINA;FRANK BEHRENS;GERD-MARIE ALENIUS;GIUSEPPE NOVELLI;HARALD BURKHARDT;HEIKO TRAUPE;HEINZ‐ERICH WICHMANN;IAN N BRUCE;JESÚS LASCORZ;JOHN BOWES;JÖRG LOHMANN;KRISTINA JUNEBLAD","356;356;356;356;356;356;356;356;356;356;356;356;356;356;356;356;356;356;356;356","EMILIANO GIARDINA;GIUSEPPE NOVELLI;ITALO STROPPA;EUGENIO POMPEO;TOMMASO CLAUDIO MINEO;MARCO ANDREANI;FRANCESCO SELLITRI;GIOVANNI SIMONETTI;A. MARONE;ANNA MARIA CARUSO;C. MARMO;ELENA GREGORIO;G. D'ALVANO;G. ROTONDANO;GIOVANNI RICCIO;LIVIO CIPOLLETTA;MARIA ANTONIA BIANCO;N PANDOLFO;N. PROCACCIO;PINA CAPO","356;356;324;282;282;229;215;212;162;162;162;162;162;162;162;162;162;162;162;162","GIOVANNI SIMONETTI;EUGENIO POMPEO;TOMMASO CLAUDIO MINEO;SALVATORE MASALA;ANTONIO PELLEGRINO;LUIGI CHIARIELLO;MARCO ANDREANI;MATTEO MAMMUCARI;MUHAMMED BABAKIR‐MINA;PAOLO NARDI;PATRIZIO POLISCA;ELEONORA GASPARI;MARCO CIOTTI;ROBERTO FIORI;ROBERTO MIANO;FEDERICO TACCONI;PAOLO GRAVINA;ALESSANDRA PICARDI;ANASTASIOS D. ASIMAKOPOULOS;ANNA ALTIERI","7;5;5;4;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2","MEDICINE;BIOLOGY;PHYSICS;CHEMISTRY;COMPUTER SCIENCE;PSYCHOLOGY;ECONOMICS;MATHEMATICS;ENGINEERING;GEOLOGY;HISTORY;MATERIALS SCIENCE;PHILOSOPHY;POLITICAL SCIENCE","54;24;6;4;3;3;2;2;1;1;1;1;1;1","INTERNAL MEDICINE;GENETICS;SURGERY;IMMUNOLOGY;RADIOLOGY;GASTROENTEROLOGY;CARDIOLOGY;ANATOMY;ANESTHESIA;ENDOCRINOLOGY;MICROBIOLOGY;NUCLEAR MEDICINE;ONCOLOGY;OPTICS;PATHOLOGY;UROLOGY;VIROLOGY;CANCER RESEARCH;CELL BIOLOGY;ENVIRONMENTAL HEALTH;INTENSIVE CARE MEDICINE;PALEONTOLOGY","36;18;18;11;9;6;5;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3","GENE;CANCER;DISEASE;INCIDENCE (GEOMETRY);MAGNETIC RESONANCE IMAGING;TRANSPLANTATION;BONE MARROW;COMPUTED TOMOGRAPHY;CORD BLOOD;DNA;HEART FAILURE;KIDNEY;OSTEOPOROSIS;POPULATION;PROSPECTIVE COHORT STUDY;STEM CELL;VIRUS;WRIST;ANEURYSM;AORTIC VALVE;BIOPSY;CARCINOMA;CARDIOPULMONARY BYPASS;CONTEXT (ARCHAEOLOGY);CORONARY ARTERY DISEASE;ETIOLOGY;HEMATOLOGY;HORMONE;LESION;LEUKEMIA;LOGISTIC REGRESSION;LUNG;MECHANICAL VENTILATION;MITOCHONDRION;MYELOID;MYELOID LEUKEMIA;ODDS RATIO;PERCUTANEOUS;PREGNANCY;RISK FACTOR;STENOSIS;STROMAL CELL;THALASSEMIA","15;7;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","GENOTYPE;COLORECTAL CANCER;HAEMATOPOIESIS;HEMATOPOIETIC STEM CELL TRANSPLANTATION;PROSTATE;PROSTATE CANCER;CHROMOSOME;EJECTION FRACTION;GENE DUPLICATION;PERCUTANEOUS VERTEBROPLASTY;PHYLOGENETIC TREE;POLYMERASE CHAIN REACTION;ACUTE MYELOBLASTIC LEUKEMIA;ADENOCARCINOMA;ADRENOCORTICOTROPIC HORMONE;ALLELE;AMPHOTERICIN B;ANDROGEN;ANGULAR GYRUS;AORTIC ANEURYSM;AORTIC CROSS-CLAMP;AORTIC ROOT;AORTIC VALVE REPLACEMENT;ASCENDING AORTA;BACTERIOLOGY;BETA THALASSEMIA;BONE MARROW TRANSPLANTATION;BONE MINERAL;BREAKPOINT CLUSTER REGION;BULLA (SEAL);BYPASS GRAFTING;CALCINOSIS;CARPAL BONES;CARPAL JOINT;CD8;CHROMOSOMAL TRANSLOCATION;CONTRAST-ENHANCED ULTRASOUND;CORONARY ARTERY CALCIUM;CRYOABLATION;DIABETIC FOOT;DIAPHRAGM (ACOUSTICS);DIFFUSION MRI;DNA DAMAGE;DUPLEX SCANNING;ESCHERICHIA COLI;EXPANDED DISABILITY STATUS SCALE;FETUS;FIGHT-OR-FLIGHT RESPONSE;FRACTION OF INSPIRED OXYGEN;FUSION GENE;GENE REARRANGEMENT;GENETIC DIVERSITY;GENOME;GENOMIC DNA;GIST;HEART BLOCK;HEMAGGLUTININ (INFLUENZA);HEPATITIS B VIRUS;HEPATITIS C VIRUS;HYDRONEPHROSIS;HYPEREOSINOPHILIA;HYPEREOSINOPHILIC SYNDROME;IMATINIB;INFECTIOUS DISEASE (MEDICAL SPECIALTY);INFLUENZA A VIRUS;INFLUENZA A VIRUS SUBTYPE H5N1;INTRAPARIETAL SULCUS;KIDNEY TRANSPLANTATION;LEFT BUNDLE BRANCH BLOCK;LEFT VENTRICULAR ANEURYSM;LIVER BIOPSY;LIVER FIBROSIS;LOCUS (GENETICS);LUNG VOLUME REDUCTION;LUNG VOLUMES;MERKEL CELL CARCINOMA;MINIMAL RESIDUAL DISEASE;MISCARRIAGE;MITOCHONDRIAL BIOGENESIS;MITOCHONDRIAL DNA;MOTOR CORTEX;MUTATION;NECK OF URINARY BLADDER;NEPHRECTOMY;NEURAMINIDASE;NEURODEGENERATION;NONMEM;NOREPINEPHRINE;PERCUTANEOUS NEPHROLITHOTOMY;PET-CT;PHARMACODYNAMICS;PHENOTYPE;POSITRON EMISSION;POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY;POSTCENTRAL GYRUS;PREMOTOR CORTEX;PROGENITOR CELL;PSEUDOEXFOLIATION;PSEUDOEXFOLIATION SYNDROME;PSORIATIC ARTHRITIS;PULMONARY ANGIOGRAPHY;PULMONARY EMPHYSEMA;PULMONARY WEDGE PRESSURE;RATE RATIO;REAL-TIME POLYMERASE CHAIN REACTION;RESPIRATORY TRACT;RIGHT BUNDLE BRANCH BLOCK;STAPHYLOCOCCUS AUREUS;STRONTIUM RANELATE;SUPRAMARGINAL GYRUS;T CELL;TRANSCRANIAL MAGNETIC STIMULATION;UMBILICAL VEIN;UPPER URINARY TRACT;VALVE REPLACEMENT;VASCULAR RESISTANCE;VENOUS THROMBOSIS;VENTRICULAR ANEURYSM;VERTEBRAL COMPRESSION FRACTURE;VIABILITY ASSAY;VIRAL MATRIX PROTEIN;WRIST PAIN","5;3;3;3;3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","COLONOSCOPY;AGATSTON SCORE;ALLELE FREQUENCY;ANDROGEN RECEPTOR;BENTALL PROCEDURE;BK VIRUS;BLADDER OUTLET OBSTRUCTION;BREAKPOINT;BUSULFAN;CASPOFUNGIN;COMPARATIVE GENOMIC HYBRIDIZATION;CONGENITAL DIAPHRAGMATIC HERNIA;CORONARY CALCIUM SCORE;CORONAVIRUS DISEASE 2019 (COVID-19);DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;FLAVIVIRIDAE;GENOTYPING;HBSAG;HEPACIVIRUS;IMATINIB MESYLATE;KARYOTYPE;KLEBSIELLA;KLEBSIELLA PNEUMONIAE;LAMIVUDINE;LOWER URINARY TRACT SYMPTOMS;LUNG VOLUME REDUCTION SURGERY;MERKEL CELL;MERKEL CELL POLYOMAVIRUS;METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS;MICRODELETION SYNDROME;MOLECULAR EPIDEMIOLOGY;NUCLEAR DNA;PDGFRA;POINT MUTATION;POLYMORPHISM (COMPUTER SCIENCE);POPLITEAL VEIN;PROSTATE BIOPSY;PROSTATE-SPECIFIC ANTIGEN;PROSTATECTOMY;RECURRENT MISCARRIAGE;RETROGRADE EJACULATION;RIBAVIRIN;SINGLE-NUCLEOTIDE POLYMORPHISM;TRACTOGRAPHY;VIRILIZATION","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;MIDDLE AGED;ADULT;AGED;;YOUNG ADULT;LEUKEMIA, MYELOID, ACUTE;TREATMENT OUTCOME;ADOLESCENT;PROSPECTIVE STUDIES;CHILD;ITALY;PULMONARY EMPHYSEMA;AGED, 80 AND OVER;ANESTHESIA, EPIDURAL;FOLLOW-UP STUDIES;HEART VALVE PROSTHESIS IMPLANTATION;HIV-1","44;32;32;24;19;17;14;10;9;9;8;8;7;7;7;6;6;6;6;6","HEMATOPOIETIC STEM CELL BIOLOGY;TREATMENT AND OUTCOMES OF HAND INJURIES;GLOBAL TRENDS IN COLORECTAL CANCER RESEARCH;PROSTATE CANCER RESEARCH AND TREATMENT;SPINE SURGERY TECHNIQUES AND TECHNOLOGIES;ACUTE MYELOID LEUKEMIA;ANORECTAL SURGICAL PROCEDURES;ATOMIC MAGNETOMETRY TECHNIQUES;BIOLOGICAL EFFECTS OF ELECTROMAGNETIC FIELDS;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;CHRONIC KIDNEY DISEASE AND DIALYSIS TREATMENT;DIAGNOSIS AND MANAGEMENT OF AORTIC DISEASES;DIAGNOSIS AND MANAGEMENT OF CONGENITAL DIAPHRAGMATIC HERNIA;DIAGNOSIS AND MANAGEMENT OF GASTROINTESTINAL BLEEDING;DIAGNOSIS AND MANAGEMENT OF PLEURAL DISEASES;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;DIFFUSION MAGNETIC RESONANCE IMAGING;ENHANCED RECOVERY AFTER SURGERY PROTOCOLS;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;ETHICAL AND MEDICAL ASPECTS OF ORGAN DONATION","3;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CORD BLOOD;ETIOLOGY;HEMATOLOGY;HEMATOPOIETIC CELL TRANSPLANTATION;OSTEOPOROTIC COMPRESSION FRACTURES;PERCUTANEOUS VERTEBROPLASTY;PROSTHETIC VALVES EVALUATION;SURGICAL AORTIC-VALVE REPLACEMENT;TRANSCATHETER AORTIC-VALVE REPLACEMENT;ABDOMINAL WALL DEFECTS;ABNORMALITY;ACUTE MYELOBLASTIC LEUKEMIA;ACUTE-ON-CHRONIC LIVER FAILURE;AGATSTON SCORE;AMPHOTERICIN B DEOXYCHOLATE;AMPUTATION;ANEUPLOIDY SCREENING;ANGULAR GYRUS;ANTIBODY ENGINEERING;AORTIC CROSS-CLAMP","3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","CORD BLOOD;ACUTE MYELOID;AORTIC VALVE;BLOOD TRANSPLANTATION;CELL TRANSPLANTATION;DEL CARPO;RISK FACTORS;STEM CELL;AATSUBNSUB REPEAT;ABBOTT REALTIME;ACUTE MYELOBLASTIC;ACUTE PATIENTS;AD SYNAPSES;ADULT ACUTE;ADULT INTRA-THORACIC;ADULT WOMEN;ALBICANS PERITONEAL;AMPUTATION RATE;ANALOGUE SCALE;ANATOMIA FUNZIONALE;ANATOMY PRESERVATION;ANGIOGRAPHIC EVALUATION;ANTERIOR ANEURYSM;AORTIC ROOT;ARRAY-BASED CGH;ARTERY BYPASS;ATROPHY LESIONS;AUREUS CA-MRSA;AWAKE THORACOSCOPIC;AWAKE VIDEOTHORACOSCOPIC","3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MINOR AMPUTATION;COMPUTED TOMOGRAPHY;AGATSTON SCORES;AMPUTATION RATE;MAGNETIC RESONANCE;NUCLEATED CELLS;ODDS RATIO;BOCHDALEK HERNIA;CONFIDENCE INTERVAL;DONOR ORIGIN;HCV GENOTYPE;MIXED CHIMERISM;PERITONEAL DIALYSIS;PERSISTENT PAIN;RATIO CONFIDENCE;RESPIRATORY TRACT;ADULT PATIENTS;AGE PTH;AWAKE VATS;BURST-FORMING UNIT;CD CD;CLASSIC RISK;CONTROL SUBJECTS;DIABETIC FOOT;EPIDURAL ANESTHESIA;ERYTHROID COLONIES;LEFT KIDNEY;LIVER FIBROSIS;LOWER RESPIRATORY;MERKEL CELL","10;7;6;5;5;5;5;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3",15,0.26,3.5,1.5,1,1,0,0,6.75,0,1,2.5,0,0,1,0,1,1,1,1.5,0,0,0,77.5,77.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,10,7.8,225.2,5.46,3,0.3,65.8,1,0,2,1,4,0,0,2,0,9,1,0,0,0,0,0,0,10,0,0,10,0,0,0,0,0,0,0,0,0,"United States;Switzerland","7;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3202 CLINICAL SCIENCES;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;4007 CONTROL ENGINEERING, MECHATRONICS AND ROBOTICS","9;6;3;3;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;RARE DISEASES;CANCER;HEMATOLOGY;ARTHRITIS;LYMPHOMA;PAIN RESEARCH;AUTOIMMUNE DISEASE;PATIENT SAFETY;PEDIATRIC;PSORIASIS;BIOENGINEERING;BIOTECHNOLOGY;CHILDHOOD LEUKEMIA;CHRONIC PAIN;COMPLEMENTARY AND INTEGRATIVE HEALTH;ORPHAN DRUG;PEDIATRIC CANCER;REHABILITATION","10;8;8;7;7;3;3;3;2;2;2;2;1;1;1;1;1;1;1;1","CANCER;INFLAMMATORY AND IMMUNE SYSTEM;BLOOD","4;3;1","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;5.1 PHARMACEUTICALS","9;3;1","LEUKEMIA / LEUKAEMIA;NON-HODGKIN'S LYMPHOMA","4;3","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT","5;2",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_TORVERGATA",2011,82,9.34146341463415,3.86585365853659,0.585365853658537,0.48780487804878,0.634146341463415,1.50236966824645,1.33333333333333,1.66666666666667,1.36842105263158,0.439024390243902,1,33,17,11,11,0.4,0.21,0.13,0.13,37.07,0.871606728722222,NA,0.24390243902439,0.695121951219512,0.434,0.355,0.415,0.37,"MARCO ANDREANI;MARCO CIOTTI;CARLO FEDERICO PERNO;GIOVANNI SIMONETTI;MASSIMO CICCOZZI;M. TESTI;MARIA TROIANO;ALESSANDRO MESCHINI;GIACOMO KOCH;MANUELA TESTI;VALERIA CENTO;GUIDO LUCARELLI;DIEGO CENTONZE;GUGLIELMO MANENTI;C. ALMERIGHI;CECILIA ALFIERI;ALESSANDRA LO PRESTI;GIORGIO BERNARDI;CRISTIANO GALLUCCI;MARIAROSA BATTARRA","12;8;8;7;6;6;5;5;5;5;4;4;3;3;3;3;3;3;3;3","MARCO ANDREANI;MARCO CIOTTI;CARLO FEDERICO PERNO;C. ALMERIGHI;MASSIMO CICCOZZI;M. TESTI;GIOVANNI SIMONETTI;MANUELA TESTI;MARIA TROIANO;MARIAROSA BATTARRA;GUIDO LUCARELLI;ALESSANDRO MESCHINI;EUGENIO POMPEO;VALERIA CENTO;GIACOMO KOCH;ANTONIO GATTI;CHIARA TROMBETTA;NICOLA ROSATO;CALOGERO FOTI;PAOLO ABUNDO","1.73;1.39;1.39;1.18;1.05;0.86;0.8;0.74;0.71;0.7;0.62;0.62;0.58;0.56;0.56;0.54;0.5;0.5;0.5;0.5","MARCO ANDREANI;MARCO CIOTTI;CARLO FEDERICO PERNO;GIOVANNI SIMONETTI;M. TESTI;MARIA TROIANO;ALESSANDRO MESCHINI;GIACOMO KOCH;MANUELA TESTI;GUIDO LUCARELLI;DIEGO CENTONZE;GUGLIELMO MANENTI;C. ALMERIGHI;CECILIA ALFIERI;GIORGIO BERNARDI;CRISTIANO GALLUCCI;MARIAROSA BATTARRA;JAVID GAZIEV;SALVATORE MASALA;FERDINANDO CALABRIA","12;8;8;7;6;5;5;5;5;4;3;3;3;3;3;3;3;3;3;3","MARCO ANDREANI;MARCO CIOTTI;CARLO FEDERICO PERNO;C. ALMERIGHI;M. TESTI;GIOVANNI SIMONETTI;MANUELA TESTI;MARIA TROIANO;MARIAROSA BATTARRA;GUIDO LUCARELLI;ALESSANDRO MESCHINI;EUGENIO POMPEO;GIACOMO KOCH;ANTONIO GATTI;CHIARA TROMBETTA;PAOLO ABUNDO;FEDERICO TACCONI;TOMMASO CLAUDIO MINEO;JAVID GAZIEV;LAVINIA FABENI","1.73;1.39;1.39;1.18;0.86;0.8;0.74;0.71;0.7;0.62;0.62;0.58;0.56;0.54;0.5;0.5;0.48;0.48;0.46;0.45","SERGIO BERNARDINI;A. ZARA HERSKOVITS;AASE HANDBERG;ABHAY MOGHEKAR;ALBERT LLADÓ;ALESSANDRO STEFANI;ANDERS SKINNINGSRUD;ANNE M. FAGAN;ANNETTE SPREER;BIANCA VAN BROECK;BRADLEY T. HYMAN;BRITH SKROGSTAD;CHARLOTTE E. TEUNISSEN;CHRISTIAN HUMPEL;CINDY SOENDERSOE KNUDSEN;COLIN L. MASTERS;DANIEL KIDD;DANIELA GALIMBERTI;DAVID M. HOLTZMAN;DAVID PRVULOVIC","441;383;383;383;383;383;383;383;383;383;383;383;383;383;383;383;383;383;383;383","SERGIO BERNARDINI;GIOVANNI SIMONETTI;GIACOMO KOCH;MARCO ANDREANI;CARLO CALTAGIRONE;ANASTASIOS D. ASIMAKOPOULOS;BARBARA BASILE;F.A. LUPO;G. BUCCHI;MARCO BOZZALI;SONIA BONNÌ;V. GIACOBBE;VIVIANA VERSACE;EUGENIO POMPEO;FEDERICO TACCONI;TOMMASO CLAUDIO MINEO;ALESSANDRO MESCHINI;ROBERTO FLORIS;SALVATORE MASALA;GIORGIA SERAFINI","441;326;305;293;233;196;193;193;193;193;193;193;193;160;160;160;156;146;141;139","MARCO ANDREANI;GIOVANNI SIMONETTI;CARLO FEDERICO PERNO;MARCO CIOTTI;ALESSANDRO MESCHINI;M. TESTI;GIACOMO KOCH;MANUELA TESTI;MARIA TROIANO;ANDREA ROVEDA;ANTONELLA ISGRÒ;CECILIA ALFIERI;CRISTIANO GALLUCCI;JAVID GAZIEV;KATIA PACIARONI;MARCO MARZIALI;PIETRO SODANI;GUGLIELMO MANENTI;SALVATORE MASALA;SONIA CRUSCO","12;7;7;7;5;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3","MEDICINE;BIOLOGY;COMPUTER SCIENCE;PHYSICS;PSYCHOLOGY;ECONOMICS;ENGINEERING;PHILOSOPHY;CHEMISTRY;MATHEMATICS;GEOGRAPHY;GEOLOGY;POLITICAL SCIENCE;SOCIOLOGY","73;29;9;8;7;3;3;3;2;2;1;1;1;1","INTERNAL MEDICINE;SURGERY;GENETICS;IMMUNOLOGY;RADIOLOGY;PATHOLOGY;PHYSICAL THERAPY;VIROLOGY;PSYCHIATRY;BIOCHEMISTRY;CARDIOLOGY;ENVIRONMENTAL HEALTH;NUCLEAR MEDICINE;ANESTHESIA;GASTROENTEROLOGY;INTENSIVE CARE MEDICINE;NEUROSCIENCE;PHYSICAL MEDICINE AND REHABILITATION;ANATOMY;GYNECOLOGY;OPTICS;UROLOGY","49;28;23;15;14;12;10;9;8;7;7;7;7;6;6;5;5;5;4;4;4;4","GENE;CANCER;ANTIGEN;TRANSPLANTATION;STEM CELL;DISEASE;POPULATION;MAGNETIC RESONANCE IMAGING;ADVERSE EFFECT;BODY MASS INDEX;NEUROLOGY;RANDOMIZED CONTROLLED TRIAL;VIRUS;OSTEOPOROSIS;THALASSEMIA;ABLATION;BLOOD LOSS;HUMAN IMMUNODEFICIENCY VIRUS (HIV);IMMUNE SYSTEM;MULTIPLE SCLEROSIS;MYOCARDIAL INFARCTION;OBESITY;PERCUTANEOUS;POSITRON EMISSION TOMOGRAPHY;RECEPTOR;REHABILITATION;STIMULATION;TYPING","19;11;9;9;8;7;7;6;5;5;5;5;5;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3","HUMAN LEUKOCYTE ANTIGEN;ALLELE;PROSTATE CANCER;GENOTYPE;HAEMATOPOIESIS;NEURORADIOLOGY;PROSTATE;EXON;NUCLEOTIDE;TOLERABILITY;BETA THALASSEMIA;CD34;ERYTHROPOIESIS;EXPANDED DISABILITY STATUS SCALE;FIXATION (POPULATION GENETICS);HARMONIC SCALPEL;HEMATOPOIETIC STEM CELL TRANSPLANTATION;HEPATITIS C VIRUS;LIVER TRANSPLANTATION;LUNG VOLUMES;PARKINSON'S DISEASE;PHYLOGENETIC TREE;RADIATION TREATMENT PLANNING;REAL-TIME POLYMERASE CHAIN REACTION;THYROIDECTOMY;TRANSCRANIAL MAGNETIC STIMULATION","8;6;6;5;5;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","PROSTATE BIOPSY;RECTAL EXAMINATION;ALLELE FREQUENCY;DEEP BRAIN STIMULATION;HAPLOTYPE;HEPACIVIRUS;HISTOCOMPATIBILITY TESTING;INEFFECTIVE ERYTHROPOIESIS;LUNG VOLUME REDUCTION SURGERY;MOLECULAR EPIDEMIOLOGY;PRIMARY MOTOR CORTEX;TAQMAN;ANTIGEN-PRESENTING CELL;ANTIRETROVIRAL THERAPY;CAROTID STENTING;CLADE;CORONAVIRUS DISEASE 2019 (COVID-19);CROSSOVER STUDY;DIABETIC FOOT ULCER;DNA METHYLATION;DOUBLECORTIN;DYSKINESIA;EXCESSIVE DAYTIME SLEEPINESS;GENOTYPING;GLYCOGEN STORAGE DISEASE TYPE I;GRANZYME B;HAPLOINSUFFICIENCY;HEMATOPOIETIC STEM CELL;HLA-C;HLA-DRB1;HPV INFECTION;IN UTERO;INTERFERON BETA-1A;LENTIVIRUS;LEVODOPA;LOW-AFFINITY NERVE GROWTH FACTOR RECEPTOR;MERKEL CELL POLYOMAVIRUS;MITRAL VALVE ANNULOPLASTY;MODIFIED RANKIN SCALE;OXYCODONE;PAPILLOMAVIRIDAE;PROSTATECTOMY;RIGHT CORONARY ARTERY;TAU PATHOLOGY;TAU PROTEIN;THROMBOPOIETIN;TOTAL THYROIDECTOMY;TROPOMYOSIN RECEPTOR KINASE A","3;3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;MIDDLE AGED;AGED;;ADULT;PROSTATIC NEOPLASMS;TREATMENT OUTCOME;MAGNETIC RESONANCE IMAGING;AGED, 80 AND OVER;ITALY;MULTIPLE SCLEROSIS, RELAPSING-REMITTING;HEPATITIS C;TRANSCRANIAL MAGNETIC STIMULATION;OSTEOPOROSIS, POSTMENOPAUSAL;PREDICTIVE VALUE OF TESTS;PROSPECTIVE STUDIES;SENSITIVITY AND SPECIFICITY;THYROIDECTOMY","57;41;39;39;26;23;21;19;13;12;11;11;10;8;8;7;7;7;7;7","HEMATOPOIETIC STEM CELL BIOLOGY;REGULATORY T CELL DEVELOPMENT AND FUNCTION;HEPATITIS C INFECTION AND TREATMENT;PROSTATE CANCER RESEARCH AND TREATMENT;CHALLENGES IN PAIN MANAGEMENT AND TREATMENT;COMPLICATIONS AND TECHNIQUES IN THYROID SURGERY;DEEP BRAIN STIMULATION FOR NEUROLOGICAL DISORDERS;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;EFFECTS OF WHOLE BODY VIBRATION TRAINING;EPIDEMIOLOGY AND MANAGEMENT OF SEPSIS AND SEPTIC SHOCK;HUMAN IMMUNODEFICIENCY VIRUS/ACQUIRED IMMUNODEFICIENCY SYNDROME;HUMAN PAPILLOMAVIRUS AND CERVICAL CANCER EPIDEMIOLOGY;OSTEOPOROSIS;RADIOTHERAPY PHYSICS AND TECHNOLOGY;;ACUTE MYELOID LEUKEMIA;ADULT NEUROGENESIS AND BRAIN DEVELOPMENT;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;ADVANCEMENTS IN PROSTATE CANCER RESEARCH;BIOAVAILABILITY AND HEALTH EFFECTS OF CURCUMIN","6;5;3;3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1","HEMATOPOIETIC CELL TRANSPLANTATION;NEURORADIOLOGY;ANTIGEN PRESENTATION;PROSTATE BIOPSY;RECTAL EXAMINATION;STROKE (ENGINE);TOLERABILITY;TRANSCRANIAL MAGNETIC STIMULATION;BETA THALASSEMIA;BODY MASS INDEX;CORTICAL EXCITABILITY;CTBS;DYNAMIC CONTRAST-ENHANCED MRI;ETIOLOGY;EXERCISE INTERVENTION;GRAFT-VERSUS-HOST DISEASE;HARMONIC SCALPEL;HISTOCOMPATIBILITY TESTING;HIV;HPV VACCINATION","5;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2","PROSTATE CANCER;MULTIPLE SCLEROSIS;BLOOD CELLS;DISEASE PATIENTS;BONE MARROW;BURST STIMULATION;CLINICAL TRIAL;CORONARY ANGIOGRAPHY;DYSKINETIC PARKINSONS;GENETIC ANALYSIS;HARMONIC FOCUS;HCV GENOTYPES;LONG-TERM FOLLOW-UP;LUNG VOLUME;MARROW TRANSPLANTATION;MITRAL VALVE;MM THREADED;MULTICENTER RANDOMIZED;PARKINSONS DISEASE;PATIENTS TREATED;PERFORMANCE EVALUATION;RANDOMIZED COMPARISON;RED BLOOD;RETROSPECTIVE STUDY;SPLIT CHIMERISM;THETA BURST;TOTAL THYROIDECTOMY;VOLUME REDUCTION;ABDOMINAL OBESITY;ABLATIVE TREATMENT","5;4;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1","LOWER GENETIC-BARRIER;SP RATES;TR CELLS;HOSPITAL STAY;INDUCED DYSKINESIA;LEVODOPA INDUCED;LUNG VOLUME;PATIENTS UNDERGOING;PATIENTS UNDERWENT;PROSTATE CANCER;REDUCTION SURGERY;STEM-CELL TRANSPLANTATION;VOLUME REDUCTION;ADVERSE EVENTS;DRUG USERS;EXPIRATORY VOLUME;FORCED EXPIRATORY;INTERFERON BETA-A;NUCLEATED CELLS;RECEIVED AVG;SEPTIC PATIENTS;SEPTIC SHOCK;STATISTICALLY SIGNIFICANT;STROKE RECURRENCE;TEMPORARY VA;ABBOTT REALTIME;AMINO-ACIDIC SEQUENCES;AMINOACIDS RESIDUES;AMINOACIDS SEQUENCES;AML-SIV-AVS-A-KMTQ-STV-ATRESULTS PROTEASE","6;6;6;5;5;5;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3",17,0.21,6,3,1,3.25,1,3.25,2.5,0,1.5,4,0,1,3,1,3.5,1,1,2.75,1,0,0,96,96,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,13,5.33,462.31,6.5,4,0.31,97.54,0,0,3,1,2,0,2,5,0,10,3,0,0,0,0,0,0,13,0,0,13,0,0,0,0,0,0,0,0,0,"United States;Italy;Germany","4;2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3204 IMMUNOLOGY;3207 MEDICAL MICROBIOLOGY;3209 NEUROSCIENCES;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","12;8;2;1;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DIGESTIVE DISEASES;PATIENT SAFETY;RARE DISEASES;CANCER;INFECTIOUS DISEASES;LIVER DISEASE;NEUROSCIENCES;AUTOIMMUNE DISEASE;CARDIOVASCULAR;CHRONIC LIVER DISEASE AND CIRRHOSIS;CHRONIC PAIN;HEART DISEASE;HEPATITIS;NEURODEGENERATIVE;PAIN RESEARCH;ASSISTIVE TECHNOLOGY;ATHEROSCLEROSIS;BIOENGINEERING","11;6;4;4;4;3;3;3;3;2;2;2;2;2;2;2;2;1;1;1","INFECTION;CARDIOVASCULAR;NEUROLOGICAL;CANCER;INFLAMMATORY AND IMMUNE SYSTEM;METABOLIC AND ENDOCRINE;ORAL AND GASTROINTESTINAL","3;2;2;1;1;1;1","6.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;6.4 SURGERY","8;1;1;1;1","LIVER CANCER;LEUKEMIA / LEUKAEMIA;SKIN CANCER","3;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;2.1 EXOGENOUS FACTORS IN THE ORIGIN AND CAUSE OF CANCER","4;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOU_TORVERGATA",2012,101,10.1287128712871,3.85148514851485,0.475247524752475,0.425742574257426,0.762376237623762,1.54980079681275,1.2972972972973,1.53571428571429,1.22222222222222,0.336633663366337,0,47,21,11,5,0.47,0.21,0.11,0.05,24.91,0.596406133798316,4.86075949367089,0.257425742574257,0.752475247524752,0.367,0.308,0.363,0.3,"GIOVANNI SIMONETTI;MARCO ANDREANI;ROBERTO GANDINI;ELEONORA GASPARI;WILLIAM ARCESE;COSTANTINO DEL GIUDICE;MARCO CIOTTI;ALESSANDRA LO PRESTI;P ROSSI;FABIO CICERI;PIETRO SODANI;SERGIO SPANO;MASSIMO CICCOZZI;M. TESTI;CARLO FEDERICO PERNO;MANUELA TESTI;ACHILLE GASPARI;G SIMONETTI;ANTONIO GATTI;AMEDEO TAGLIERI","14;7;7;6;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;3","GIOVANNI SIMONETTI;MARCO ANDREANI;ROBERTO GANDINI;ELEONORA GASPARI;ANASTASIOS D. ASIMAKOPOULOS;GIACOMO KOCH;ACHILLE GASPARI;P ROSSI;M. TESTI;ANTONIO GATTI;COSTANTINO DEL GIUDICE;FABRIZIO SALLUSTIO;PIERPAOLO SILERI;LUANA FRANCESCHILLI;ALESSANDRO SABATO;RICHARD GASTÓN;SERGIO SPANO;VINCENZO AMBROGI;TOMMASO CLAUDIO MINEO;G SIMONETTI","1.69;0.94;0.82;0.68;0.68;0.67;0.67;0.65;0.65;0.64;0.61;0.59;0.58;0.58;0.54;0.53;0.51;0.5;0.5;0.48","GIOVANNI SIMONETTI;MARCO ANDREANI;ROBERTO GANDINI;ELEONORA GASPARI;WILLIAM ARCESE;COSTANTINO DEL GIUDICE;MARCO CIOTTI;P ROSSI;PIETRO SODANI;SERGIO SPANO;M. TESTI;CARLO FEDERICO PERNO;MANUELA TESTI;ACHILLE GASPARI;G SIMONETTI;ANTONIO GATTI;AMEDEO TAGLIERI;MARIA TROIANO;ANNA MARIA NARDONE;MATTEO STEFANINI","14;7;7;6;5;5;4;4;4;4;4;4;4;4;4;4;3;3;3;3","GIOVANNI SIMONETTI;MARCO ANDREANI;ROBERTO GANDINI;ELEONORA GASPARI;ANASTASIOS D. ASIMAKOPOULOS;GIACOMO KOCH;ACHILLE GASPARI;P ROSSI;M. TESTI;ANTONIO GATTI;COSTANTINO DEL GIUDICE;FABRIZIO SALLUSTIO;PIERPAOLO SILERI;LUANA FRANCESCHILLI;ALESSANDRO SABATO;SERGIO SPANO;TOMMASO CLAUDIO MINEO;G SIMONETTI;CARLO FEDERICO PERNO;MARCO CIOTTI","1.69;0.94;0.82;0.68;0.68;0.67;0.67;0.65;0.65;0.64;0.61;0.59;0.58;0.58;0.54;0.51;0.5;0.48;0.47;0.45","MARCO ANDREANI;PAOLA ROGLIANI;CESARE SALTINI;GIOVANNI SIMONETTI;ANTONIO GATTI;WILLIAM ARCESE;AMEDEO TAGLIERI;LAURA CUDILLO;ALESSANDRA PICARDI;ARNON NAGLER;F. PAPOLA;GABRIELE PAPALINETTI;GASPARE ADORNO;GOTTARDO DE ANGELIS;LIDIA DE FELICE;LOREDANA SARMATI;MARIA CRISTINA RAPANOTTI;MARTA DI NICOLA;MAURO MONTANARI;P BAVARO","299;293;282;256;241;238;228;213;211;211;211;211;211;211;211;211;211;211;211;211","MARCO ANDREANI;CESARE SALTINI;PAOLA ROGLIANI;ANTONIO GATTI;GIOVANNI SIMONETTI;AMEDEO TAGLIERI;GIANLUIGI SERGIACOMI;MARIA ASSUNTA PORRETTA;ALESSANDRO SABATO;ENRICO FINAZZI AGRÒ;ANNA MARIA NARDONE;ROBERTO MIANO;ALBERTO GALANTE;JACOPO M. LEGRAMANTE;FRANCESCO BRANCATI;MARZIA LAZZARI;ROBERTO GANDINI;ANNARITA DI PAOLO;ELISABETTA SABATO;VALENTINA GIANFELICE","299;282;282;241;241;228;202;200;165;160;159;144;136;136;119;115;114;90;90;90","GIOVANNI SIMONETTI;MARCO ANDREANI;ROBERTO GANDINI;ELEONORA GASPARI;ANTONIO GATTI;CARLO FEDERICO PERNO;COSTANTINO DEL GIUDICE;M. TESTI;MANUELA TESTI;MARCO CIOTTI;SERGIO SPANO;ANNA MARIA NARDONE;LUIGI CHIARIELLO;ALESSANDRO SABATO;AMEDEO TAGLIERI;AURORA RICCI;G SIMONETTI;IRENE COCO;MARIA TROIANO;ORAZIO SCHILLACI","13;7;6;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3","MEDICINE;BIOLOGY;COMPUTER SCIENCE;PHYSICS;PSYCHOLOGY;ENGINEERING;MATERIALS SCIENCE;CHEMISTRY;ECONOMICS;POLITICAL SCIENCE;GEOGRAPHY;SOCIOLOGY;ART;BUSINESS;MATHEMATICS","87;30;8;6;6;5;5;4;4;3;2;2;1;1;1","INTERNAL MEDICINE;SURGERY;GENETICS;RADIOLOGY;IMMUNOLOGY;PATHOLOGY;CARDIOLOGY;ANESTHESIA;ENVIRONMENTAL HEALTH;GASTROENTEROLOGY;NUCLEAR MEDICINE;VIROLOGY;INTENSIVE CARE MEDICINE;ONCOLOGY;PHYSICAL THERAPY;PSYCHIATRY;NEUROSCIENCE;BIOCHEMISTRY;BOTANY;GENERAL SURGERY;MOLECULAR BIOLOGY","65;33;27;22;16;13;9;8;8;8;8;8;7;7;7;7;5;4;4;4;4","GENE;CANCER;CHEMOTHERAPY;TRANSPLANTATION;ANTIGEN;DISEASE;POPULATION;STENOSIS;ADVERSE EFFECT;MAGNETIC RESONANCE IMAGING;RECEPTOR;ANTIBODY;RANDOMIZED CONTROLLED TRIAL;STEM CELL;ALTERNATIVE MEDICINE;BIOPSY;BONE MARROW;CLINICAL TRIAL;COHORT;CONCOMITANT;LUNG;PERCUTANEOUS;RETROSPECTIVE COHORT STUDY;SEQUENCE (BIOLOGY);TYPING;ULTRASOUND;VIRUS","20;10;10;10;8;7;7;7;6;6;6;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4","ALLELE;HUMAN LEUKOCYTE ANTIGEN;CLINICAL ENDPOINT;CYCLOPHOSPHAMIDE;GENOTYPE;BREAST CANCER;EXON;HEMATOPOIETIC STEM CELL TRANSPLANTATION;PROSTATE CANCER;AORTIC VALVE REPLACEMENT;GENE EXPRESSION;PROSTATE;ARTERIAL DISEASE;AUTOIMMUNITY;BONE MARROW TRANSPLANTATION;CHROMOSOME;CUMULATIVE INCIDENCE;GENBANK;GENE DUPLICATION;GENOME;HAEMATOPOIESIS;HEMATOLOGIC NEOPLASMS;HEPATITIS B VIRUS;LOCUS (GENETICS);LOW BACK PAIN;MUTATION;NUCLEOTIDE;OPIOID;PHENOTYPE;RESPIRATORY DISEASE;REVASCULARIZATION;TOLERABILITY;TROPISM;TYPE 1 DIABETES","6;6;5;5;5;4;4;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","MOLECULAR EPIDEMIOLOGY;PROSTATECTOMY;BUSULFAN;DNA METHYLATION;FLUDARABINE;IDARUBICIN;SINGLE-NUCLEOTIDE POLYMORPHISM;THIOTEPA;TOTAL BODY IRRADIATION;VINCRISTINE;(+)-NALOXONE;ACCESSION NUMBER (LIBRARY SCIENCE);ACUTE PROMYELOCYTIC LEUKEMIA;ALLELE FREQUENCY;ANTHRACYCLINE;ANTIRETROVIRAL THERAPY;BASILIXIMAB;BRAIN-DERIVED NEUROTROPHIC FACTOR;CANNABINOID RECEPTOR;CHROMATID;CLADE;CLAUDICATION;CLINICAL GLOBAL IMPRESSION;COPAYMENT;COPY-NUMBER VARIATION;CRITICAL LIMB ISCHEMIA;CXCR4;CYTOREDUCTIVE SURGERY;DENDROGRAM;DHPS;DIFFUSING CAPACITY;ERYTHROBLAST;GENE DOSAGE;GENE MAPPING;GENETIC HETEROGENEITY;GENOTYPING;HAPLOTYPE;HBSAG;HEMATOPOIETIC CELL;HLA-A;HOMEOTIC GENE;HUMAN METAPNEUMOVIRUS;INDACATEROL;INTERFERON BETA-1A;LMNA;LNCAP;MAMMOGRAPHY;MISSENSE MUTATION;MOST RECENT COMMON ANCESTOR;MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION;NEOADJUVANT THERAPY;NONALCOHOLIC FATTY LIVER DISEASE;OXYCODONE;PALIPERIDONE;PALIPERIDONE PALMITATE;PARATUBERCULOSIS;PHYLOGEOGRAPHY;PLEURAL DISEASE;PNEUMOCYSTIS PNEUMONIA;POINT MUTATION;PROSTATIC URETHRA;RANIBIZUMAB;RENAL SYMPATHETIC DENERVATION;STEATOHEPATITIS;STREPTOCOCCUS AGALACTIAE;TAPENTADOL;UNTRANSLATED REGION;UPPER MOTOR NEURON","3;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;MIDDLE AGED;AGED;ADULT;;TREATMENT OUTCOME;ADOLESCENT;YOUNG ADULT;ITALY;AGED, 80 AND OVER;CHRONIC PAIN;HEMATOLOGIC NEOPLASMS;CHILD;GRAFT VS HOST DISEASE;TOMOGRAPHY, X-RAY COMPUTED;ISCHEMIA;CHILD, PRESCHOOL;HIV INFECTIONS","74;55;52;38;32;29;26;20;15;15;13;11;11;11;10;10;10;9;8;8","HEMATOPOIETIC STEM CELL BIOLOGY;ANORECTAL SURGICAL PROCEDURES;MANAGEMENT AND TREATMENT OF PERIPHERAL ARTERIAL DISEASE;MANAGEMENT OF VALVULAR HEART DISEASE;REGULATORY T CELL DEVELOPMENT AND FUNCTION;DIAGNOSIS AND TREATMENT OF CAROTID ARTERY DISEASE;HEALTH RISKS OF MEDICAL IMAGING RADIATION EXPOSURE;IDIOPATHIC PULMONARY FIBROSIS: DIAGNOSIS AND MANAGEMENT;LYMPHOID NEOPLASMS;MANAGEMENT OF VASCULAR ACCESS IN HEALTHCARE;MECHANISMS AND MANAGEMENT OF NEUROPATHIC PAIN;UROTRAUMA AND GENITOURINARY DEVELOPMENT;ACUTE MYELOID LEUKEMIA;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;AGE-RELATED MACULAR DEGENERATION RESEARCH;ANALYSIS AND APPLICATIONS OF HEART RATE VARIABILITY;ATRIAL FIBRILLATION;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;BOTULINUM TOXIN IN NEUROLOGY AND MEDICINE;BREAST MAGNETIC RESONANCE IMAGING IN ONCOLOGY","5;3;3;3;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1","CLINICAL ENDPOINT;HEMATOPOIETIC CELL TRANSPLANTATION;SEQUENCE (BIOLOGY);CONCOMITANT;DIAGNOSIS;HIV;IDENTIFICATION (BIOLOGY);MOLECULAR EPIDEMIOLOGY;PAIN MODULATION;STROKE (ENGINE);TRANSCATHETER AORTIC-VALVE REPLACEMENT;ABVD;AORTIC ROOT REPLACEMENT;BREAST MRI;CARDIAC IMAGING;CAROTID ARTERY STENOSIS;CENTRAL VENOUS CATHETERIZATION;COMPUTED TOMOGRAPHY;CUMULATIVE INCIDENCE;IDARUBICIN","5;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2","STEM CELL;BONE MARROW;CELL TRANSPLANTATION;HEMATOPOIETIC STEM;MARROW TRANSPLANTATION;PEDIATRIC PATIENTS;ACUTE STROKE;AFRICAN SICKLE;AORTIC VALVE;CELL ANEMIA;CHRONIC LOW;DIABETIC PATIENTS;FEMORAL ARTERY;HIGH-RISK ACUTE;HLA-IDENTICAL STEM;ITALIAN COHORT;ITALIAN SOCIETY;MOLECULAR ANALYSIS;MULTIPLE SCLEROSIS;NERVE STIMULATION;NEWLY DIAGNOSED;PHASE III;RADICAL PROSTATECTOMY;RISK FACTORS;SEQUENCEBASED TYPING;SICKLE CELL;SUPERFICIAL FEMORAL;TIBIAL NERVE;TYPE DIABETES;ABVD COURSES","6;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1","MMLMATH XMLNSMMLHTTPWWWWORGMATHMATHML;XMLNSMMLHTTPWWWWORGMATHMATHML IDMMMLMNMMLMNMMLMOMMLMOMMLMNMMLMNMMLMATH;IDMMMLMNMMLMNMMLMOMMLMOMMLMNMMLMNMMLMATH MM;INDACATEROL ΜG;AORTIC ROOT;APACHE II;ASCENDING AORTA;BASILIC VEIN;MITRAL REGURGITATION;STATISTICALLY SIGNIFICANT;VASCULAR ACCESS;AVA SOFTWARE;BONE MARROW;COMPUTED TOMOGRAPHY;LANCING DEVICE;MENTAL HEALTH;MITRAL VALVE;MULTI-PATIENTS LANCING;PROSTATE CANCER;UPRIGHT POSITION;ACUTE LEUKEMIA;ADHERENCE QUESTIONNAIRE;AML- TRIAL;AORTIC VALVE;CAROTID ARTERIES;CHAIN REACTION;CO-RECEPTOR USAGE;CONSECUTIVE PATIENTS;CORONARY ARTERIES;CPG ISLANDS","9;8;7;7;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3",36,0.36,4.32,2,1,1,0,1,7,0,1,3.25,1,1,2,1,2,1,1,2.5,1.5,0,0,74.75,74.75,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,19,5.65,807,8.15,11,0.58,77.84,0,0,5,0,5,0,2,7,0,14,5,0,0,0,0,0,0,19,0,0,19,0,0,0,0,0,0,0,0,0,"United States;Italy;Netherlands","3;2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3204 IMMUNOLOGY;3207 MEDICAL MICROBIOLOGY;3212 OPHTHALMOLOGY AND OPTOMETRY;40 ENGINEERING;4009 ELECTRONICS, SENSORS AND DIGITAL HARDWARE;47 LANGUAGE, COMMUNICATION AND CULTURE;4704 LINGUISTICS","18;11;5;3;1;1;1;1;1;1;1","CLINICAL RESEARCH;CANCER;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DIGESTIVE DISEASES;HEMATOLOGY;INFECTIOUS DISEASES;RARE DISEASES;CHRONIC LIVER DISEASE AND CIRRHOSIS;EMERGING INFECTIOUS DISEASES;HEPATITIS;LIVER DISEASE;HEPATITIS - C;PEDIATRIC;PREVENTION;STEM CELL RESEARCH;TRANSPLANTATION;CHILDHOOD LEUKEMIA;GENETICS;NEURODEGENERATIVE;NEUROSCIENCES","17;10;9;7;6;5;5;4;4;4;4;3;3;3;3;3;2;2;2;2","CANCER;INFECTION;ORAL AND GASTROINTESTINAL;INFLAMMATORY AND IMMUNE SYSTEM","7;4;2;1","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.2 CELLULAR AND GENE THERAPIES","12;3;1;1","LEUKEMIA / LEUKAEMIA;LIVER CANCER;COLON AND RECTAL CANCER;LUNG CANCER;MELANOMA;NON-HODGKIN'S LYMPHOMA","5;4;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;2.1 EXOGENOUS FACTORS IN THE ORIGIN AND CAUSE OF CANCER;3.3 CHEMOPREVENTION;4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING;1.4 CANCER PROGRESSION AND METASTASIS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","9;3;2;2;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,"PUBLIC LIBRARY OF SCIENCE","4","31 BIOLOGICAL SCIENCES;3105 GENETICS;32 BIOMEDICAL AND CLINICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY","8;2;2;1;1","ANTIMICROBIAL RESISTANCE;CHRONIC LIVER DISEASE AND CIRRHOSIS;DIGESTIVE DISEASES;EMERGING INFECTIOUS DISEASES;GENETICS;HEPATITIS;HEPATITIS - C;HIV/AIDS;INFECTIOUS DISEASES;LIVER DISEASE;BIOTECHNOLOGY","3;3;3;3;3;3;3;3;3;3;2","INFECTION","1","5.1 PHARMACEUTICALS","3",NA,NA,"BASIC SCIENCE","1","LIVER CANCER","1",NA,NA
"AOU_TORVERGATA",2013,115,11.7478260869565,3.73913043478261,0.530434782608696,0.547826086956522,0.617391304347826,1.58088235294118,1.38636363636364,1.8,1.26785714285714,0.408695652173913,1,47,32,11,6,0.41,0.28,0.1,0.05,26.77,0.767075095474877,4.71767810026385,0.31304347826087,0.747826086956522,0.41,0.336,0.457,0.34,"GIOVANNI SIMONETTI;MARCO ANDREANI;SALVATORE MASALA;ROBERTO GANDINI;UMBERTO TARANTINO;GUGLIELMO MANENTI;LUIGI UCCIOLI;CARLO FEDERICO PERNO;KRISTIAN REICH;PAOLO NARDI;MARCO CIOTTI;GIAMPIERO GIROLOMONI;GIOVANNI B. FORLEO;JEAN‐FRANÇOIS NICOLAS;LUIGI CHIARIELLO;L. PUIG;KNUD KRAGBALLE;MARCELLO CHIOCCHI;C. PAUL;ORAZIO SCHILLACI","22;8;6;6;6;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4","GIOVANNI SIMONETTI;EUGENIO POMPEO;CARLO FEDERICO PERNO;MARCO ANDREANI;UMBERTO TARANTINO;ORAZIO SCHILLACI;MARCO CIOTTI;M. TESTI;ROBERTO GANDINI;SALVATORE MASALA;LUIGI CHIARIELLO;CHIARA ADRIANA PISTOLESE;GUGLIELMO MANENTI;PAOLO NARDI;DANIELE MOROSETTI;S. COLIZZA;GIOVANNI B. FORLEO;FERDINANDO CALABRIA;MARCELLO CHIOCCHI;JACOB ZEITANI","3.18;1.6;1.05;1.04;0.89;0.83;0.8;0.8;0.79;0.73;0.67;0.66;0.65;0.64;0.6;0.6;0.58;0.58;0.55;0.5","GIOVANNI SIMONETTI;MARCO ANDREANI;SALVATORE MASALA;ROBERTO GANDINI;UMBERTO TARANTINO;GUGLIELMO MANENTI;LUIGI UCCIOLI;CARLO FEDERICO PERNO;PAOLO NARDI;MARCO CIOTTI;GIOVANNI B. FORLEO;LUIGI CHIARIELLO;MARCELLO CHIOCCHI;ORAZIO SCHILLACI;DANIELE MOROSETTI;CHIARA ADRIANA PISTOLESE;M. TESTI;GUIDO LUCARELLI;MARZIA LAZZARI;ELENA GASBARRA","22;8;6;6;6;5;5;5;4;4;4;4;4;4;4;4;4;4;3;3","GIOVANNI SIMONETTI;EUGENIO POMPEO;CARLO FEDERICO PERNO;MARCO ANDREANI;UMBERTO TARANTINO;ORAZIO SCHILLACI;MARCO CIOTTI;M. TESTI;ROBERTO GANDINI;SALVATORE MASALA;LUIGI CHIARIELLO;CHIARA ADRIANA PISTOLESE;GUGLIELMO MANENTI;PAOLO NARDI;DANIELE MOROSETTI;GIOVANNI B. FORLEO;MARCELLO CHIOCCHI;JACOB ZEITANI;MARIO DAURI;ROSA PORROVECCHIO","3.18;1.6;1.05;1.04;0.89;0.83;0.8;0.8;0.79;0.73;0.67;0.66;0.65;0.64;0.6;0.58;0.55;0.5;0.5;0.5","MARCO ANDREANI;ALESSANDRO BULFONE;BINGGEGE GUO;CHIARA F. MAGNANI;CLELIA DI SERIO;DE’BROSKI R. HERBERT;FILIPPO TRENTINI;LEONIE BROCKMANN;MARIA-GRAZIA RONCAROLO;MAURO PALA;MONICA E. GIANOLINI;NICOLA GAGLIANI;PAULA LICONA-LIMÓN;RICHARD A. FLAVELL;ROSA BACCHETTA;SAMUEL HUBER;SILVIA GREGORI;GIOVANNI SIMONETTI;LUIGI UCCIOLI;ROBERTO GANDINI","793;723;723;723;723;723;723;723;723;723;723;723;723;723;723;723;723;454;343;243","MARCO ANDREANI;GIOVANNI SIMONETTI;LUIGI UCCIOLI;ROBERTO GANDINI;COSTANTINO DEL GIUDICE;DANIELE MOROSETTI;ENRICO PAMPANA;UMBERTO TARANTINO;FRANCESCO ROMEO;STEFANO MEROLLA;LAURA GIURATO;ORAZIO SCHILLACI;CHIARA ADRIANA PISTOLESE;AGOSTINO CHIARAVALLOTI;PIERLUIGI BOVE;L CHINI;VIVIANA MOSCHESE;ELENA GASBARRA;VALERIA LIBERTO;FRANCESCO BRANCATI","793;341;273;243;153;145;137;121;102;95;91;88;84;83;81;79;79;77;77;69","GIOVANNI SIMONETTI;MARCO ANDREANI;ROBERTO GANDINI;UMBERTO TARANTINO;DANIELE MOROSETTI;GIOVANNI B. FORLEO;M. TESTI;MARCELLO CHIOCCHI;MARCO CIOTTI;PAOLO NARDI;SALVATORE MASALA;ALESSANDRO SABATO;GIOIA DE ANGELIS;GUIDO LUCARELLI;KATIA PACIARONI;M. FORNARI;MANUELA TESTI;MARZIA LAZZARI;R. DI TRAPANO;AURORA RICCI","18;8;6;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3","MEDICINE;BIOLOGY;PHYSICS;COMPUTER SCIENCE;PSYCHOLOGY;ECONOMICS;ENGINEERING;CHEMISTRY;MATERIALS SCIENCE;PHILOSOPHY;POLITICAL SCIENCE;BUSINESS;GEOLOGY;HISTORY;MATHEMATICS;SOCIOLOGY","103;32;9;8;6;5;5;3;3;2;2;1;1;1;1;1","INTERNAL MEDICINE;SURGERY;RADIOLOGY;PATHOLOGY;GENETICS;IMMUNOLOGY;ENVIRONMENTAL HEALTH;NUCLEAR MEDICINE;GASTROENTEROLOGY;CARDIOLOGY;ENDOCRINOLOGY;PHYSICAL THERAPY;BIOCHEMISTRY;NURSING;PSYCHIATRY;ANESTHESIA;GENERAL SURGERY;OPTICS;DERMATOLOGY;MEDICAL EMERGENCY;PEDIATRICS;VIROLOGY","77;41;30;25;20;14;10;10;9;8;8;8;7;7;7;6;6;6;5;5;5;5","GENE;MAGNETIC RESONANCE IMAGING;CANCER;DISEASE;TRANSPLANTATION;POPULATION;ANTIGEN;ADVERSE EFFECT;OSTEOPOROSIS;QUALITY OF LIFE (HEALTHCARE);ABLATION;COMPLICATION;DIABETES MELLITUS;INCIDENCE (GEOMETRY);OBSERVATIONAL STUDY;PERCUTANEOUS;RANDOMIZED CONTROLLED TRIAL;RECEPTOR;ALTERNATIVE MEDICINE;ASTHMA;BONE MARROW;PSORIASIS;RECTUM;STEM CELL;STENT;VIRUS","16;16;15;11;11;10;7;6;6;6;5;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4","GENOTYPE;ALLELE;DIABETIC FOOT;HEMATOPOIETIC STEM CELL TRANSPLANTATION;HUMAN LEUKOCYTE ANTIGEN;BREAST CANCER;COLORECTAL CANCER;PROSTATE CANCER;BONE DENSITY;BONE MINERAL;COLORECTAL SURGERY;CYCLOPHOSPHAMIDE;EXON;INFLIXIMAB;OPIOID;PHENOTYPE;PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;ADALIMUMAB;AORTIC ANEURYSM;ASCENDING AORTA;BONE MARROW TRANSPLANTATION;CATHETER ABLATION;DEMENTIA;DESCENDING AORTA;DIFFUSION MRI;DOWNREGULATION AND UPREGULATION;EJECTION FRACTION;GRAFT-VERSUS-HOST DISEASE;HAEMATOPOIESIS;LIVER TRANSPLANTATION;MUTATION;PERCUTANEOUS VERTEBROPLASTY;PHYLOGENETIC TREE;PSORIATIC ARTHRITIS;RADIOFREQUENCY ABLATION;RESTENOSIS;SPIROMETRY;TOLERABILITY;UNIVARIATE ANALYSIS;WHITE MATTER","7;5;5;5;5;4;4;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","DIABETIC FOOT ULCER;JC VIRUS;OXYCODONE;SINGLE-NUCLEOTIDE POLYMORPHISM;THIOTEPA;USTEKINUMAB;BUSULFAN;CARDIAC RESYNCHRONIZATION THERAPY;DUAL-ENERGY X-RAY ABSORPTIOMETRY;FLUDARABINE;FRACTIONAL ANISOTROPY;MAMMOGRAPHY;PROSTATECTOMY;(+)-NALOXONE;ANTI-THYROID AUTOANTIBODIES;ANTIRETROVIRAL THERAPY;AORTIC RUPTURE;ATHERECTOMY;BK VIRUS;BONE MARROW TRANSPLANT;BRONCHODILATION;CAPITAL FORMATION;CARDIAC ABLATION;CD3;COGNITIVE DECLINE;COMPARATIVE GENOMIC HYBRIDIZATION;CONDITIONING REGIMEN;CRITICAL LIMB ISCHEMIA;CROSSOVER STUDY;CYP2C9;CYSTECTOMY;DEBULKING;DUAL ENERGY;ELEPHANT TRUNKS;ENDOVASCULAR ANEURYSM REPAIR;EPWORTH SLEEPINESS SCALE;EXCESSIVE DAYTIME SLEEPINESS;FLAVIVIRIDAE;FRAGILITY FRACTURE;GENICULATE GANGLION;GENOTYPING;HAPLOTYPE;HEMATOPOIETIC STEM CELL;HEPACIVIRUS;HEREDITARY SPASTIC PARAPLEGIA;HISTOCOMPATIBILITY;HLA-A;HLA-DRB1;HOMICIDE;INDACATEROL;INTERLEUKIN 21;INTERNAL CAPSULE;INTERNATIONAL PROGNOSTIC SCORING SYSTEM;KARYOTYPE;LENTIVIRUS;MERKEL CELL;MERKEL CELL POLYOMAVIRUS;MITRAL VALVE ANNULOPLASTY;MMP9;MOLECULAR EPIDEMIOLOGY;NEOINTIMA;NITROTYROSINE;NONSYNONYMOUS SUBSTITUTION;ORAL ALLERGY SYNDROME;OXYBUTYNIN;PALIPERIDONE;PALIPERIDONE PALMITATE;PEROXYNITRITE;PHENOCOPY;PITTSBURGH SLEEP QUALITY INDEX;PRENATAL DIAGNOSIS;PROPIDIUM IODIDE;PYONEPHROSIS;QUANTITATIVE COMPUTED TOMOGRAPHY;STEREOTACTIC RADIOTHERAPY;STROKE VOLUME;SUICIDE RATES;THORACIC AORTIC ANEURYSM;THYMOGLOBULIN;TOLTERODINE;UMBILICAL CORD BLOOD TRANSPLANTATION;UNTRANSLATED REGION;VARICOCELE;VASCULAR DEMENTIA;ZONISAMIDE","3;3;3;3;3;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;MIDDLE AGED;;AGED;TREATMENT OUTCOME;ADULT;ITALY;DIABETIC FOOT;ENDOVASCULAR PROCEDURES;AGED, 80 AND OVER;OSTEOPOROTIC FRACTURES;PROSPECTIVE STUDIES;TOMOGRAPHY, X-RAY COMPUTED;ADOLESCENT;CATHETER ABLATION;CHILD;ISCHEMIA;PERIPHERAL ARTERIAL DISEASE","75;55;48;42;40;33;25;22;21;18;16;14;11;11;10;9;9;9;9;9","PREVENTION AND MANAGEMENT OF DIABETIC FOOT ULCERS;HEMATOPOIETIC STEM CELL BIOLOGY;REGULATORY T CELL DEVELOPMENT AND FUNCTION;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;COLORECTAL CANCER RESEARCH AND TREATMENT;DIAGNOSIS AND MANAGEMENT OF AORTIC DISEASES;NATURAL KILLER CELLS IN IMMUNITY;POLYOMAVIRUS-ASSOCIATED CARCINOGENESIS AND CLINICAL MANIFESTATIONS;RECIPROCAL DEVELOPMENT OF TH17 AND TREG CELLS;ATRIAL FIBRILLATION;DIAGNOSIS AND TREATMENT OF CAROTID ARTERY DISEASE;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;OSTEOPOROSIS;POSITRON EMISSION TOMOGRAPHY IMAGING IN ONCOLOGY;PROSTATE CANCER RESEARCH AND TREATMENT;SPINE SURGERY TECHNIQUES AND TECHNOLOGIES;STANDARDISATION AND MANAGEMENT OF COPD;ACUTE MYELOID LEUKEMIA;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;AGE-RELATED MACULAR DEGENERATION RESEARCH","5;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;1;1;1","TREATMENT;AORTIC ROOT REPLACEMENT;COLORECTAL SURGERY;DIABETES;DIABETIC FOOT ULCER;FOOT ULCERS;HEMATOPOIETIC CELL TRANSPLANTATION;NK CELL RECOGNITION;RADIOFREQUENCY ABLATION;THIOTEPA;USTEKINUMAB;AORTIC DISSECTION;ATRIAL FIBRILLATION;ATRIAL FLUTTER;BONE MINERAL DENSITY;BONE REMODELING;BREAST MRI;CARDIAC RESYNCHRONIZATION THERAPY;CATHETER ABLATION;CHOLINE","7;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2","MAGNETIC RESONANCE;ATRIAL FIBRILLATION;BONE MARROW;MARROW TRANSPLANTATION;STEM CELL;ELDERLY PATIENTS;HEMATOPOIETIC STEM;ITALIAN REGISTRY;RESONANCE IMAGING;ABLATION PROCEDURES;ACUTE LEUKEMIA;ALLELE ISCPHLADQBSCPI;AORTIC RUPTURE;CATHETER ABLATION;CELL TRANSPLANTATION;COLORECTAL SURGERY;CONTROLLED TRIAL;DIFFUSION TENSOR;EURODIALE STUDY;F-CHOLINE PETCT;FIBRILLATION ABLATION;MITRAL VALVE;MULTIPLE SCLEROSIS;NAVX ATRIAL;NEUROPATHIC PAIN;PROLONGED-RELEASE OXYCODONENALOXONE;PSORIATIC ARTHRITIS;RADICAL PROSTATECTOMY;RADIOFREQUENCY ABLATION;RANDOMIZED CONTROLLED","7;4;4;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","ACADEMIC GOOGLE;OXFORD ACADEMIC;FRANCE SEARCH;GERMANY SEARCH;MAGNETIC RESONANCE;SPAIN SEARCH;ITALY SEARCH;RESONANCE IMAGING;FEMORAL NECK;IMAGING MRI;COMPUTED TOMOGRAPHY;ENGLAND SEARCH;GD PATIENTS;MS PATIENTS;PATIENTS UNDERWENT;POLLEN-INDUCED AR;VAGINAL WALL;AUTOMATIC ALERTS;BARCELONA SPAIN;BELGIUM SEARCH;BONE MARROW;CLINICAL DECISIONS;DIABETIC PATIENTS;HEART FAILURE;JF NICOLAS;MADRID SPAIN;MAJOR AMPUTATION;OSTEOPOROTIC SUBJECTS;PATIENT UNDERWENT;RV COIL","115;115;21;17;14;14;13;9;6;6;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4",28,0.24,3.5,4,2.5,1,0,1,16,0,1,4.25,0,1,4,0,3,2.5,3,3,1.5,0,0,65.75,65.75,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,14,5.38,902,5.38,5,0.36,99.86,2,0,4,0,2,0,0,6,0,9,5,0,0,0,0,0,0,14,0,0,14,0,0,0,0,0,0,0,0,0,"United States;Italy","4;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;35 COMMERCE, MANAGEMENT, TOURISM AND SERVICES;3505 HUMAN RESOURCES AND INDUSTRIAL RELATIONS;42 HEALTH SCIENCES","14;9;4;2;1;1;1;1","CLINICAL RESEARCH;AUTOIMMUNE DISEASE;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DIGESTIVE DISEASES;RARE DISEASES;BIOENGINEERING;CANCER;HEMATOLOGY;PATIENT SAFETY;CARDIOVASCULAR;HEART DISEASE;INFLAMMATORY BOWEL DISEASE;LUNG;ORPHAN DRUG;TRANSPLANTATION;ARTHRITIS;ASSISTIVE TECHNOLOGY;CHRONIC PAIN;EMERGING INFECTIOUS DISEASES;INFECTIOUS DISEASES","11;5;5;4;4;3;3;3;3;2;2;2;2;2;2;1;1;1;1;1","CARDIOVASCULAR;BLOOD;CANCER;INFLAMMATORY AND IMMUNE SYSTEM;RESPIRATORY","3;2;2;1;1","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;6.3 MEDICAL DEVICES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.3 MEDICAL DEVICES","8;3;2;1;1","LEUKEMIA / LEUKAEMIA;COLON AND RECTAL CANCER;NON-HODGKIN'S LYMPHOMA;HODGKIN'S DISEASE;MYELOMA","3;2;2;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","3;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,17,"PUBLIC LIBRARY OF SCIENCE","17","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;42 HEALTH SCIENCES;3105 GENETICS;3202 CLINICAL SCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;52 PSYCHOLOGY;49 MATHEMATICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3204 IMMUNOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;44 HUMAN SOCIETY;4905 STATISTICS;5203 CLINICAL AND HEALTH PSYCHOLOGY","12;6;4;3;3;3;3;2;1;1;1;1;1;1","CLINICAL RESEARCH;STEM CELL RESEARCH;DIGESTIVE DISEASES;HEMATOLOGY;HEPATITIS;HEPATITIS - B;INFECTIOUS DISEASES;LIVER DISEASE;CANCER;CHRONIC LIVER DISEASE AND CIRRHOSIS;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;HIV/AIDS;LYMPHOMA;ORPHAN DRUG;RARE DISEASES;REGENERATIVE MEDICINE;STEM CELL RESEARCH - NONEMBRYONIC - NON-HUMAN","3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1","NEUROLOGICAL;CANCER;INFECTION","2;1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS","2","CLINICAL;POPULATION & SOCIETY","5;1","CLINICAL MEDICINE AND SCIENCE","6","BLOOD CANCER;LEUKEMIA / LEUKAEMIA;MYELOMA;NON-HODGKIN'S LYMPHOMA","1;1;1;1","3 GOOD HEALTH AND WELL BEING;4 QUALITY EDUCATION","1;1"
"AOU_TORVERGATA",2014,117,11.0512820512821,3.36752136752137,0.504273504273504,0.461538461538462,0.581196581196581,1.52123552123552,1.37209302325581,1.74193548387097,1.30769230769231,0.495726495726496,5,42,25,14,11,0.36,0.21,0.12,0.09,26.5,0.701325231503366,4.98845265588914,0.239316239316239,0.794871794871795,0.448,0.334,0.399,0.344,"GIOVANNI SIMONETTI;MARCO ANDREANI;FRANCESCO BRANCATI;COSTANTINO DEL GIUDICE;JAVID GAZIEV;GUIDO LUCARELLI;AMEDEO TAGLIERI;VINCENZO AMBROGI;DANIELE CITRARO;NICOLA DI DANIELE;FABIO CICERI;LUCA MAURILLO;SALVATORE MASALA;ANASTASIOS D. ASIMAKOPOULOS;MASSIMO FEDERICI;KATIA PACIARONI;PIETRO SODANI;EUGENIO POMPEO;EROS CALABRIA;GIUSEPPE NOVELLI","20;7;6;6;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4","EUGENIO POMPEO;GIOVANNI SIMONETTI;VINCENZO AMBROGI;TOMMASO CLAUDIO MINEO;COSTANTINO DEL GIUDICE;CARLA FONTANA;MARCO ANDREANI;M. ORANSKY;ALESSANDRO ARE;MARIO ARDUINI;ALESSANDRO SILI;ROBERTA FIDA;DANIELE MOROSETTI;FRANCESCO BRANCATI;MARCO FAVARO;DANIELE CITRARO;UMBERTO TARANTINO;ANASTASIOS D. ASIMAKOPOULOS;GUGLIELMO MANENTI;SALVATORE MASALA","4;2.54;2.08;1.08;0.98;0.83;0.69;0.67;0.67;0.67;0.6;0.6;0.6;0.58;0.58;0.56;0.52;0.52;0.51;0.5","GIOVANNI SIMONETTI;MARCO ANDREANI;FRANCESCO BRANCATI;COSTANTINO DEL GIUDICE;JAVID GAZIEV;GUIDO LUCARELLI;AMEDEO TAGLIERI;VINCENZO AMBROGI;DANIELE CITRARO;LUCA MAURILLO;SALVATORE MASALA;MASSIMO FEDERICI;KATIA PACIARONI;PIETRO SODANI;EUGENIO POMPEO;EROS CALABRIA;GIUSEPPE NOVELLI;DANIELE MOROSETTI;M. TESTI;ANTONIO CHIARAVALLOTI","20;7;6;6;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4","EUGENIO POMPEO;GIOVANNI SIMONETTI;VINCENZO AMBROGI;TOMMASO CLAUDIO MINEO;COSTANTINO DEL GIUDICE;CARLA FONTANA;MARCO ANDREANI;MARIO ARDUINI;ALESSANDRO SILI;DANIELE MOROSETTI;FRANCESCO BRANCATI;DANIELE CITRARO;UMBERTO TARANTINO;GUGLIELMO MANENTI;SALVATORE MASALA;CARLO TICCONI;ANTONIO CHIARAVALLOTI;ROBERTO GANDINI;G SIMONETTI;AMEDEO TAGLIERI","4;2.54;2.08;1.08;0.98;0.83;0.69;0.67;0.6;0.6;0.58;0.56;0.52;0.51;0.5;0.5;0.48;0.48;0.48;0.46","ALESSANDRO RAMBALDI;GIAN PAOLO USSIA;ANTONIO COLOMBO;CORRADO TAMBURINO;FEDERICA ETTORI;FRANCESCO MAISANO;ANNA SONIA PETRONIO;BJÖRN PLICHT;CARLO DI MARIO;CARMELO GRASSO;EDITH LUBOS;FARQAD ALAMGIR;FREIDOON KESHAVARZI;GEORG NICKENIG;GIANNI DALL’ARA;HEINZ‐JOACHIM BÜTTNER;HELMUT BAUMGARTNER;HENNING EBELT;HORST SIEVERT;JAN C. BALZER","476;416;410;410;410;410;401;401;401;401;401;401;401;401;401;401;401;401;401;401","GIAN PAOLO USSIA;GIOVANNI SIMONETTI;LAURA CUDILLO;RAFFAELLA CERRETTI;L CHINI;VIVIANA MOSCHESE;ENRICO FINAZZI AGRÒ;SERGIO CHIMENTI;GIACOMO KOCH;MASSIMO FEDERICI;COSTANTINO DEL GIUDICE;FRANCESCO BRANCATI;DIONISIO FERDINANDO COLELLA;FABRIZIO CHEGAI;E. DI CAPRERA;ELISA COSTANZO;MARIO STAMPANONI BASSI;GUGLIELMO MANENTI;VINCENZO AMBROGI;TOMMASO CLAUDIO MINEO","407;342;308;168;164;164;158;152;150;140;116;114;98;98;90;90;90;89;83;80","GIOVANNI SIMONETTI;COSTANTINO DEL GIUDICE;FRANCESCO BRANCATI;MARCO ANDREANI;AMEDEO TAGLIERI;ANTONIO CHIARAVALLOTI;DANIELE CITRARO;EROS CALABRIA;EUGENIO POMPEO;M. TESTI;SALVATORE MASALA;VINCENZO AMBROGI;FABRIZIO CHEGAI;ALESSANDRO SILI;CARLA FONTANA;DANIELE MOROSETTI;E. DI CAPRERA;ELISA COSTANZO;ENRICO FINAZZI AGRÒ;GIANLUIGI SERGIACOMI","18;5;5;5;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3","MEDICINE;BIOLOGY;PHYSICS;CHEMISTRY;PSYCHOLOGY;COMPUTER SCIENCE;MATHEMATICS;ENGINEERING;PHILOSOPHY;ECONOMICS;MATERIALS SCIENCE;SOCIOLOGY;ART;BUSINESS;HISTORY;POLITICAL SCIENCE","103;47;11;10;7;5;5;3;3;2;2;2;1;1;1;1","INTERNAL MEDICINE;SURGERY;GENETICS;RADIOLOGY;IMMUNOLOGY;PATHOLOGY;GASTROENTEROLOGY;BIOCHEMISTRY;ANESTHESIA;UROLOGY;PALEONTOLOGY;CARDIOLOGY;ENDOCRINOLOGY;ENVIRONMENTAL HEALTH;MICROBIOLOGY;NUCLEAR MEDICINE;NURSING;OPTICS;INTENSIVE CARE MEDICINE;CELL BIOLOGY;MOLECULAR BIOLOGY;PEDIATRICS","78;41;26;21;20;17;16;12;10;10;9;8;7;7;6;6;6;6;5;4;4;4","GENE;CANCER;TRANSPLANTATION;DISEASE;BONE MARROW;RANDOMIZED CONTROLLED TRIAL;ALTERNATIVE MEDICINE;ANTIGEN;LUNG;STEM CELL;ADVERSE EFFECT;ANTIBODY;CONTEXT (ARCHAEOLOGY);INCIDENCE (GEOMETRY);PERCUTANEOUS;POPULATION;ANEMIA;BIOPSY;MAGNETIC RESONANCE IMAGING;MYOCARDIAL INFARCTION;RECEPTOR","20;11;11;9;8;7;6;6;6;6;5;5;5;5;5;5;4;4;4;4;4","HEMATOPOIETIC STEM CELL TRANSPLANTATION;ALLELE;PROSTATE;GENOTYPE;HUMAN LEUKOCYTE ANTIGEN;MUTATION;PHENOTYPE;HAEMATOPOIESIS;MYELODYSPLASTIC SYNDROMES;PROSTATE CANCER;PLACEBO;POLYMERASE CHAIN REACTION;TACROLIMUS;TOLERABILITY;BYPASS GRAFTING;CADHERIN;CLINICAL ENDPOINT;CONFIRMATORY FACTOR ANALYSIS;ESCHERICHIA COLI;ESOPHAGOGASTRODUODENOSCOPY;EUROSCORE;GENE EXPRESSION;LIVER TRANSPLANTATION;LOW BACK PAIN;LUNG BIOPSY;LUNG VOLUMES;MITRAL VALVE REPLACEMENT;MUTANT;PERFORATION;PERFUSION SCANNING;RADIATION TREATMENT PLANNING;RITUXIMAB;THYROID NODULES;TRANSCRANIAL MAGNETIC STIMULATION","7;6;6;5;5;5;5;4;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","ADHERENS JUNCTION;ALLELE FREQUENCY;GENOTYPING;HAPLOTYPE;INTERNATIONAL PROGNOSTIC SCORING SYSTEM;LUNG VOLUME REDUCTION SURGERY;MULTIPLEX POLYMERASE CHAIN REACTION;OFF-PUMP CORONARY ARTERY BYPASS;18S RIBOSOMAL RNA;ADIPOSE TISSUE MACROPHAGES;ALPHA (FINANCE);ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY;BASDAI;BASILIXIMAB;BENDAMUSTINE;BLADDER OUTLET OBSTRUCTION;BONE MARROW FAILURE;BUSULFAN;COLPOSCOPY;COPD EXACERBATION;DESMIN;DIFFUSING CAPACITY;DNA EXTRACTION;DNA METHYLATION;DOSE-VOLUME HISTOGRAM;DUAL ENERGY;DUAL-ENERGY X-RAY ABSORPTIOMETRY;ENDOVASCULAR ANEURYSM REPAIR;ENHANCER;ENTEROBACTER AEROGENES;ENTEROBACTERIACEAE;ERYTHROBLAST;ESOPHAGITIS;FETAL HEMOGLOBIN;FLUDARABINE;FRAMESHIFT MUTATION;GENE MUTATION;GERD;GERMINAL CENTER;GESTATIONAL DIABETES;HIATAL HERNIA;HIGH RESOLUTION MELT;HLA-B;INFLAMMATORY BOWEL DISEASES;KARYOTYPE;KLEBSIELLA PNEUMONIAE;LAMIVUDINE;LEVODOPA;LISTERIA;LOWER URINARY TRACT SYMPTOMS;MACE;MEDIASTINAL EMPHYSEMA;MELTING CURVE ANALYSIS;MITRAL VALVE ANNULOPLASTY;MODIC CHANGES;MONOAMINE OXIDASE A;MULTIFOCAL MOTOR NEUROPATHY;MULTILEAF COLLIMATOR;NECTIN;OSWESTRY DISABILITY INDEX;P2Y12;POINT MUTATION;PONSETI METHOD;PRIMARY MOTOR CORTEX;PROMOTER;PROSTATE-SPECIFIC ANTIGEN;PROSTATECTOMY;REFLUX ESOPHAGITIS;RENAL ARTERY STENOSIS;RESTRICTION FRAGMENT LENGTH POLYMORPHISM;RNA SPLICING;SANGER SEQUENCING;THROMBIN RECEPTOR;ULTRASOUND ELASTOGRAPHY;WILD TYPE;ZINC FINGER;ZONA","2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;;MIDDLE AGED;AGED;ADULT;TREATMENT OUTCOME;ITALY;MYELODYSPLASTIC SYNDROMES;ADOLESCENT;AGED, 80 AND OVER;RETROSPECTIVE STUDIES;YOUNG ADULT;TIME FACTORS;ANIMALS;PROSPECTIVE STUDIES;CHILD;KIDNEY FAILURE, CHRONIC;LIVER NEOPLASMS","74;56;54;39;35;31;30;19;15;12;11;10;10;10;9;8;8;7;7;7","ACUTE MYELOID LEUKEMIA;HEMATOPOIETIC STEM CELL BIOLOGY;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;KIDNEY TRANSPLANTATION;MANAGEMENT OF DIFFICULT AIRWAY IN ANESTHESIA PRACTICE;MANAGEMENT OF VALVULAR HEART DISEASE;BREATH ANALYSIS TECHNOLOGY;CARDIAC SURGERY AND BYPASS GRAFTING OUTCOMES;GLOBAL CHALLENGE OF ANTIBIOTIC RESISTANCE IN BACTERIA;IDIOPATHIC PULMONARY FIBROSIS: DIAGNOSIS AND MANAGEMENT;NATURAL KILLER CELLS IN IMMUNITY;OPERATIVE MANAGEMENT OF PELVIC FRACTURES;PATHOGENESIS AND TREATMENT OF SYSTEMIC SCLEROSIS;PROSTATE CANCER RESEARCH AND TREATMENT;REGULATORY T CELL DEVELOPMENT AND FUNCTION;SPINE SURGERY TECHNIQUES AND TECHNOLOGIES;STANDARDISATION AND MANAGEMENT OF COPD;WNT SIGNALING IN DEVELOPMENT AND DISEASE;WORKPLACE BULLYING AND HARASSMENT IN PROFESSIONAL ENVIRONMENTS;14-3-3 PROTEINS: STRUCTURE, FUNCTION, AND REGULATION","4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;1","TREATMENT;TRANSCATHETER AORTIC-VALVE REPLACEMENT;HEMATOPOIETIC CELL TRANSPLANTATION;NONCARDIAC SURGERY;OSTEOPOROTIC COMPRESSION FRACTURES;REGIMEN;TACROLIMUS PHARMACOGENETICS;TOLERABILITY;TRANSFUSION THERAPY;ADHERENS JUNCTION;CLINICAL ENDPOINT;CORONARY ARTERY BYPASS SURGERY;DISENGAGEMENT THEORY;ESOPHAGOGASTRODUODENOSCOPY;EUROSCORE;HYPERTENSION;IMAGE-GUIDED RADIOTHERAPY;LIVER TRANSPLANTATION;LUNG BIOPSY;MITRAL REGURGITATION","5;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2","CELL TRANSPLANTATION;DE NOVO;PROSTATE CANCER;STEM CELL;CONTROLLED TRIAL;LIVER TRANSPLANTATION;NOVO LIVER;RANDOMIZED CONTROLLED;SICKLE CELL;THORACIC SURGERY;AD HOC;ARTERY BYPASS;BONE MARROW;BYPASS GRAFTING;CELL ANEMIA;CORONARY ARTERY;DIAMOND RANDOMIZED;DISEASE PATIENTS;END-STAGE RENAL;FUNCTION OUTCOMES;GRAFTING SURGERY;HEMATOPOIETIC STEM;HOC ANALYSIS;ITALIAN PATIENTS;LEFT VENTRICULAR;MARROW TRANSPLANTATION;MYELODYSPLASTIC SYNDROMES;NON-INTUBATED THORACIC;OFF-PUMP CORONARY;PATIENTS TREATED","4;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","PUBMED SCOPUS;CROSSREF PUBMED;FILIPPI SYNDROME;SRSF MUTATIONS;AFFECTED INDIVIDUALS;DYSMORPHOL -CROSSREF;MED GENET;BONE MARROW;WEEKS WEEKS;MITOTIC SPINDLE;PUBMED GOOGLE;SANGER SEQUENCING;CELL DIVISION;CELL LINES;GERMINAL CENTERS;HEMATOLOGIC DISEASES;MYELODYSPLASTIC SYNDROME;ADIPOSE TISSUE;ANALYSIS REVEALED;ANKLE ARTHROSCOPY;CA FILIPPI;CHRONIC MYELOMONOCYTIC;CLINICAL CHARACTERIZATIONAM;FRONTAL CORTEX;INFERIOR FRONTAL;INTELLECTUAL DISABILITY;MAGNETIC RESONANCE;MITRAL REGURGITATION;MYELOMONOCYTIC LEUKEMIA;MYELOPROLIFERATIVE NEOPLASMS","52;47;31;15;14;12;10;9;9;8;8;8;7;7;7;7;7;6;6;6;6;6;6;6;6;6;6;6;6;6",49,0.42,3,3,1.5,0,0,1,2,0,1,3,0,1,3.75,0,1,1,1,2,3,0,0,53,53,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,19,5.21,416.42,7.79,10,0.53,85.11,0,0,1,0,9,0,2,7,0,15,4,0,0,0,0,0,0,18,1,0,19,0,0,0,0,0,0,0,0,0,"Italy;United States;Belgium;Japan","5;2;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3207 MEDICAL MICROBIOLOGY;3212 OPHTHALMOLOGY AND OPTOMETRY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","19;13;5;2;2;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;DIGESTIVE DISEASES;PATIENT SAFETY;PEDIATRIC;HEMATOLOGY;RARE DISEASES;AGING;AUTOIMMUNE DISEASE;CHILDHOOD LEUKEMIA;GENETICS;INFECTIOUS DISEASES;INFLAMMATORY BOWEL DISEASE;NUTRITION;PEDIATRIC CANCER;PREVENTION;NEURODEGENERATIVE;NEUROSCIENCES;ORPHAN DRUG","16;12;7;6;6;5;4;4;3;3;3;3;3;3;3;3;3;2;2;2","CANCER;ORAL AND GASTROINTESTINAL;INFECTION;BLOOD;CARDIOVASCULAR;EYE;GENERIC HEALTH RELEVANCE;NEUROLOGICAL;SKIN","6;3;2;1;1;1;1;1;1","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS;6.3 MEDICAL DEVICES;6.4 SURGERY","13;2;1;1;1;1;1","LEUKEMIA / LEUKAEMIA;BLOOD CANCER;BREAST CANCER;COLON AND RECTAL CANCER;LIVER CANCER;LUNG CANCER;NOT SITE-SPECIFIC CANCER","4;1;1;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES;3.3 CHEMOPREVENTION;4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT","6;3;1;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,"PUBLIC LIBRARY OF SCIENCE","4","32 BIOMEDICAL AND CLINICAL SCIENCES;3207 MEDICAL MICROBIOLOGY;3202 CLINICAL SCIENCES","8;3;1","HIV/AIDS;INFECTIOUS DISEASES;ANTIMICROBIAL RESISTANCE;DIGESTIVE DISEASES;HEPATITIS;LIVER DISEASE","2;2;1;1;1;1","INFECTION","3","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES","3;2;1",NA,NA,"CLINICAL MEDICINE AND SCIENCE","3",NA,NA,NA,NA
"AOU_TORVERGATA",2015,141,13.5744680851064,3.46808510638298,0.382978723404255,0.460992907801418,0.617021276595745,1.54746835443038,1.14893617021277,1.54761904761905,1.31818181818182,0.453900709219858,3,68,35,14,12,0.48,0.25,0.1,0.09,38.34,1.02877030364074,4.68714011516315,0.333333333333333,0.843971631205674,0.458,0.359,0.401,0.374,"GIUSEPPE NOVELLI;WILLIAM ARCESE;MARCO ANDREANI;MASSIMO FEDERICI;MARIA ROSARIA D’APICE;AUGUSTO ORLANDI;ADRIANO VENDITTI;FEDERICA SANGIUOLO;LUCA MAURILLO;FRANCESCO BRANCATI;PAOLO SBRACCIA;VINCENZO FORMICA;UMBERTO TARANTINO;FRANCESCO BUCCISANO;ALESSANDRA PICARDI;LAURA CUDILLO;M. TESTI;MANUELA TESTI;GIOVANNI SIMONETTI;ALFONSO BELLIA","12;10;9;8;8;7;7;6;6;6;6;6;6;5;5;5;5;5;5;4","ANTONIO ORLACCHIO;EUGENIO POMPEO;UMBERTO TARANTINO;TOMMASO CLAUDIO MINEO;GIUSEPPE NOVELLI;MARCO ANDREANI;VINCENZO AMBROGI;TOMMASO MARIA MANZIA;M. TESTI;GIACOMO KOCH;MARIA ROSARIA D’APICE;ALESSANDRO STEFANI;GIOVANNI SIMONETTI;AUGUSTO ORLANDI;MASSIMO FEDERICI;FABRIZIO CHEGAI;PAOLO SBRACCIA;FEDERICA SANGIUOLO;FRANCESCO BRANCATI;WILLIAM ARCESE","1.45;1.35;1.34;1.2;1.19;1.04;1;1;0.76;0.73;0.73;0.7;0.68;0.67;0.63;0.62;0.59;0.57;0.56;0.54","GIUSEPPE NOVELLI;WILLIAM ARCESE;MARCO ANDREANI;MASSIMO FEDERICI;MARIA ROSARIA D’APICE;AUGUSTO ORLANDI;ADRIANO VENDITTI;FEDERICA SANGIUOLO;LUCA MAURILLO;FRANCESCO BRANCATI;PAOLO SBRACCIA;VINCENZO FORMICA;UMBERTO TARANTINO;FRANCESCO BUCCISANO;ALESSANDRA PICARDI;M. TESTI;MANUELA TESTI;GIOVANNI SIMONETTI;ALFONSO BELLIA;DAVIDE LAURO","12;10;9;8;8;7;7;6;6;6;6;6;6;5;5;5;5;5;4;4","ANTONIO ORLACCHIO;EUGENIO POMPEO;UMBERTO TARANTINO;TOMMASO CLAUDIO MINEO;GIUSEPPE NOVELLI;MARCO ANDREANI;VINCENZO AMBROGI;TOMMASO MARIA MANZIA;M. TESTI;GIACOMO KOCH;MARIA ROSARIA D’APICE;ALESSANDRO STEFANI;GIOVANNI SIMONETTI;AUGUSTO ORLANDI;MASSIMO FEDERICI;FABRIZIO CHEGAI;PAOLO SBRACCIA;FEDERICA SANGIUOLO;FRANCESCO BRANCATI;WILLIAM ARCESE","1.45;1.35;1.34;1.2;1.19;1.04;1;1;0.76;0.73;0.73;0.7;0.68;0.67;0.63;0.62;0.59;0.57;0.56;0.54","FRANCESCO BRANCATI;AXEL VISEL;BERND TIMMERMANN;BRIGITTE GILBERT‐DUSSARDIER;DARÍO G. LUPIÁÑEZ;DENISE HORN;EVA KLOPOCKI;FERNANDO SANTOS‐SIMARRO;HÜLYA KAYSERILI;JOCHEN HECHT;JOHN M. OPITZ;KATERINA KRAFT;LARS WITTLER;MALTE SPIELMANN;MARCO OSTERWALDER;MARINA BORSCHIWER;MARTIN FRANKE;PETER KRAWITZ;RENATA LAXOVÁ;STEFAN A. HAAS","2031;1936;1936;1936;1936;1936;1936;1936;1936;1936;1936;1936;1936;1936;1936;1936;1936;1936;1936;1936","FRANCESCO BRANCATI;WILLIAM ARCESE;MARIA ROSARIA D’APICE;GIACOMO KOCH;LUIGI UCCIOLI;EMILIANO GIARDINA;PAOLO SBRACCIA;ALBERTO SIRACUSANO;CINZIA NIOLU;ANDREA DAVERIO;GIUSEPPE NOVELLI;MARCO ANDREANI;MONICA D’ADAMO;ROBERTO PERRICONE;SAVINO M. DI STASI;VALERIA GUGLIELMI;YLENIA BARONE;MARIA DOMENICA GUARINO;PIERPAOLO SILERI;UMBERTO TARANTINO","2031;273;256;215;181;169;158;152;152;134;131;129;125;125;125;125;124;122;121;114","MARCO ANDREANI;MARIA ROSARIA D’APICE;WILLIAM ARCESE;FRANCESCO BRANCATI;GIUSEPPE NOVELLI;UMBERTO TARANTINO;VINCENZO FORMICA;FEDERICA SANGIUOLO;M. TESTI;GIOVANNI SIMONETTI;MANUELA TESTI;MASSIMO FEDERICI;LUCA MAURILLO;MARIO ROSELLI;PAOLO SBRACCIA;FRANCESCO GARACI;ROBERTO FLORIS;ROBERTO GANDINI;SIMONE MARZIALI;ALBERTO SIRACUSANO","9;8;7;6;6;6;6;5;5;5;5;5;5;4;4;3;3;3;3;3","MEDICINE;BIOLOGY;PSYCHOLOGY;PHYSICS;CHEMISTRY;COMPUTER SCIENCE;ENGINEERING;ECONOMICS;MATHEMATICS;PHILOSOPHY;MATERIALS SCIENCE;POLITICAL SCIENCE;SOCIOLOGY;ENVIRONMENTAL SCIENCE;GEOLOGY","128;46;14;12;11;9;6;3;3;3;2;2;2;1;1","INTERNAL MEDICINE;SURGERY;GENETICS;PATHOLOGY;IMMUNOLOGY;GASTROENTEROLOGY;ONCOLOGY;BIOCHEMISTRY;RADIOLOGY;ENDOCRINOLOGY;CARDIOLOGY;PSYCHIATRY;NEUROSCIENCE;INTENSIVE CARE MEDICINE;PEDIATRICS;CELL BIOLOGY;ENVIRONMENTAL HEALTH;OPTICS;UROLOGY;NURSING","90;46;33;21;19;18;18;17;15;12;11;11;10;9;9;8;8;8;7;6","GENE;TRANSPLANTATION;CANCER;CHEMOTHERAPY;DISEASE;POPULATION;ANTIGEN;LEUKEMIA;RECEPTOR;INCIDENCE (GEOMETRY);MYELOID LEUKEMIA;STEM CELL;EMBOLIZATION;MAGNETIC RESONANCE IMAGING;STIMULATION;ADVERSE EFFECT;BONE MARROW;COHORT;DIABETES MELLITUS;QUALITY OF LIFE (HEALTHCARE)","30;17;16;13;11;10;8;8;7;6;6;6;5;5;5;4;4;4;4;4","CYCLOPHOSPHAMIDE;GENOTYPE;HEMATOPOIETIC STEM CELL TRANSPLANTATION;ALLELE;HUMAN LEUKOCYTE ANTIGEN;MUTATION;COLORECTAL CANCER;GENE EXPRESSION;PHENOTYPE;ACUTE LEUKEMIA;GRAFT-VERSUS-HOST DISEASE;PROSTATE;BONE MINERAL;C1-INHIBITOR;FETUS;INSULIN RESISTANCE;LIVER TRANSPLANTATION;LOCUS (GENETICS);PARKINSON'S DISEASE;PROTEIN KINASE B;TOLERABILITY","9;9;9;8;8;7;5;5;5;4;4;4;3;3;3;3;3;3;3;3;3","BUSULFAN;FLUDARABINE;SINGLE-NUCLEOTIDE POLYMORPHISM;MISSENSE MUTATION;ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY;COPY-NUMBER VARIATION;DNA METHYLATION;GENE DOSAGE;GENOTYPING;HAPLOTYPE;HISTOCOMPATIBILITY TESTING;KRAS;LMNA;PRENATAL DIAGNOSIS;PROSTATE BIOPSY;RIBAVIRIN;ACTIN CYTOSKELETON;ACUTE LYMPHOCYTIC LEUKEMIA;ADENOCARCINOMA OF THE LUNG;ADVANCED MATERNAL AGE;AEROALLERGEN;ALLELE FREQUENCY;ALPHA (FINANCE);AMINO ACID SUBSTITUTION;ANEUPLOIDY;ASYMMETRIC DIMETHYLARGININE;BASILIXIMAB;BIOMARKER DISCOVERY;BONE MARROW TRANSPLANT;BONE METASTASIS;CANCER IMMUNOTHERAPY;CAPECITABINE;CARDIAC INDEX;CAROTID STENTING;CERVICAL CANAL;CHROMATIN REMODELING;COLONOSCOPY;COMPARATIVE GENOMIC HYBRIDIZATION;CRITICAL LIMB ISCHEMIA;CTGF;DEEP BRAIN STIMULATION;DIABETIC FOOT ULCER;DIABETIC ULCERS;DNA EXTRACTION;ELEVATED ALKALINE PHOSPHATASE;ENDOVASCULAR ANEURYSM REPAIR;ENHANCER;EXTRAVERSION AND INTROVERSION;FAMILY PLANNING;FOXO1;FRACTIONAL ANISOTROPY;FRAGILITY FRACTURE;FRAMESHIFT MUTATION;GASTRIC ADENOCARCINOMA;GENE MUTATION;GENETIC HETEROGENEITY;GLUCOSE HOMEOSTASIS;GLUTATHIONE S-TRANSFERASE;HAPLOINSUFFICIENCY;HEMATOPOIETIC CELL;HLA-A;HLA-DRB1;INDUCED PLURIPOTENT STEM CELL;INGUINAL CANAL;INGUINAL HERNIA SURGERY;INSULIN RECEPTOR;IONIZATION CHAMBER;IRINOTECAN;LEFT VENTRICULAR NONCOMPACTION;LEVODOPA;LOWER URINARY TRACT SYMPTOMS;METASTASECTOMY;MHC CLASS I;MILAN CRITERIA;MOLECULAR BEACON;MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION;MURINE NOROVIRUS;NATURAL KILLER CELL;NONALCOHOLIC FATTY LIVER DISEASE;NOX4;NULL ALLELE;ORAL ALLERGY SYNDROME;OSTEOPROTEGERIN;OXALIPLATIN;P2Y12;PARADOXICAL EMBOLISM;PENETRANCE;PERCUTANEOUS ETHANOL INJECTION;PHARMACOGENETICS;PHENOCOPY;PLATELET-DERIVED GROWTH FACTOR RECEPTOR;PRIMARY MOTOR CORTEX;PRODUCTS OF CONCEPTION;PROSTATE GLAND;PROSTATE-SPECIFIC ANTIGEN;PROSTATECTOMY;PROSTATITIS;PSEUDOGENE;RECTAL EXAMINATION;RECURRENT MISCARRIAGE;RIGHT-TO-LEFT SHUNT;RNA EXTRACTION;RYR1;SEROTONERGIC;SOX2;STROKE VOLUME;THIOTEPA;THYMOGLOBULIN;TOTAL BODY IRRADIATION;TRANSURETHRAL RESECTION OF THE PROSTATE","7;7;6;4;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;;MIDDLE AGED;AGED;ADULT;ITALY;AGED, 80 AND OVER;TREATMENT OUTCOME;ADOLESCENT;RETROSPECTIVE STUDIES;YOUNG ADULT;OSTEOPOROTIC FRACTURES;RISK FACTORS;CHILD;GENETIC PREDISPOSITION TO DISEASE;GRAFT VS HOST DISEASE;HEMATOPOIETIC STEM CELL TRANSPLANTATION;CHILD, PRESCHOOL","84;59;59;55;40;38;33;25;16;15;13;13;13;12;10;9;9;9;8;7","HEMATOPOIETIC STEM CELL BIOLOGY;ACUTE MYELOID LEUKEMIA;REGULATORY T CELL DEVELOPMENT AND FUNCTION;DIAGNOSIS AND MANAGEMENT OF HYPERTROPHIC CARDIOMYOPATHY;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;HEREDITARY ANGIOEDEMA: MOLECULAR MECHANISMS AND CLINICAL MANAGEMENT;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;PROSTATE CANCER RESEARCH AND TREATMENT;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;CALCINEURIN-NFAT SIGNALING IN TRANSCRIPTIONAL REGULATION;CEREBELLAR CONTRIBUTIONS TO NEUROLOGICAL DISORDERS AND FUNCTIONS;EPIDEMIOLOGY AND TREATMENT OF CHILDHOOD LEUKEMIA;GASTRIC CANCER RESEARCH AND TREATMENT;GLOBAL TRENDS IN COLORECTAL CANCER RESEARCH;HEPATITIS C INFECTION AND TREATMENT;HEPATOCELLULAR CARCINOMA;MORAL DISTRESS IN HEALTHCARE PROFESSIONALS;PREVENTION AND MANAGEMENT OF DIABETIC FOOT ULCERS;RADIOTHERAPY PHYSICS AND TECHNOLOGY;STRUCTURE AND FUNCTION OF THE NUCLEAR PORE COMPLEX","8;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2","HEMATOPOIETIC CELL TRANSPLANTATION;TREATMENT;ACUTE MYELOID LEUKEMIA;C1-INHIBITOR;CONCOMITANT;CORTICAL EXCITABILITY;HEREDITARY ANGIOEDEMA;REGIMEN;STROKE (ENGINE);TOLERABILITY;TRANSCRANIAL MAGNETIC STIMULATION;AZACITIDINE;BASILIXIMAB;BIOPSY;BONE MINERAL DENSITY;BRAIN STIMULATION;C1 INHIBITOR DEFICIENCY;CANCER;CARDIAC IMAGING;CARDIOTHORACIC SURGERY","9;7;5;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2","STEM CELL;ACUTE MYELOID;CELL TRANSPLANTATION;MYELOID LEUKEMIA;MARROW TRANSPLANTATION;BONE MARROW;CLASS PATIENTS;HEREDITARY ANGIOEDEMA;LEUKEMIA AML;LIVER TRANSPLANT;ACUTE LEUKEMIA;ALLOGENEIC HEMATOPOIETIC;ALLOGENEIC STEM;ANGIOEDEMA DUE;AUTOLOGOUS STEM;CARDIAC SURGERY;CELL TRANSPLANT;CIRRHOTIC PATIENTS;COMPUTED TOMOGRAPHY;CORD BLOOD;EBMT LYMPHOMA;FRAGILITY FRACTURES;HEMATOPOIETIC STEM;HEPATOCELLULAR CARCINOMA;INHIBITOR DEFICIENCY;ITALIAN REGISTRY;MONOCLONAL ANTIBODY;NATIONWIDE SURVEY;OBSERVATIONAL STUDY;PARKINSONS DISEASE","9;8;7;7;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","RESEARCH FUNDING;PROLONGED-RELEASE TACROLIMUS;HONORARIA RESEARCH;MEDIAN AGE;AJCC GRADE;ACUTE FAECAL;CONSULTANCY HONORARIA;FAECAL INCONTINENCE;ADVISORY COMMITTEES;ELDERLY PATIENTS;ENTITYS BOARD;MORAL DISENGAGEMENT;ARM PROLONGED-RELEASE;BCAR INCIDENCE;BOLOGNA ITALY;C-INH-HAE TYPE;DIABETIC FOOT;GROWTH FACTOR;MEDIAN FOLLOW-UP;MEDIAN NA;RENAL FUNCTION;SURVIVAL OS;TUBULAR APPLICATORS;WOUND HEALING;BEDSIDE ULTRASONOGRAPHY;COMPLETE RESPONSE;DE NOVO;DISTAL-ONSET MYOPATHY;ENDOTHELIAL DYSFUNCTION;FAECAL MANAGEMENT","17;14;12;11;10;9;9;9;7;7;7;7;6;6;6;6;6;6;6;6;6;6;6;6;5;5;5;5;5;5",56,0.4,5.01,5,2,1,1,4,2,0,1,5,0,1,4,0,5,2,2,4.5,2,0,0,85.75,85.75,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,17,5.76,1439.47,5.69,12,0.71,145.41,1,0,3,1,4,0,1,7,0,13,4,0,0,0,0,0,0,17,0,0,17,0,0,0,0,0,0,0,0,0,"Japan;United States;Italy;Canada;Switzerland","3;3;2;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3204 IMMUNOLOGY;3212 OPHTHALMOLOGY AND OPTOMETRY;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","17;8;4;3;2;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PATIENT SAFETY;DIGESTIVE DISEASES;CANCER;HEMATOLOGY;RARE DISEASES;AUTOIMMUNE DISEASE;CHILDHOOD LEUKEMIA;NUTRITION;PEDIATRIC;PEDIATRIC CANCER;STEM CELL RESEARCH;CARDIOVASCULAR;CROHN'S DISEASE;HEART DISEASE;INFLAMMATORY BOWEL DISEASE;LIVER DISEASE;LUNG;ORPHAN DRUG","17;13;7;6;5;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2","ORAL AND GASTROINTESTINAL;CANCER;BLOOD;EYE;INFLAMMATORY AND IMMUNE SYSTEM;METABOLIC AND ENDOCRINE;RESPIRATORY","5;3;1;1;1;1;1","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.4 SURGERY;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.1 PHARMACEUTICALS","12;3;2;2;1;1","LEUKEMIA / LEUKAEMIA;BLOOD CANCER;COLON AND RECTAL CANCER;LUNG CANCER","4;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES;5.2 LOCALIZED THERAPIES - CLINICAL APPLICATIONS;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT","5;2;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,"PUBLIC LIBRARY OF SCIENCE","2","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3207 MEDICAL MICROBIOLOGY","4;1;1","HIV/AIDS;INFECTIOUS DISEASES;CLINICAL RESEARCH;GENETICS;PREVENTION","2;2;1;1;1","INFECTION","2","2.2 FACTORS RELATING TO THE PHYSICAL ENVIRONMENT","1","POPULATION & SOCIETY","1",NA,NA,NA,NA,NA,NA
"AOU_TORVERGATA",2016,140,12.3071428571429,2.81428571428571,0.392857142857143,0.435714285714286,0.55,1.5390625,1.27906976744186,1.56410256410256,1.26229508196721,0.542857142857143,3,64,31,15,16,0.46,0.22,0.11,0.11,25.23,0.776669752318839,4.60672268907563,0.278571428571429,0.857142857142857,0.44,0.387,0.391,0.368,"GIACOMO KOCH;ROBERTO FLORIS;CARLO CALTAGIRONE;PAOLO NARDI;MARCO CIOTTI;UMBERTO TARANTINO;GUGLIELMO MANENTI;VIVIANA PONZO;RICCARDO SANTONI;MASSIMO CICCOZZI;GIORGIO DI LORENZO;SILVIA NATOLI;NOVELLA RAPINI;FRANCESCO ROMEO;MARZIA LAZZARI;ALESSANDRA LO PRESTI;FRANCESCO DI LORENZO;WILLIAM ARCESE;GIOVANNI RUVOLO;MARCO RUSSO","11;9;8;7;7;7;6;6;5;5;5;4;4;4;4;4;4;4;4;4","PAOLO NARDI;GIACOMO KOCH;EUGENIO POMPEO;ROBERTO FLORIS;CARLO CALTAGIRONE;MARCO RUSSO;ANNUNZIATA DATTOLA;MARCO CIOTTI;UMBERTO TARANTINO;GIOVANNI RUVOLO;GUGLIELMO MANENTI;ROBERTO GANDINI;VIVIANA PONZO;GUGLIELMO SAITTO;AUGUSTO ORLANDI;GIAN PAOLO USSIA;SILVIA NATOLI;MARZIA LAZZARI;MASSIMO CICCOZZI;GIORGIO DI LORENZO","2.47;1.45;1.45;1.19;1.07;1.04;1;1;0.93;0.84;0.83;0.82;0.74;0.64;0.58;0.58;0.56;0.56;0.54;0.53","GIACOMO KOCH;ROBERTO FLORIS;CARLO CALTAGIRONE;PAOLO NARDI;MARCO CIOTTI;UMBERTO TARANTINO;GUGLIELMO MANENTI;RICCARDO SANTONI;GIORGIO DI LORENZO;SILVIA NATOLI;NOVELLA RAPINI;FRANCESCO ROMEO;MARZIA LAZZARI;FRANCESCO DI LORENZO;WILLIAM ARCESE;GIOVANNI RUVOLO;MARCO RUSSO;AUGUSTO ORLANDI;VALERIA FIASCHETTI;ROBERTO GANDINI","11;9;8;7;7;7;6;5;5;4;4;4;4;4;4;4;4;4;4;4","PAOLO NARDI;GIACOMO KOCH;EUGENIO POMPEO;ROBERTO FLORIS;CARLO CALTAGIRONE;MARCO RUSSO;ANNUNZIATA DATTOLA;MARCO CIOTTI;UMBERTO TARANTINO;GIOVANNI RUVOLO;GUGLIELMO MANENTI;ROBERTO GANDINI;GUGLIELMO SAITTO;AUGUSTO ORLANDI;GIAN PAOLO USSIA;SILVIA NATOLI;MARZIA LAZZARI;GIORGIO DI LORENZO;VALERIA FIASCHETTI;ORAZIO SCHILLACI","2.47;1.45;1.45;1.19;1.07;1.04;1;1;0.93;0.84;0.83;0.82;0.64;0.58;0.58;0.56;0.56;0.53;0.53;0.52","GIUSEPPE TISONE;GIACOMO KOCH;A. SANCHEZ FUEYO;ABRAHAM SHAKED;ADRIANA ZEEVI;ALBERT J. CZAJA;ANNETTE S.H. GOUW;ANNIKA WERNERSON;ANTHONY J. DEMETRIS;ARNAUD DEL BELLO;ATHANASSIOS C. TSAMANDAS;ATUL K. BHAN;AURELIO SONZOGNI;B. SIS;CARLOS THADEU SCHMIDT CERSKI;CHARLES LASSMAN;CHRISTOPHER BELLAMY;DESLEY NEIL;EIZABURO SASATOMI;EMMA E. FURTH","539;527;502;502;502;502;502;502;502;502;502;502;502;502;502;502;502;502;502;502","LEONARDO BAIOCCHI;GIACOMO KOCH;UMBERTO TARANTINO;NOVELLA RAPINI;FEDERICO RICCI;WILLIAM ARCESE;ELENA GASBARRA;EUGENIO POMPEO;RICCARDO SANTONI;GUGLIELMO MANENTI;JACOPO M. LEGRAMANTE;ROBERTO FLORIS;ANTONELLA BRANDI;G. GIOVAGNOLI;GIUSEPPE VISCONTI;VITO N. DI LECCE;VIVIANA MOSCHESE;GIORGIO DI LORENZO;MARCO CIOTTI;CECILIA RAO","502;469;170;165;139;133;122;106;104;100;99;99;96;96;96;96;96;95;91;84","GIACOMO KOCH;ROBERTO FLORIS;MARCO CIOTTI;PAOLO NARDI;UMBERTO TARANTINO;FRANCESCO ROMEO;GUGLIELMO MANENTI;MARCO RUSSO;RICCARDO SANTONI;EUGENIO POMPEO;GIORGIO DI LORENZO;NOVELLA RAPINI;VALERIA FIASCHETTI;GIANLUCA INGROSSO;GIOVANNI RUVOLO;GIUSEPPE TISONE;WILLIAM ARCESE;ALBERTO SIRACUSANO;ANGELO SCUTERI;AUGUSTO ORLANDI","10;8;7;6;6;5;5;5;5;4;4;4;4;4;4;4;4;3;3;3","MEDICINE;BIOLOGY;PSYCHOLOGY;PHYSICS;CHEMISTRY;COMPUTER SCIENCE;MATHEMATICS;ECONOMICS;ENGINEERING;SOCIOLOGY;ART;GEOGRAPHY;GEOLOGY;MATERIALS SCIENCE;PHILOSOPHY;POLITICAL SCIENCE","130;40;24;13;7;7;6;4;3;3;1;1;1;1;1;1","INTERNAL MEDICINE;SURGERY;RADIOLOGY;CARDIOLOGY;GENETICS;IMMUNOLOGY;PATHOLOGY;GASTROENTEROLOGY;NEUROSCIENCE;PSYCHIATRY;ONCOLOGY;ENVIRONMENTAL HEALTH;BIOCHEMISTRY;ENDOCRINOLOGY;NUCLEAR MEDICINE;PHYSICAL THERAPY;INTENSIVE CARE MEDICINE;PALEONTOLOGY;VIROLOGY;CLINICAL PSYCHOLOGY","99;32;21;20;19;18;17;15;14;14;13;12;10;9;9;9;8;8;8;7","CANCER;TRANSPLANTATION;GENE;POPULATION;DISEASE;COHORT;RECEPTOR;STENOSIS;CHEMOTHERAPY;COGNITION;DIABETES MELLITUS;RADIATION THERAPY;ALTERNATIVE MEDICINE;ANTIBODY;BLOOD PRESSURE;CONFIDENCE INTERVAL;MAGNETIC RESONANCE IMAGING;STIMULATION;ADVERSE EFFECT;HEART FAILURE;OSTEOPOROSIS;PROPORTIONAL HAZARDS MODEL;RANDOMIZED CONTROLLED TRIAL;VIRUS","18;13;12;12;10;9;8;8;7;7;7;7;6;6;6;6;6;6;5;5;5;5;5;5","HEMATOPOIETIC STEM CELL TRANSPLANTATION;PROSTATE;BONE MINERAL;COLORECTAL CANCER;PROSTATE CANCER;TRANSCRANIAL MAGNETIC STIMULATION;CYCLOPHOSPHAMIDE;LIVER TRANSPLANTATION;PARKINSON'S DISEASE;AORTIC VALVE REPLACEMENT;BYPASS GRAFTING;CARCINOGENESIS;CUMULATIVE INCIDENCE;KIDNEY TRANSPLANTATION;LONG-TERM POTENTIATION;MOTOR CORTEX;NEUROPSYCHOLOGY;PHYLOGENETIC TREE;RADIOSURGERY;TYPE 1 DIABETES","7;6;5;5;5;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3","ABATACEPT;ARTIFICIAL PANCREAS;CLADE;CROSSOVER STUDY;CYBERKNIFE;DUAL-ENERGY X-RAY ABSORPTIOMETRY;FLUDARABINE;INTERNATIONAL PROGNOSTIC SCORING SYSTEM;LEVODOPA;OXYCODONE;PARATUBERCULOSIS;SABR VOLATILITY MODEL;THYMOGLOBULIN;ABDOMINAL OBESITY;ACUTE PROMYELOCYTIC LEUKEMIA;ADENOSINE RECEPTOR;AFLIBERCEPT;ANAPHASE;BAROREFLEX;BK VIRUS;BREAKTHROUGH PAIN;BRENTUXIMAB VEDOTIN;BRONCHODILATATION;BUSULFAN;CARDIAC RESYNCHRONIZATION THERAPY;CLASSIFICATION OF MENTAL DISORDERS;COGNITIVE DECLINE;COGNITIVE RESERVE;CONCURRENT VALIDITY;CRITICAL LIMB ISCHEMIA;CRYOGLOBULINEMIA;DEEP BRAIN STIMULATION;DIABETES TREATMENT;DIABETIC FOOT ULCER;DIAGNOSTIC CLASSIFICATION OF MENTAL HEALTH AND DEVELOPMENTAL DISORDERS OF INFANCY AND EARLY CHILDHOOD;DIGITAL POLYMERASE CHAIN REACTION;DNA-BINDING PROTEIN;DORSOLATERAL PREFRONTAL CORTEX;DRY-POWDER INHALER;FIBROMUSCULAR DYSPLASIA;FOXO1;FRACTIONAL ANISOTROPY;GASTRIC BYPASS;HEPATITIS E;HEPATITIS E VIRUS;HERPESVIRIDAE;IMATINIB MESYLATE;INVOLUCRIN;KU70;MARGINAL ZONE;MIGRAINE WITH AURA;MODIFIED RANKIN SCALE;MOST RECENT COMMON ANCESTOR;MUCOSA-ASSOCIATED LYMPHOID TISSUE;MULTIPLEX POLYMERASE CHAIN REACTION;NEOADJUVANT THERAPY;NEUROPSYCHOLOGICAL ASSESSMENT;NS3;NUCLEAR PROTEIN;NUCLEOPLASM;ORAL ALLERGY SYNDROME;OSTEOCALCIN;OSTEOPROTEGERIN;P2Y12;PAIN LADDER;POSACONAZOLE;PROSTATE ADENOCARCINOMA;PROSTATECTOMY;PROSTATIC ADENOCARCINOMA;PROTEIN SYNTHESIS INHIBITOR;RANIBIZUMAB;RENAL ARTERY STENOSIS;RETINOIC ACID RECEPTOR;RETINOID;RHIPICEPHALUS SANGUINEUS;RIGHT RENAL ARTERY;RUNX2;RUXOLITINIB;SEMINAL VESICLE;SPIKE-TIMING-DEPENDENT PLASTICITY;SPOTTED FEVER;STROKE VOLUME;TAQMAN;THIOTEPA;TOTAL BODY IRRADIATION;TRETINOIN;VANCOMYCIN;VENETOCLAX","2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;;FEMALE;MALE;MIDDLE AGED;AGED;ITALY;ADULT;AGED, 80 AND OVER;OSTEOPOROSIS;TREATMENT OUTCOME;RETROSPECTIVE STUDIES;DIABETES MELLITUS, TYPE 1;HEART FAILURE;PARKINSON DISEASE;ADOLESCENT;ALZHEIMER DISEASE;MOTOR CORTEX;TRANSCRANIAL MAGNETIC STIMULATION;YOUNG ADULT","79;58;58;58;46;45;34;24;18;13;13;12;10;10;10;9;9;9;9;9","MANAGEMENT OF VALVULAR HEART DISEASE;CHALLENGES IN PAIN MANAGEMENT AND TREATMENT;EFFECTS OF BRAIN STIMULATION ON MOTOR CORTEX;GENOMIC ABERRATIONS AND TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA;HEPATITIS C INFECTION AND TREATMENT;PROSTATE CANCER RESEARCH AND TREATMENT;RADIOTHERAPY PHYSICS AND TECHNOLOGY;ANALYSIS OF BRAIN FUNCTIONAL CONNECTIVITY NETWORKS;ANTIPLATELET THERAPY IN CARDIOVASCULAR DISEASE;DEEP BRAIN STIMULATION FOR NEUROLOGICAL DISORDERS;DIAGNOSIS AND TREATMENT OF CAROTID ARTERY DISEASE;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;HEMATOPOIETIC STEM CELL BIOLOGY;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;LIVER TRANSPLANTATION AND GRAFT SURVIVAL ANALYSIS;LYMPHOID NEOPLASMS;MANAGEMENT OF DIABETES MELLITUS AND HYPOGLYCEMIA;MOLECULAR PATHOGENESIS OF MYELOPROLIFERATIVE DISORDERS;PATHOGENESIS AND TREATMENT OF OSTEONECROSIS;PREVENTION AND MANAGEMENT OF DIABETIC FOOT ULCERS","4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2","TRANSCRANIAL MAGNETIC STIMULATION;CORTICAL EXCITABILITY;DIABETES;HEMATOPOIETIC CELL TRANSPLANTATION;NEUROIMAGING DATA ANALYSIS;REGIMEN;TRANSCATHETER AORTIC-VALVE REPLACEMENT;TRANSCRANIAL DIRECT CURRENT STIMULATION;BONE MINERAL DENSITY;CARDIOVASCULAR EVALUATION;CUMULATIVE INCIDENCE;INTENSITY-MODULATED RADIOTHERAPY;LIVER BIOPSY;PROSTHETIC VALVES EVALUATION;STROKE (ENGINE);TREATMENT;TYPE 1 DIABETES;ABATACEPT;ABLATIVE CASE;ABNORMALITY","6;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;2;2;2","PATIENTS UNDERGOING;STEM CELL;CELL TRANSPLANTATION;LONG-TERM FOLLOW-UP;ALZHEIMERS DISEASE;ARTERY BYPASS;BYPASS GRAFTING;CONSENSUS DOCUMENT;CORONARY ARTERY;HAEMATOPOIETIC STEM;HEMATOPOIETIC STEM;PLANNING COMPARISON;ALLOGENEIC HAEMATOPOIETIC;ANMCOSICSICI-GISESICCH CONSENSUS;ANTI-THYMOCYTE GLOBULIN;AORTIC VALVE;ARTIFICIAL PANCREAS;BLOOD PRESSURE;BODY RADIOTHERAPY;CARDIAC SURGICAL;COHORT STUDY;COLORECTAL CANCER;COMBINED LIVER;COMPUTED TOMOGRAPHY;CORTICAL PLASTICITY;DISEASE PATIENTS;ECONOMICAL EVALUATION;ELDERLY PATIENTS;ENDOVASCULAR TREATMENT;HEART FAILURE","6;6;5;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HR CI;SUSTAIN PROGRAM;TOR VERGATA;RHEUMATOLOGY CENTRES;ROME ITALY;CONSULTANCY HONORARIA;PATIENTS RECEIVING;POST-TRANSPLANT CYCLOPHOSPHAMIDE-BASED;CHRONIC PAIN;CORTICAL PLASTICITY;CYCLOPHOSPHAMIDE-BASED REGIMEN;GRAFT-VERSUS-HOST DISEASE;ADVISORY COMMITTEES;ANTI-THYMOCYTE GLOBULIN-BASED;AORTIC VALVE;ENTITYS BOARD;PATIENTS UNDERGOING;SPEAKERS BUREAU;CANCER PATIENTS;INGUINAL HERNIA;INTER-LABORATORY VARIABILITY;ITALY DEPARTMENT;MG BID;PATIENTS UNDERWENT;UNIVERSITY HOSPITAL;VERGATA UNIVERSITY;ABATACEPT IVI;BCG CONNAUGHT;BLADDER EMPTYING;BONE MARROW","16;12;11;10;9;8;8;8;7;7;7;7;6;6;6;6;6;6;5;5;5;5;5;5;5;5;4;4;4;4",59,0.42,4.6,4.5,2,1,0,3,1,1,1,5,0,1,4,0,0,1.75,2,4,1.25,0,0,84,84,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,20,4.3,507.45,8.62,17,0.85,134.55,1,0,3,1,12,0,1,2,0,18,2,0,0,0,0,0,0,20,0,0,19,0,0,1,0,0,0,0,0,0,"United States;Japan;Germany","7;3;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;3204 IMMUNOLOGY;3212 OPHTHALMOLOGY AND OPTOMETRY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;42 HEALTH SCIENCES","20;12;7;5;2;2;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;RARE DISEASES;HEMATOLOGY;DIGESTIVE DISEASES;PATIENT SAFETY;PREVENTION;AGING;AUTOIMMUNE DISEASE;NEUROSCIENCES;PEDIATRIC;PEDIATRIC CANCER;BRAIN DISORDERS;CHILDHOOD LEUKEMIA;LYMPHOMA;NEURODEGENERATIVE;ORPHAN DRUG;STEM CELL RESEARCH;STEM CELL RESEARCH - NONEMBRYONIC - HUMAN","19;18;8;7;6;5;5;5;3;3;3;3;3;2;2;2;2;2;2;2","CANCER;BLOOD;EYE;INFLAMMATORY AND IMMUNE SYSTEM;MUSCULOSKELETAL;ORAL AND GASTROINTESTINAL","6;1;1;1;1;1","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES","20;3;1;1","LEUKEMIA / LEUKAEMIA;NON-HODGKIN'S LYMPHOMA;BLOOD CANCER;COLON AND RECTAL CANCER;LUNG CANCER;PANCREATIC CANCER","5;2;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","7;3;3",1,369375,123125,4,3,1,1,0,30781.25,4.54822335025381,"CENTRO CLINICO NEMO;FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO;POLICLINICO TOR VERGATA","1;1;1","TELETHON FOUNDATION","1",NA,NA,"TELETHON - UILDM CLINICAL GRANT PROJECTS - 2015 (PROGRAM)","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY","1;1","BEHAVIORAL AND SOCIAL SCIENCE;BRAIN DISORDERS;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;INTELLECTUAL AND DEVELOPMENTAL DISABILITIES (IDD);MUSCULAR DYSTROPHY;NEUROSCIENCES;RARE DISEASES","1;1;1;1;1;1;1;1",NA,NA,"6.1 PHARMACEUTICALS","1",NA,NA,NA,NA,"A01 CLINICAL MEDICINE","1",NA,NA,6,"PUBLIC LIBRARY OF SCIENCE","6","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;34 CHEMICAL SCIENCES;3406 PHYSICAL CHEMISTRY;44 HUMAN SOCIETY","7;2;2;2;1;1;1;1","AGING;CLINICAL RESEARCH;EMERGENCY CARE;HEALTH SERVICES;PREVENTION","1;1;1;1;1",NA,NA,"3.1 PRIMARY PREVENTION INTERVENTIONS TO MODIFY BEHAVIOURS OR PROMOTE WELLBEING;8.1 ORGANISATION AND DELIVERY OF SERVICES","1;1","CLINICAL","3","CLINICAL MEDICINE AND SCIENCE;HEALTH SERVICES RESEARCH","1;1",NA,NA,NA,NA
"AOU_TORVERGATA",2017,165,12.7212121212121,2.92727272727273,0.327272727272727,0.357575757575758,0.466666666666667,1.67708333333333,1.17391304347826,1.78787878787879,1.203125,0.606060606060606,4,63,30,28,23,0.38,0.18,0.17,0.14,21.01,0.712878775020151,4.63988095238094,0.303030303030303,0.884848484848485,0.456,0.425,0.424,0.437,"MARCO ANDREANI;WILLIAM ARCESE;M. ANGÉLICO;GIACOMO KOCH;CARLO FEDERICO PERNO;VIVIANA PONZO;ILARIA LENCI;CARLO CALTAGIRONE;MARTINA MILANA;ROBERTO LATAGLIATA;SONIA BONNÌ;FRANCESCO DI LORENZO;UMBERTO TARANTINO;MASSIMO BRECCIA;MARCO CIOTTI;FABIO CICERI;BENEDETTO BRUNO;FRANCESCA CECCHERINI‐SILBERSTEIN;ADRIANO VENDITTI;VINCENZO AMBROGI","11;11;11;11;10;9;9;8;8;7;7;7;7;7;6;6;6;6;6;5","UMBERTO TARANTINO;MARCO ANDREANI;GIACOMO KOCH;ADRIANO VENDITTI;VINCENZO AMBROGI;TOMMASO CLAUDIO MINEO;MANUELE BASILI;NARDI PAOLO;VIVIANA PONZO;M. ANGÉLICO;SONIA BONNÌ;CARLO FEDERICO PERNO;CARLO CALTAGIRONE;MARCO CIOTTI;ILARIA LENCI;MARIAROSA BATTARRA;R. CONDELLO;MARTINA MILANA;MARÍA CELESTE;FRANCESCO DI LORENZO","1.55;1.48;1.3;1.25;1.23;1.23;1;1;0.97;0.95;0.83;0.81;0.8;0.8;0.8;0.8;0.8;0.78;0.7;0.66","MARCO ANDREANI;WILLIAM ARCESE;M. ANGÉLICO;GIACOMO KOCH;CARLO FEDERICO PERNO;VIVIANA PONZO;ILARIA LENCI;CARLO CALTAGIRONE;MARTINA MILANA;FRANCESCO DI LORENZO;UMBERTO TARANTINO;MARCO CIOTTI;FRANCESCA CECCHERINI‐SILBERSTEIN;ADRIANO VENDITTI;VINCENZO AMBROGI;FRANCESCO ROMEO;PAOLO NARDI;AMBRA DI VEROLI;ROBERTO FLORIS;LEONARDO BAIOCCHI","11;11;11;11;10;9;9;8;8;7;7;6;6;6;5;5;5;5;5;5","UMBERTO TARANTINO;MARCO ANDREANI;GIACOMO KOCH;ADRIANO VENDITTI;VINCENZO AMBROGI;MANUELE BASILI;NARDI PAOLO;VIVIANA PONZO;M. ANGÉLICO;CARLO FEDERICO PERNO;CARLO CALTAGIRONE;MARCO CIOTTI;ILARIA LENCI;MARIAROSA BATTARRA;R. CONDELLO;MARTINA MILANA;MARÍA CELESTE;FRANCESCO DI LORENZO;PAOLO NARDI;FRANCESCO SELLITRI","1.55;1.48;1.3;1.25;1.23;1;1;0.97;0.95;0.81;0.8;0.8;0.8;0.8;0.8;0.78;0.7;0.66;0.66;0.65","GIACOMO KOCH;CARLO CALTAGIRONE;VIVIANA PONZO;FRANCESCO DI LORENZO;ALESSANDRO MARTORANA;WILLIAM ARCESE;SONIA BONNÌ;UMBERTO TARANTINO;MARCO BOZZALI;CATERINA MOTTA;BENEDETTO BRUNO;FABIO CICERI;SIMONA SICA;LUCA CASTAGNA;ELIAS PAOLO CASULA;SILVIA PICAZIO;CAMILLO MARRA;LAURA SERRA;MARA CERCIGNANI;MARIA CONCETTA PELLICCIARI","512;499;499;488;432;392;366;342;327;326;316;316;314;280;270;270;269;269;269;269","GIACOMO KOCH;UMBERTO TARANTINO;MAURIZIO FEOLA;CECILIA RAO;ELEONORA PICCIRILLI;LAURA CUDILLO;WILLIAM ARCESE;MARCO ANDREANI;RICCARDO SANTONI;GIANLUCA INGROSSO;CARLO CALTAGIRONE;FRANCESCO ROMEO;JAVID GAZIEV;MARIA GIUSEPPINA PALMIERI;ALBERTO BENUSSI;ALESSANDRA FLAMMINI;ALESSANDRO DEPARI;ALESSANDRO MARTORANA;ALESSANDRO PADOVANI;ANNA MICHELI","455;308;267;260;257;256;229;204;195;194;163;144;134;133;106;106;106;106;106;106","MARCO ANDREANI;GIACOMO KOCH;ILARIA LENCI;M. ANGÉLICO;FRANCESCO ROMEO;MARCO CIOTTI;MARTINA MILANA;UMBERTO TARANTINO;WILLIAM ARCESE;ADRIANO VENDITTI;AMBRA DI VEROLI;MAURIZIO FEOLA;ROBERTO FLORIS;A. BOSA;CARLO FEDERICO PERNO;CHIARA MASETTI;LEONARDO BAIOCCHI;MARIAROSA BATTARRA;R. CONDELLO;RICCARDO SANTONI","11;10;9;8;6;6;6;6;6;5;5;5;5;4;4;4;4;4;4;4","MEDICINE;BIOLOGY;PSYCHOLOGY;PHYSICS;COMPUTER SCIENCE;CHEMISTRY;ENGINEERING;ECONOMICS;MATHEMATICS;POLITICAL SCIENCE;SOCIOLOGY;MATERIALS SCIENCE;GEOLOGY;ART;PHILOSOPHY","150;34;23;13;11;10;9;4;4;4;4;3;2;1;1","INTERNAL MEDICINE;SURGERY;ONCOLOGY;RADIOLOGY;GASTROENTEROLOGY;GENETICS;PATHOLOGY;IMMUNOLOGY;CARDIOLOGY;ENVIRONMENTAL HEALTH;BIOCHEMISTRY;NEUROSCIENCE;PSYCHIATRY;ANESTHESIA;INTENSIVE CARE MEDICINE;ENDOCRINOLOGY;NURSING;FAMILY MEDICINE;PEDIATRICS;PHYSICAL THERAPY;VIROLOGY","117;52;23;22;20;20;19;16;15;14;13;12;12;9;9;8;8;7;7;7;7","GENE;CANCER;DISEASE;TRANSPLANTATION;POPULATION;CHEMOTHERAPY;STIMULATION;ANTIGEN;COHORT;BONE MARROW;CONFIDENCE INTERVAL;RECEPTOR;VIRUS;ADVERSE EFFECT;MYELOID LEUKEMIA;RETROSPECTIVE COHORT STUDY;LEUKEMIA;LUNG;QUALITY OF LIFE (HEALTHCARE);RADIATION THERAPY;STROKE (ENGINE)","24;21;21;21;13;12;11;10;9;8;8;8;8;7;7;7;6;6;6;6;6","HEMATOPOIETIC STEM CELL TRANSPLANTATION;HUMAN LEUKOCYTE ANTIGEN;TRANSCRANIAL MAGNETIC STIMULATION;HAZARD RATIO;ALLELE;MYELOFIBROSIS;PROSTATE CANCER;CUMULATIVE INCIDENCE;HEPATITIS C VIRUS;METASTASIS;MOTOR CORTEX;LIVER TRANSPLANTATION;LONG-TERM POTENTIATION;MYELODYSPLASTIC SYNDROMES;ACUTE LEUKEMIA;ALZHEIMER'S DISEASE;AORTIC VALVE REPLACEMENT;GENOTYPE;PORTAL HYPERTENSION;PROSTATE;TYPE 2 DIABETES","12;10;9;8;7;6;6;5;5;5;5;4;4;4;3;3;3;3;3;3;3","ANDROGEN DEPRIVATION THERAPY;INTERNATIONAL PROGNOSTIC SCORING SYSTEM;RIBAVIRIN;RUXOLITINIB;HEPACIVIRUS;METASTASECTOMY;ACUTE CHEST SYNDROME;ANDROGEN RECEPTOR;CARDIAC RESYNCHRONIZATION THERAPY;DABIGATRAN;GOLIMUMAB;KARYOTYPE;RIVAROXABAN;USTEKINUMAB;ACINETOBACTER BAUMANNII;ACUTE PROMYELOCYTIC LEUKEMIA;AMPA RECEPTOR;ANTIVIRAL THERAPY;AORTIC RUPTURE;AORTIC VALVULOPLASTY;BASDAI;BENTALL PROCEDURE;BK VIRUS;BONE MARROW TRANSPLANT;BONE METASTASIS;BREAST CARCINOMA;BRENTUXIMAB VEDOTIN;BRUTON'S TYROSINE KINASE;CA15-3;CARBOPLATIN;CARDIAC SKELETON;CD3;CERVICAL LYMPH NODES;CHEMOIMMUNOTHERAPY;COGNITIVE DECLINE;COLONOSCOPY;CONDITIONING REGIMEN;CRITICAL LIMB ISCHEMIA;CYANOACRYLATE;DNA METHYLATION;DONOR SPECIFIC ANTIBODIES;DOUBLE BLINDED;DYSKINESIA;EGFR INHIBITORS;ELLAGIC ACID;ENTEROBACTERIACEAE;ENTHESITIS;EPWORTH SLEEPINESS SCALE;ERLOTINIB;FRACTIONAL FLOW RESERVE;FRAGILITY FRACTURE;FRONTOTEMPORAL DEMENTIA;GENOTYPING;GLUCOSE HOMEOSTASIS;HERPESVIRIDAE;HISTOCOMPATIBILITY;HISTOCOMPATIBILITY TESTING;HYPERTRIGLYCERIDEMIA;IBRUTINIB;IMIPENEM;INGUINAL CANAL;KLEBSIELLA PNEUMONIAE;LEFT ATRIAL APPENDAGE OCCLUSION;LEVODOPA;LOW LEVEL LASER THERAPY;LUNG VOLUME REDUCTION SURGERY;MERKEL CELL POLYOMAVIRUS;MILAN CRITERIA;NIVOLUMAB;OSTEOCALCIN;OSTEOCYTE;OSTEOPOROTIC FRACTURE;POSTMENOPAUSAL OSTEOPOROSIS;PRIMARY MOTOR CORTEX;PROSTATECTOMY;RANKL;RECTAL EXAMINATION;RENAL MASS;REPRESSOR;RUNX2;SECONDARY HYPERPARATHYROIDISM;SPLENIC VEIN;SUICIDAL IDEATION;TAPENTADOL;TAQMAN;THIOTEPA;TOTAL BODY IRRADIATION;TRETINOIN;VENETOCLAX;WEIGHT CHANGE","4;4;4;4;3;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;;MALE;FEMALE;MIDDLE AGED;AGED;ADULT;ADOLESCENT;ITALY;TREATMENT OUTCOME;RETROSPECTIVE STUDIES;PROSTATIC NEOPLASMS, CASTRATION-RESISTANT;YOUNG ADULT;HEMATOPOIETIC STEM CELL TRANSPLANTATION;RISK FACTORS;AGED, 80 AND OVER;ANTIVIRAL AGENTS;HEPATITIS C, CHRONIC;HEPACIVIRUS;OSTEOPOROSIS","92;73;67;66;51;37;29;17;17;17;16;15;15;14;14;12;12;12;11;11","HEPATITIS C INFECTION AND TREATMENT;HEMATOPOIETIC STEM CELL BIOLOGY;MOLECULAR PATHOGENESIS OF MYELOPROLIFERATIVE DISORDERS;REGULATORY T CELL DEVELOPMENT AND FUNCTION;ACUTE MYELOID LEUKEMIA;ADVANCEMENTS IN PROSTATE CANCER RESEARCH;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;MANAGEMENT OF VALVULAR HEART DISEASE;ANALYSIS OF BRAIN FUNCTIONAL CONNECTIVITY NETWORKS;DIAGNOSIS AND MANAGEMENT OF AORTIC DISEASES;EFFECTS OF BRAIN STIMULATION ON MOTOR CORTEX;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;ROLE OF PENTRAXINS IN INNATE IMMUNITY AND INFLAMMATION;AGE-RELATED MACULAR DEGENERATION RESEARCH;ALLERGIC RHINITIS AND ITS IMPACT ON ASTHMA;DIAGNOSIS AND TREATMENT OF LUNG CANCER;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;GLIOMAS;HEPATOCELLULAR CARCINOMA","7;6;6;6;5;5;4;4;3;3;3;3;3;2;2;2;2;2;2;2","HEMATOPOIETIC CELL TRANSPLANTATION;TREATMENT;STROKE (ENGINE);TRANSCRANIAL MAGNETIC STIMULATION;CUMULATIVE INCIDENCE;IDENTIFICATION (BIOLOGY);MYELOFIBROSIS;REGIMEN;METASTATIC PROSTATE CANCER;PROSTHETIC VALVES EVALUATION;RADIOTHERAPY;RUXOLITINIB;TRANSCATHETER AORTIC-VALVE REPLACEMENT;TRANSCRANIAL DIRECT CURRENT STIMULATION;ABIRATERONE ACETATE;CARDIAC RESYNCHRONIZATION THERAPY;HEMATOLOGY;IMAGE-GUIDED RADIOTHERAPY;METASTASECTOMY;NEUROIMAGING DATA ANALYSIS","8;7;6;6;5;5;5;5;4;4;4;4;4;4;3;3;3;3;3;3","CELL TRANSPLANTATION;STEM CELL;ACUTE MYELOID;HEMATOPOIETIC STEM;ITALIAN SOCIETY;MYELOID LEUKEMIA;PROSTATE CANCER;BOWEL DISEASE;CANCER PATIENTS;CONSENSUS DOCUMENT;INFLAMMATORY BOWEL;ACUTE LEUKEMIA;AORTIC VALVE;HAPLOIDENTICAL HEMATOPOIETIC;KIDNEY DISEASE;LUNG METASTASECTOMY;MULTICENTER STUDY;OBSERVATIONAL STUDY;PATIENTS TREATED;REAL LIFE;SURGICAL TREATMENT;VALVE REPLACEMENT;ABIRATERONE ACETATE;ALZHEIMERS DISEASE;ANTIVIRAL AGENTS;AORTIC DISSECTION;ATRIAL FIBRILLATION;BLOOD PRESSURE;BONE MARROW;CARDIAC RESYNCHRONIZATION","10;8;6;6;5;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2","HR CI;RISK FACTORS;HOSPITAL STAY;STEM CELL;CELL TRANSPLANTATION;DOSE ESCALATION;ACUTE LEUKEMIA;CLINICAL OUTCOME;CONFIDENCE INTERVAL;MULTIVARIATE ANALYSIS;DOSE TAPERING;GAD AA;HAZARD RATIO;HEMATOPOIETIC STEM;MEDIAN FOLLOW-UP;PATIENTS TREATED;PLT GEL;AD PATIENTS;APOE GENOTYPE;CLINICAL PRACTICE;COMPUTED TOMOGRAPHY;ELLAGIC ACID;HEART FAILURE;INTERVAL CI;MYASTHENIA GRAVIS;PROSTATE CANCER;AORTIC DISSECTION;BONE MARROW;CHRONIC GVHD;ENDOTRACHEAL INTUBATION","19;13;12;11;10;10;9;9;9;9;8;8;8;8;8;8;8;7;7;7;7;7;7;7;7;7;6;6;6;6",58,0.35,4.57,6,2,1,1,5.75,1,0,1,7,0,0,5,1,2,2,2,4.75,2.5,0,0,67.75,67.75,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,26,3.96,615.76,9.85,17,0.65,176.85,0,0,3,0,14,0,1,8,0,19,7,0,0,0,0,0,0,26,0,0,26,0,0,0,0,0,0,0,0,0,"United States;Italy;Denmark;Japan;Switzerland","14;2;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;4205 NURSING","25;15;8;8;4;2;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DIGESTIVE DISEASES;AUTOIMMUNE DISEASE;CANCER;PATIENT SAFETY;RARE DISEASES;BRAIN DISORDERS;HEMATOLOGY;AGING;INFLAMMATORY BOWEL DISEASE;NEURODEGENERATIVE;NEUROSCIENCES;CHILDHOOD LEUKEMIA;CROHN'S DISEASE;PEDIATRIC;PEDIATRIC CANCER;PREVENTION;CARDIOVASCULAR;EMERGING INFECTIOUS DISEASES","24;17;8;7;7;7;7;6;6;5;5;5;5;4;4;4;4;4;3;3","CANCER;ORAL AND GASTROINTESTINAL;CARDIOVASCULAR;NEUROLOGICAL;INFLAMMATORY AND IMMUNE SYSTEM;SKIN","5;5;2;2;1;1","6.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;7.1 INDIVIDUAL CARE NEEDS;8.4 RESEARCH DESIGN AND METHODOLOGIES (HEALTH SERVICES)","20;1;1;1","LEUKEMIA / LEUKAEMIA;COLON AND RECTAL CANCER;MYELOMA","4;2;2","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES;4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING;4.4 RESOURCES AND INFRASTRUCTURE RELATED TO DETECTION, DIAGNOSIS, OR PROGNOSIS","2;2;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,18,"PUBLIC LIBRARY OF SCIENCE","18","32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;34 CHEMICAL SCIENCES;49 MATHEMATICAL SCIENCES;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES;3407 THEORETICAL AND COMPUTATIONAL CHEMISTRY;4203 HEALTH SERVICES AND SYSTEMS;31 BIOLOGICAL SCIENCES;40 ENGINEERING;4007 CONTROL ENGINEERING, MECHATRONICS AND ROBOTICS;46 INFORMATION AND COMPUTING SCIENCES;4613 THEORY OF COMPUTATION;4904 PURE MATHEMATICS;50 PHILOSOPHY AND RELIGIOUS STUDIES;5003 PHILOSOPHY","18;6;4;4;3;3;2;2;1;1;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;HEALTH SERVICES;LUNG;PATIENT SAFETY","1;1;1;1;1","CANCER","2","4.2 EVALUATION OF MARKERS AND TECHNOLOGIES","1","HEALTH SERVICES & SYSTEMS","1","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE","7;1","BREAST CANCER","3",NA,NA
"AOU_TORVERGATA",2018,149,13.2147651006711,2.73825503355705,0.288590604026846,0.348993288590604,0.429530201342282,1.52808988764045,1.16216216216216,1.79310344827586,1.23076923076923,0.597315436241611,1,55,34,20,18,0.37,0.23,0.13,0.12,23.72,0.777432906857944,4.64730290456431,0.369127516778524,0.87248322147651,0.427,0.351,0.321,0.381,"PAOLO NARDI;GIOVANNI RUVOLO;MASSIMO FEDERICI;WILLIAM ARCESE;ROBERTO FLORIS;MOHAMAD MOHTY;MYRIAM LABOPIN;ARNON NAGLER;GIUSEPPE NOVELLI;VINCENZO AMBROGI;LUCA BIANCHI;DIDIER BLAISE;BENEDETTO BRUNO;FABIO BERTOLDO;SARA RITA VACIRCA;MANUEL SCIMECA;TOMMASO CLAUDIO MINEO;RICCARDO SANTONI;MARINA CARDELLINI;VINCENZO SERRETTA","9;9;7;7;7;6;6;6;6;5;5;5;5;5;5;5;5;5;5;4","VINCENZO AMBROGI;TOMMASO CLAUDIO MINEO;EUGENIO POMPEO;AHMED ELKHOULY;PAOLO NARDI;GIOVANNI RUVOLO;SAITTO GUGLIELMO;MASSIMO FEDERICI;ROBERTO FLORIS;ROSSELLA MENGHINI;SARA RITA VACIRCA;MANUEL SCIMECA;GIUSEPPE NOVELLI;MARCO RUSSO;ORAZIO SCHILLACI;ALESSANDRO SILI;FRANCESCO ZAGHINI;ANTONIO PELLEGRINO;FABIO BERTOLDO;CARLO BASSANO","1.92;1.92;1.41;1.33;1.24;1.24;1;0.99;0.88;0.69;0.63;0.59;0.56;0.54;0.54;0.5;0.5;0.49;0.49;0.48","PAOLO NARDI;GIOVANNI RUVOLO;MASSIMO FEDERICI;WILLIAM ARCESE;ROBERTO FLORIS;VINCENZO AMBROGI;LUCA BIANCHI;FABIO BERTOLDO;SARA RITA VACIRCA;TOMMASO CLAUDIO MINEO;RICCARDO SANTONI;MARINA CARDELLINI;MARIA CANTONETTI;SAVINO M. DI STASI;ANDREA LANCIA;ANTONIO PELLEGRINO;AUGUSTO ORLANDI;STEFANO RIZZA;GIACOMO KOCH;CALOGERA PISANO","9;9;7;7;7;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4","VINCENZO AMBROGI;TOMMASO CLAUDIO MINEO;EUGENIO POMPEO;PAOLO NARDI;GIOVANNI RUVOLO;SAITTO GUGLIELMO;MASSIMO FEDERICI;ROBERTO FLORIS;ROSSELLA MENGHINI;SARA RITA VACIRCA;MARCO RUSSO;ALESSANDRO SILI;FRANCESCO ZAGHINI;ANTONIO PELLEGRINO;FABIO BERTOLDO;CARLO BASSANO;GUGLIELMO SAITTO;RICCARDO SANTONI;NICOLA BIAGIO MERCURI;LUCA BIANCHI","1.92;1.92;1.41;1.24;1.24;1;0.99;0.88;0.69;0.63;0.54;0.5;0.5;0.49;0.49;0.48;0.47;0.46;0.45;0.44","ANDREA LANCIA;ANTOINE HOLLEBECQUE;AURÉLIEN MARABELLE;CHARLES FERTÉ;CHARLOTTE ROBERT;CHRISTOPHE MASSARD;DAVID BRANDÃO;ELAINE JOHANNA LIMKIN;JEAN‐CHARLES SORIA;JEAN‐YVES SCOAZEC;LAURENT DERCLE;LOÏC VERLINGUE;MARIA VAKALOPOULOU;NIKOS PARAGIOS;ROGER SUN;SAMY AMMARI;SHAN RONG HAN;STÉPHANE CHAMPIAT;ÉRIC DEUTSCH;AXEL SCHMERMUND","969;935;935;935;935;935;935;935;935;935;935;935;935;935;935;935;935;935;935;350","ANDREA LANCIA;EUGENIO MARTUSCELLI;WILLIAM ARCESE;GIACOMO KOCH;SAVINO M. DI STASI;FABRIZIO SALLUSTIO;MASSIMO FEDERICI;PIERLUIGI BOVE;GASPARE ADORNO;GIORGIO DI LORENZO;UMBERTO TARANTINO;MARCO ANDREANI;CECILIA ALFIERI;JAVID GAZIEV;KATIA PACIARONI;ALESSANDRO LANTI;ANTONELLA ISGRÒ;GIOIA DE ANGELIS;MARCO MARZIALI;MICHELA RIBERSANI","969;350;217;202;169;168;149;119;106;92;91;86;80;80;80;78;78;78;78;78","GIOVANNI RUVOLO;PAOLO NARDI;WILLIAM ARCESE;ROBERTO FLORIS;MASSIMO FEDERICI;SARA RITA VACIRCA;VINCENZO AMBROGI;MARCO RUSSO;RICCARDO SANTONI;ANDREA LANCIA;ANTONIO PELLEGRINO;CARLO BASSANO;EUGENIO POMPEO;FABIO BERTOLDO;GIORGIO DI LORENZO;MARINA CARDELLINI;SAVINO M. DI STASI;MARIA CANTONETTI;ANTONIO SCAFURI;CALOGERA PISANO","8;8;7;6;6;5;5;5;5;4;4;4;4;4;4;4;4;3;3;3","MEDICINE;BIOLOGY;PSYCHOLOGY;CHEMISTRY;PHYSICS;COMPUTER SCIENCE;MATHEMATICS;POLITICAL SCIENCE;ENGINEERING;PHILOSOPHY;ECONOMICS;MATERIALS SCIENCE;ART;BUSINESS;SOCIOLOGY","138;47;13;11;10;9;6;6;5;3;2;2;1;1;1","INTERNAL MEDICINE;SURGERY;ONCOLOGY;GASTROENTEROLOGY;IMMUNOLOGY;PATHOLOGY;RADIOLOGY;GENETICS;CARDIOLOGY;BIOCHEMISTRY;NEUROSCIENCE;PEDIATRICS;PSYCHIATRY;ENDOCRINOLOGY;NURSING;PHYSICAL THERAPY;ANESTHESIA;CANCER RESEARCH;ENVIRONMENTAL HEALTH;INTENSIVE CARE MEDICINE;PALEONTOLOGY","102;45;27;26;26;24;24;20;17;15;9;9;9;8;8;8;7;7;7;7;7","CANCER;DISEASE;GENE;TRANSPLANTATION;CHEMOTHERAPY;RETROSPECTIVE COHORT STUDY;COHORT;STENOSIS;MAGNETIC RESONANCE IMAGING;MYELOID LEUKEMIA;CONFIDENCE INTERVAL;POPULATION;RANDOMIZED CONTROLLED TRIAL;COMPUTED TOMOGRAPHY;DIABETES MELLITUS;HEPATOCELLULAR CARCINOMA;IMMUNE SYSTEM;INCIDENCE (GEOMETRY);LEUKEMIA;LYMPHOMA;MULTIVARIATE ANALYSIS;MYOCARDIAL INFARCTION;PROPORTIONAL HAZARDS MODEL;QUALITY OF LIFE (HEALTHCARE)","19;16;16;13;11;11;8;8;7;7;6;6;6;5;5;5;5;5;5;5;5;5;5;5","HEMATOPOIETIC STEM CELL TRANSPLANTATION;CYCLOPHOSPHAMIDE;AORTIC VALVE REPLACEMENT;BLADDER CANCER;BREAST CANCER;COLORECTAL CANCER;GENE EXPRESSION;GENOTYPE;HAZARD RATIO;PROSTATE;PROSTATE CANCER;RITUXIMAB;ACUTE LEUKEMIA;AORTIC ANEURYSM;CLINICAL ENDPOINT;CUMULATIVE INCIDENCE;LIVER TRANSPLANTATION;PHENOTYPE;PSORIATIC ARTHRITIS;ALLELE;AORTIC DISSECTION;AORTIC REPAIR;AORTIC VALVE STENOSIS;CARDIOMYOPATHY;CD34;CD8;CHROMOSOME;COCHRANE LIBRARY;COMPUTED TOMOGRAPHY ANGIOGRAPHY;DEMENTIA;EJECTION FRACTION;HUMAN LEUKOCYTE ANTIGEN;LIVER CANCER;LUNG VOLUMES;METASTASIS;MITRAL VALVE REPLACEMENT;MULTICENTER STUDY;NEUROPSYCHOLOGY;OSTEOBLAST;OVERWEIGHT;PRIMARY IMMUNODEFICIENCY;PSORIASIS AREA AND SEVERITY INDEX;RETINOIC ACID;SYSTEMATIC REVIEW;THYMECTOMY;TYPE 2 DIABETES;VALVE REPLACEMENT;WHITE MATTER","8;5;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","BUSULFAN;FLUDARABINE;THIOTEPA;ACUTE PROMYELOCYTIC LEUKEMIA;BONE METASTASIS;DNA METHYLATION;JADAD SCALE;LUNG VOLUME REDUCTION SURGERY;MAMMOGRAPHY;MILAN CRITERIA;RUNX2;SINGLE-NUCLEOTIDE POLYMORPHISM;ACTIN CYTOSKELETON;ACUTE AORTIC SYNDROME;ADIPONECTIN;ANAL VERGE;ANTIMICROBIAL STEWARDSHIP;ANTIVIRAL THERAPY;BICUSPID VALVE;BIORESORBABLE SCAFFOLD;CAPECITABINE;CARDIAC SKELETON;CAREGIVER BURDEN;CD3;CERVICAL DILATION;COGNITIVE DECLINE;COLOANAL ANASTOMOSIS;COLONOSCOPY;COPY-NUMBER VARIATION;CYSTECTOMY;DIABETIC MACULAR EDEMA;DUAL ENERGY;DUAL-ENERGY X-RAY ABSORPTIOMETRY;ENDOVASCULAR ANEURYSM REPAIR;ENHANCER;EXTRAPULMONARY TUBERCULOSIS;FRACTIONAL ANISOTROPY;FUNCTIONAL MITRAL REGURGITATION;GREY MATTER;HAPLOTYPE;HERPESVIRIDAE;HISTOCOMPATIBILITY;HLA-A;HSP90;INDUCED PLURIPOTENT STEM CELL;INEFFECTIVE ERYTHROPOIESIS;KARYOTYPE;KRAS;LEFT SUBCLAVIAN ARTERY;LEUKAPHERESIS;LYMPHOCYTE SUBSETS;MENINGOCOCCAL DISEASE;MITRAL VALVE ANNULOPLASTY;MODIFIED RANKIN SCALE;MUCIN 2;NECROPTOSIS;NEOINTIMAL HYPERPLASIA;NKG2D;NONALCOHOLIC FATTY LIVER DISEASE;OXALIPLATIN;OXFORD KNEE SCORE;PARATHYROIDECTOMY;PCA3;PD-L1;PENETRANCE;POLYMORPHISM (COMPUTER SCIENCE);PRODUCTS OF CONCEPTION;PROTEIN PHOSPHORYLATION;RANIBIZUMAB;RECURRENT MISCARRIAGE;RETINOIC ACID RECEPTOR;SANGER SEQUENCING;SECUKINUMAB;STEATOHEPATITIS;STRAIGHT SINUS;TAKOTSUBO SYNDROME;TERIFLUNOMIDE;TRETINOIN;TROLOX;UMBILICAL CORD BLOOD TRANSPLANTATION;URINARY URGENCY;VENTRAL TEGMENTAL AREA;VINCRISTINE;VOXEL-BASED MORPHOMETRY","4;3;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;;MIDDLE AGED;ADULT;AGED;TREATMENT OUTCOME;RETROSPECTIVE STUDIES;ITALY;YOUNG ADULT;LEUKEMIA, MYELOID, ACUTE;AGED, 80 AND OVER;PSORIASIS;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;ATHEROSCLEROSIS;HEMATOPOIETIC STEM CELL TRANSPLANTATION;ADOLESCENT;INDUCED PLURIPOTENT STEM CELLS;BUSULFAN","89;70;65;58;55;47;45;31;30;23;23;22;20;14;13;13;12;11;11;9","MANAGEMENT OF VALVULAR HEART DISEASE;ACUTE MYELOID LEUKEMIA;DIAGNOSIS AND TREATMENT OF BLADDER CANCER;HEMATOPOIETIC STEM CELL BIOLOGY;MYASTHENIA GRAVIS AND THYMIC TUMORS RESEARCH;COLORECTAL CANCER RESEARCH AND TREATMENT;GENETIC BASIS OF PRIMARY IMMUNODEFICIENCY DISORDERS;ROLE OF RETINOIC ACID IN BIOLOGICAL PROCESSES;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;ANALYSIS OF BRAIN FUNCTIONAL CONNECTIVITY NETWORKS;DIAGNOSIS AND MANAGEMENT OF AORTIC DISEASES;DIAGNOSIS AND MANAGEMENT OF FIBROMYALGIA SYNDROME;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;DIAGNOSIS AND TREATMENT OF CAROTID ARTERY DISEASE;DIAGNOSIS AND TREATMENT OF LUNG CANCER;EFFECTS OF BRAIN STIMULATION ON MOTOR CORTEX;EPIDEMIOLOGY AND PATHOGENESIS OF BACTERIAL MENINGITIS;HEALTH RISKS OF MEDICAL IMAGING RADIATION EXPOSURE;HEPATITIS C INFECTION AND TREATMENT;HEPATOCELLULAR CARCINOMA","6;5;4;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2","HEMATOPOIETIC CELL TRANSPLANTATION;TREATMENT;TRANSCATHETER AORTIC-VALVE REPLACEMENT;CARDIAC IMAGING;SURGICAL AORTIC-VALVE REPLACEMENT;HEMATOLOGY;PROSTHETIC VALVES EVALUATION;REGIMEN;STROKE (ENGINE);ACUTE MYELOID LEUKEMIA;BLADDER CANCER;CARDIOTHORACIC SURGERY;CLINICAL ENDPOINT;COMPUTED TOMOGRAPHY ANGIOGRAPHY;CONCOMITANT;CUMULATIVE INCIDENCE;IMAGE-GUIDED RADIOTHERAPY;MANTLE CELL LYMPHOMA;NEPHROLOGY;NEUROIMAGING DATA ANALYSIS","7;7;6;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3","STEM CELL;ACUTE MYELOID;CELL TRANSPLANTATION;MYELOID LEUKEMIA;ACUTE LEUKEMIA;COHORT STUDY;AORTIC VALVE;COMPUTED TOMOGRAPHY;BLADDER CANCER;CANCER PATIENTS;ELDERLY PATIENTS;HEMATOPOIETIC STEM;LIVER TRANSPLANT;MULTIPLE SCLEROSIS;PATIENTS TREATED;PROSTATE CANCER;SPINAL CORD;AORTIC DISSECTION;BREAST CANCER;BRIDGING THERAPIES;CANCER WAITING;CARDIOVASCULAR MORTALITY;CLINICAL PRACTICE;COLORECTAL CANCER;COMPLETE REMISSION;CORD INJURY;EUROPEAN SOCIETY;HEPATOCELLULAR CANCER;INTENSIVE CHEMOTHERAPY;ITALIAN OBSERVATIONAL","7;6;6;6;5;5;4;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2","TOR VERGATA;ROME ITALYSEARCH;VERGATA UNIVERSITY;UNIVERSITY POLICLINIC;CARDIAC SURGERY;POLICLINIC ROME;PUBMED SCOPUS;ROME ITALY;MD PHD;SURGERY TOR;VOLUME REDUCTION;LUNG VOLUME;STEM CELL;UNIT TOR;ACUTE MYELOID;ENVIRONMENTAL SCIENCES;LIFE HEALTH;MYELOID LEUKEMIA;NK CELLS;SCIENCES UNIVERSITY;CELL TRANSPLANTATION;MULTIVARIATE ANALYSIS;SUBXIPHOID ACCESS;BIOLOGY ISTITUTO;CELL BIOLOGY;DELLIMMACOLATA IDI-IRCCS;DERMOPATICO DELLIMMACOLATA;DEXAMETHASONE INTRAVITREAL;IDI-IRCCS ROME;INTRAVITREAL IMPLANTS","39;30;29;26;23;22;19;18;12;12;12;11;11;11;10;10;10;10;10;10;9;9;9;8;8;8;8;8;8;8",61,0.41,9.5,6,2.5,2,1,2,3,1,1,9,0,1,7,5,1.5,2,5.75,6,3,0,0,57,57,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,38,5,730.42,15.45,24,0.63,166.63,0,0,3,1,23,0,3,8,0,32,6,0,0,0,0,0,0,36,0,2,38,0,0,0,0,0,0,0,0,0,"United States;Germany;Italy;Japan;United Kingdom","19;2;2;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;3212 OPHTHALMOLOGY AND OPTOMETRY;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;3203 DENTISTRY;3204 IMMUNOLOGY;35 COMMERCE, MANAGEMENT, TOURISM AND SERVICES;3505 HUMAN RESOURCES AND INDUSTRIAL RELATIONS;4201 ALLIED HEALTH AND REHABILITATION SCIENCE","36;22;7;6;4;3;2;2;2;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;AUTOIMMUNE DISEASE;DIGESTIVE DISEASES;PATIENT SAFETY;INFLAMMATORY BOWEL DISEASE;CANCER;NEURODEGENERATIVE;RARE DISEASES;HEMATOLOGY;NEUROSCIENCES;PEDIATRIC;BRAIN DISORDERS;MULTIPLE SCLEROSIS;NUTRITION;CHILDHOOD LEUKEMIA;CROHN'S DISEASE;INFECTIOUS DISEASES;PEDIATRIC CANCER;PREVENTION","34;31;13;11;11;8;7;6;6;5;5;5;4;4;4;3;3;3;3;3","CANCER;ORAL AND GASTROINTESTINAL;SKIN;NEUROLOGICAL;EYE;INFECTION;INFLAMMATORY AND IMMUNE SYSTEM;METABOLIC AND ENDOCRINE","4;4;4;3;2;2;2;1","6.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.2 CELLULAR AND GENE THERAPIES;7.1 INDIVIDUAL CARE NEEDS","27;1;1;1;1","LEUKEMIA / LEUKAEMIA;COLON AND RECTAL CANCER;PROSTATE CANCER;BREAST CANCER;MYELOMA;NON-HODGKIN'S LYMPHOMA;STOMACH CANCER","6;2;2;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT","7;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,7,"PUBLIC LIBRARY OF SCIENCE","7","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3203 DENTISTRY;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;51 PHYSICAL SCIENCES;5107 PARTICLE AND HIGH ENERGY PHYSICS","10;3;1;1;1;1;1","BIOMEDICAL IMAGING;BRAIN DISORDERS;CANCER;CLINICAL RESEARCH;KIDNEY DISEASE;RARE DISEASES;TUBEROUS SCLEROSIS","1;1;1;1;1;1;1",NA,NA,"6.1 PHARMACEUTICALS","1","CLINICAL;HEALTH SERVICES & SYSTEMS","1;1","CLINICAL MEDICINE AND SCIENCE;HEALTH SERVICES RESEARCH","1;1","KIDNEY CANCER","1","3 GOOD HEALTH AND WELL BEING","1"
"AOU_TORVERGATA",2019,148,17.1756756756757,2.70945945945946,0.256756756756757,0.216216216216216,0.216216216216216,1.46350364963504,1.02702702702703,1.18518518518519,1.06666666666667,0.689189189189189,2,69,38,14,11,0.47,0.26,0.09,0.07,17.82,0.733001890259877,4.92643391521197,0.371621621621622,0.939189189189189,0.431,0.318,0.317,0.323,"WILLIAM ARCESE;MARIA ILARIA DEL PRINCIPE;MARIA TERESA VOSO;ROBERTO FLORIS;ADRIANO VENDITTI;GIOVANGIACINTO PATERNO;LUCIA ANEMONA;GIUSEPPE TISONE;MANUEL SCIMECA;MASSIMO ANDREONI;ORAZIO SCHILLACI;FABRIZIO SALLUSTIO;GIUSEPPE NOVELLI;FRANCESCO BUCCISANO;MARCO CIOTTI;FRANCESCA DI GIULIANO;ELENA BONANNO;LOREDANA SARMATI;MARIA CANTONETTI;FEDERICO RICCI","9;7;7;7;7;6;6;6;6;6;6;6;6;5;5;5;5;5;5;5","VINCENZO AMBROGI;LUCA PUGLIESE;ROBERTO GANDINI;MANUEL SCIMECA;ROBERTO FLORIS;MARCO CIOTTI;FABRIZIO CHEGAI;ORAZIO SCHILLACI;GIUSEPPE TISONE;VALERIA PIETROPAOLO;CARLA PREZIOSO;GIUSEPPE NOVELLI;FEDERICO RICCI;ELENA BONANNO;ALESSANDRO MAURIELLO;WILLIAM ARCESE;LUCIA ANEMONA;MARCELLO MIGLIORE;COSTANTINO DEL GIUDICE;MARIO DAURI","1.69;1.14;1.05;0.76;0.7;0.7;0.67;0.55;0.55;0.54;0.54;0.52;0.52;0.51;0.51;0.51;0.5;0.5;0.5;0.48","WILLIAM ARCESE;MARIA ILARIA DEL PRINCIPE;MARIA TERESA VOSO;ROBERTO FLORIS;ADRIANO VENDITTI;GIOVANGIACINTO PATERNO;LUCIA ANEMONA;GIUSEPPE TISONE;MANUEL SCIMECA;MASSIMO ANDREONI;ORAZIO SCHILLACI;FABRIZIO SALLUSTIO;GIUSEPPE NOVELLI;FRANCESCO BUCCISANO;MARCO CIOTTI;FRANCESCA DI GIULIANO;LOREDANA SARMATI;MARIA CANTONETTI;FEDERICO RICCI;ANDREA LANCIA","9;7;7;7;7;6;6;6;6;6;6;6;6;5;5;5;5;5;5;5","VINCENZO AMBROGI;LUCA PUGLIESE;ROBERTO GANDINI;MANUEL SCIMECA;ROBERTO FLORIS;MARCO CIOTTI;FABRIZIO CHEGAI;ORAZIO SCHILLACI;GIUSEPPE TISONE;GIUSEPPE NOVELLI;FEDERICO RICCI;WILLIAM ARCESE;LUCIA ANEMONA;MARIO DAURI;LUCA BIANCHI;G. P. NOVELLI;MASSIMO ANDREONI;NICOLETTA URBANO;ENRICO FINAZZI AGRÒ;MARIA TERESA VOSO","1.69;1.14;1.05;0.76;0.7;0.7;0.67;0.55;0.55;0.52;0.52;0.51;0.5;0.48;0.47;0.46;0.45;0.44;0.42;0.42","MARIA TERESA VOSO;FABRIZIO SALLUSTIO;WILLIAM ARCESE;ALESSIO BRUNI;ANDREA LANCIA;GIANLUCA INGROSSO;LUCA TRIGGIANI;BARBARA ALICJA JERECZEK‐FOSSA;BEATRICE DETTI;ERNESTO MARANZANO;FABIO TRIPPA;FILIPPO ALONGI;GIULIO FRANCOLINI;PIET OST;ADRIANO VENDITTI;MARIA ILARIA DEL PRINCIPE;ALFONSO PICIOCCHI;MARIA IRNO‐CONSALVO;ROBIN FOÀ;FRANCESCO LO‐COCO","255;228;226;208;204;204;204;198;198;198;198;198;198;198;195;194;189;188;188;179","MARIA TERESA VOSO;WILLIAM ARCESE;GIANLUCA INGROSSO;ADRIANO VENDITTI;MARIA ILARIA DEL PRINCIPE;FRANCESCO BUCCISANO;FRANCESCO LO‐COCO;LUCA MAURILLO;FABRIZIO SALLUSTIO;ELISABETTA PONTI;JACOPO M. LEGRAMANTE;MARILENA MINIERI;SERGIO BERNARDINI;NICOLETTA URBANO;FEDERICO RICCI;MARIO BENGALA;MARCO GALLUZZO;SOFIA VIDALI;ANTONELLA BRANDI;VIVIANA MOSCHESE","241;226;200;172;171;169;169;169;156;125;122;122;122;119;117;116;109;93;89;86","WILLIAM ARCESE;GIUSEPPE TISONE;ROBERTO FLORIS;FEDERICO RICCI;MARCO CIOTTI;FRANCESCA DI GIULIANO;MARIA CANTONETTI;MARIO DAURI;NICOLETTA URBANO;VINCENZO AMBROGI;VIVIANA MOSCHESE;FABRIZIO SALLUSTIO;ADRIANO VENDITTI;LUCA BIANCHI;TOMMASO MARIA MANZIA;ALESSANDRO ANSELMO;AMBRA STEFANI;ANDREA LANCIA;ELISABETTA PONTI;ENRICO FINAZZI AGRÒ","8;7;6;5;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3","MEDICINE;BIOLOGY;PHYSICS;PSYCHOLOGY;CHEMISTRY;ENGINEERING;COMPUTER SCIENCE;MATHEMATICS;ECONOMICS;SOCIOLOGY;PHILOSOPHY;POLITICAL SCIENCE;BUSINESS;GEOGRAPHY;GEOLOGY;HISTORY;MATERIALS SCIENCE","136;39;15;14;13;10;9;8;5;5;4;3;1;1;1;1;1","INTERNAL MEDICINE;SURGERY;GENETICS;IMMUNOLOGY;ONCOLOGY;RADIOLOGY;PATHOLOGY;BIOCHEMISTRY;CARDIOLOGY;GASTROENTEROLOGY;PSYCHIATRY;ENVIRONMENTAL HEALTH;VIROLOGY;CANCER RESEARCH;ENDOCRINOLOGY;NURSING;PHYSICAL THERAPY;MECHANICAL ENGINEERING;PEDIATRICS;DERMATOLOGY;OPTICS;PALEONTOLOGY","97;42;26;22;21;19;18;16;14;13;13;12;12;10;9;9;9;8;8;7;7;7","GENE;CANCER;DISEASE;COHORT;MYOCARDIAL INFARCTION;POPULATION;RETROSPECTIVE COHORT STUDY;CHEMOTHERAPY;ADVERSE EFFECT;TRANSPLANTATION;LEUKEMIA;MYELOID LEUKEMIA;CONFIDENCE INTERVAL;QUALITY OF LIFE (HEALTHCARE);ALTERNATIVE MEDICINE;CLINICAL TRIAL;DIABETES MELLITUS;IMMUNE SYSTEM;RADIATION THERAPY;VIRUS","20;19;19;12;11;11;11;10;9;9;8;8;7;7;6;6;6;6;6;6","PROSTATE;BREAST CANCER;THROMBOLYSIS;METASTASIS;MUTATION;PROSTATE CANCER;REVASCULARIZATION;CD8;CLINICAL ENDPOINT;CRONBACH'S ALPHA;GENOTYPE;HEMATOPOIETIC STEM CELL TRANSPLANTATION;HEPATITIS B VIRUS;INTERNAL CONSISTENCY;ISCHEMIC STROKE;KIDNEY TRANSPLANTATION;PERCUTANEOUS CORONARY INTERVENTION;PHENOTYPE;ACUTE LEUKEMIA;ARTERIAL DISEASE;BEVACIZUMAB;CD34;CHROMOSOME;COLORECTAL CANCER;CYCLOPHOSPHAMIDE;DEMENTIA;DIFFUSE LARGE B-CELL LYMPHOMA;GENE EXPRESSION;GRAFT-VERSUS-HOST DISEASE;HAEMATOPOIESIS;HEPATITIS C VIRUS;IMMUNOTHERAPY;LIVER TRANSPLANTATION;MACROPHAGE;METABOLIC SYNDROME;MINIMAL RESIDUAL DISEASE;MULTICENTER STUDY;NEUTROPHIL TO LYMPHOCYTE RATIO;OCCULT;PARKINSONISM;PHYLOGENETIC TREE;PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;PROGRESSIVE SUPRANUCLEAR PALSY;PSEUDOANEURYSM;PSORIATIC ARTHRITIS;TOLERABILITY;VIRAL LOAD;VIRAL REPLICATION","6;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","MODIFIED RANKIN SCALE;CRITICAL LIMB ISCHEMIA;DISCRIMINANT VALIDITY;DNA METHYLATION;HEPACIVIRUS;KARYOTYPE;LOWER URINARY TRACT SYMPTOMS;MISSENSE MUTATION;RANIBIZUMAB;RIBAVIRIN;ACUTE PROMYELOCYTIC LEUKEMIA;AEROALLERGEN;ANTIRETROVIRAL THERAPY;BENIGN PROSTATIC HYPERPLASIA (BPH);BENTALL PROCEDURE;BK VIRUS;BONE METASTASIS;CARBOPLATIN;CD163;CD38;CLAUDICATION;COGNITIVE DECLINE;COLECTOMY;CONVERGENT VALIDITY;COPY-NUMBER VARIATION;CYSTATHIONINE BETA SYNTHASE;DEMENTIA WITH LEWY BODIES;ENDOVASCULAR ANEURYSM REPAIR;EPITHELIAL–MESENCHYMAL TRANSITION;ESTROGEN RECEPTOR;EXOME SEQUENCING;EXTERNAL BEAM RADIOTHERAPY;EXTERNAL LIMITING MEMBRANE;FEBRILE NEUTROPENIA;FERTILITY PRESERVATION;GENE MUTATION;HBSAG;IBRUTINIB;INFLUENZA SEASON;INSULIN SENSITIVITY;JC VIRUS;KIDNEY TRANSPLANT;KLEBSIELLA PNEUMONIAE;LEFT SUBCLAVIAN ARTERY;LYMPHOBLASTIC LYMPHOMA;MACULAR HOLE;MACULOPATHY;MAMMOGRAPHY;MECP2;MERKEL CELL POLYOMAVIRUS;MILAN CRITERIA;MULTICENTER TRIAL;MULTILOCUS SEQUENCE TYPING;NATURAL KILLER CELL;NEOADJUVANT THERAPY;NIVOLUMAB;NS3;OXYCODONE;PIRFENIDONE;POINT MUTATION;PRIMARY MOTOR CORTEX;RANKL;RENAL ARTERY STENOSIS;RESPONSE EVALUATION CRITERIA IN SOLID TUMORS;SANGER SEQUENCING;SECUKINUMAB;SINGLE-NUCLEOTIDE POLYMORPHISM;STROKE VOLUME;TARGET LESION;TIMI;TIROFIBAN;TRANSURETHRAL RESECTION OF THE PROSTATE;USTEKINUMAB;VASCULAR DEMENTIA;VENETOCLAX;VINCRISTINE","3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;;FEMALE;MALE;MIDDLE AGED;AGED;ADULT;ITALY;AGED, 80 AND OVER;RETROSPECTIVE STUDIES;TREATMENT OUTCOME;YOUNG ADULT;PROSPECTIVE STUDIES;LIVER NEOPLASMS;LEUKEMIA, MYELOID, ACUTE;CARCINOMA, HEPATOCELLULAR;CHILD;RISK FACTORS;STROKE;ADOLESCENT","81;65;65;64;46;42;35;28;19;19;19;16;15;13;12;11;11;11;11;10","ACUTE MYELOID LEUKEMIA;EPIDEMIOLOGY AND MANAGEMENT OF STROKE;POLYOMAVIRUS-ASSOCIATED CARCINOGENESIS AND CLINICAL MANIFESTATIONS;ADVANCEMENTS IN PROSTATE CANCER RESEARCH;HEPATITIS B INFECTION AND TREATMENT;HEPATITIS C INFECTION AND TREATMENT;HEPATOCELLULAR CARCINOMA;IDIOPATHIC PULMONARY FIBROSIS: DIAGNOSIS AND MANAGEMENT;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;ROLE OF PENTRAXINS IN INNATE IMMUNITY AND INFLAMMATION;AGE-RELATED MACULAR DEGENERATION RESEARCH;ANALYSIS OF ELECTROMYOGRAPHY SIGNAL PROCESSING;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;EPIDEMIOLOGY AND TREATMENT OF CHILDHOOD LEUKEMIA;GENETIC BASIS OF PRIMARY IMMUNODEFICIENCY DISORDERS;HEMATOPOIETIC STEM CELL BIOLOGY;INFLAMMATION'S ROLE IN CANCER DEVELOPMENT AND PROGRESSION;LYMPHOID NEOPLASMS;MANAGEMENT AND TREATMENT OF PERIPHERAL ARTERIAL DISEASE;MICROBIAL IDENTIFICATION AND DIAGNOSIS","6;5;5;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2","TREATMENT;STROKE (ENGINE);ACUTE MYELOID LEUKEMIA;INFARCTION TREATMENT;INTERQUARTILE RANGE;CLINICAL ENDPOINT;ENDOVASCULAR REPAIR;HBV INFECTION;MACULAR DEGENERATION;NOMOGRAM;PROSTATE CANCER;REVASCULARIZATION;ACUTE LYMPHOBLASTIC LEUKEMIA;AML;ANOMALY (PHYSICS);ANOMALY DETECTION;AZACITIDINE;BENIGN PROSTATIC HYPERPLASIA;CANCER IMAGING;CRITICAL LIMB ISCHEMIA","7;6;4;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2","ACUTE MYELOID;MYELOID LEUKEMIA;BREAST CANCER;MULTICENTER STUDY;PATIENTS TREATED;PROSTATE CANCER;ADULT PATIENTS;ENDOVASCULAR TREATMENT;PATIENTS AFFECTED;PILOT STUDY;STEM CELLS;ABSTRACT P--;AGE-RELATED MACULAR;ANOMALY DETECTION;AZACITIDINE AZA;B-CELL LYMPHOMA;CANCER PATIENTS;CELL TRANSPLANTATION;CHEMOTHERAPY IC;CLINICAL OUTCOMES;DIAGNOSED ACUTE;ELDERLY PATIENTS;ETIOLOGICAL DIAGNOSIS;EXPERT PANEL;HEPATOCELLULAR CARCINOMA;HUMAN POLYOMAVIRUSES;INTENSIVE CHEMOTHERAPY;ITALIAN REGISTRY;LEUKEMIA AML;LEUKEMIC STEM","7;6;4;4;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","ADVISORY COMMITTEES;ENTITYS BOARD;RESEARCH FUNDING;CONSULTANCY MEMBERSHIP;SPEAKERS BUREAU;ADVISORY CONSULTANCY;CENTRAL NERVOUS;COMPLETE REMISSION;MECHANICAL THROMBECTOMY;NERVOUS SYSTEM;ASTELLAS MEMBERSHIP;ADVERSE EVENTS;CONSULTANCY HONORARIA;DISEASE PROGRESSION;FLOW CYTOMETRY;HONORARIA RESEARCH;MOS RANGE;REGRESSION ANALYSIS;STEM CELLS;SYSTEM DISEASE;CAD PATIENTS;FUNDING INSTITUTION;GRANT FUNDING;INSTI TREATMENT;INTRAVENOUS THROMBOLYSIS;NOVARTIS CONSULTANCY;ODDS RATIO;OPERATIONAL CRITERIA;RESEARCH GRANT;RISK FACTORS","50;50;28;21;19;15;11;11;11;11;10;9;9;9;9;9;9;9;9;9;8;8;8;8;8;8;8;8;8;8",70,0.47,7,5.75,1,1,0,1,2.5,0,1,6,1,1,6.75,1,0,2,3.75,5,2.25,0,0,51,51,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,25,3.72,468.76,9.96,12,0.48,77.48,0,1,2,0,9,0,3,10,0,17,8,0,0,0,0,0,0,23,0,2,25,0,0,0,0,0,0,0,0,0,"United States;Italy;Germany","6;2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;3212 OPHTHALMOLOGY AND OPTOMETRY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;35 COMMERCE, MANAGEMENT, TOURISM AND SERVICES;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS","25;12;6;6;3;3;2;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;NEUROSCIENCES;CANCER;NEURODEGENERATIVE;BRAIN DISORDERS;HEMATOLOGY;RARE DISEASES;AGING;ORPHAN DRUG;AUTOIMMUNE DISEASE;PATIENT SAFETY;PEDIATRIC;PEDIATRIC CANCER;PREVENTION;TRANSPLANTATION;ARTHRITIS;BIOENGINEERING;CARDIOVASCULAR;CHILDHOOD LEUKEMIA","23;17;9;8;8;7;7;7;4;4;3;3;3;3;3;3;2;2;2;2","CANCER;INFLAMMATORY AND IMMUNE SYSTEM;NEUROLOGICAL;EYE;SKIN;CARDIOVASCULAR;INFECTION","6;4;3;2;2;1;1","6.1 PHARMACEUTICALS;7.1 INDIVIDUAL CARE NEEDS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.2 CELLULAR AND GENE THERAPIES;7.3 MANAGEMENT AND DECISION MAKING","18;2;1;1;1","LEUKEMIA / LEUKAEMIA;BREAST CANCER;COLON AND RECTAL CANCER;LUNG CANCER;MYELOMA;NON-HODGKIN'S LYMPHOMA;NOT SITE-SPECIFIC CANCER;PROSTATE CANCER","6;1;1;1;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES;4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING;5.2 LOCALIZED THERAPIES - CLINICAL APPLICATIONS","7;3;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,10,"FRONTIERS;PUBLIC LIBRARY OF SCIENCE;KARGER PUBLISHERS","7;2;1","31 BIOLOGICAL SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;3105 GENETICS;42 HEALTH SCIENCES;34 CHEMICAL SCIENCES;3202 CLINICAL SCIENCES;3215 REPRODUCTIVE MEDICINE;3404 MEDICINAL AND BIOMOLECULAR CHEMISTRY;4203 HEALTH SERVICES AND SYSTEMS","10;9;5;3;2;1;1;1;1","CLINICAL RESEARCH;BIOTECHNOLOGY;GENETICS;GENETIC TESTING;HUMAN GENOME;PEDIATRIC;PREVENTION;BRAIN DISORDERS;RARE DISEASES;TUBEROUS SCLEROSIS;ATHEROSCLEROSIS;BIOMEDICAL IMAGING;CARDIOVASCULAR;HEALTH SERVICES;HEART DISEASE;HEART DISEASE - CORONARY HEART DISEASE","7;6;6;5;5;5;5;2;2;2;1;1;1;1;1;1","INFLAMMATORY AND IMMUNE SYSTEM;CARDIOVASCULAR;REPRODUCTIVE HEALTH AND CHILDBIRTH","5;1;1","4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;7.1 INDIVIDUAL CARE NEEDS","6;1;1","BIOMEDICAL;CLINICAL","5;1","CLINICAL MEDICINE AND SCIENCE","8","BRAIN TUMOR;KIDNEY CANCER;NOT SITE-SPECIFIC CANCER","1;1;1",NA,NA
"AOU_TORVERGATA",2020,196,15.4795918367347,3.39285714285714,0.346938775510204,0.326530612244898,0.403061224489796,2.11464968152866,1.36,1.68421052631579,1.31666666666667,0.709183673469388,1,83,50,25,8,0.42,0.26,0.13,0.04,37.59,1.49182441280388,5.72614107883818,0.301020408163265,0.892857142857143,0.475,0.507,0.5,0.495,"GIANLUCA VANNI;MARCO MATERAZZO;ORESTE CLAUDIO BUONOMO;MARCO PELLICCIARO;CHIARA ADRIANA PISTOLESE;ALBERTO SIRACUSANO;VIVIANA MOSCHESE;JONATHAN CASPI;TOMMASO PERRETTA;HERBERT VALENSISE;LOREDANA SARMATI;G. P. NOVELLI;PAOLA ROGLIANI;MASSIMO ANDREONI;AGOSTINO CHIARAVALLOTI;GIORGIO DI LORENZO;D. FARSETTI;B. VASAPOLLO;G. GAGLIARDI;FRANCESCA SANTORI","23;19;18;16;12;10;8;8;7;7;7;7;7;7;7;7;7;7;7;7","GIANLUCA VANNI;ORESTE CLAUDIO BUONOMO;MARCO MATERAZZO;ALBERTO SIRACUSANO;MARCO PELLICCIARO;FLAVIA DI MICHELE;CHIARA ADRIANA PISTOLESE;CHIARA OLDANI;PAOLA ROGLIANI;HERBERT VALENSISE;G. P. NOVELLI;D. FARSETTI;B. VASAPOLLO;G. GAGLIARDI;CINZIA NIOLU;GIORGIO DI LORENZO;MARCO CIOTTI;MICHELE RIBOLSI;ORAZIO SCHILLACI;RODOLFO ROSSI","2.49;1.99;1.64;1.61;1.3;1;0.88;0.82;0.79;0.78;0.78;0.78;0.78;0.78;0.78;0.78;0.77;0.75;0.73;0.73","GIANLUCA VANNI;MARCO MATERAZZO;ORESTE CLAUDIO BUONOMO;MARCO PELLICCIARO;CHIARA ADRIANA PISTOLESE;ALBERTO SIRACUSANO;VIVIANA MOSCHESE;JONATHAN CASPI;TOMMASO PERRETTA;LOREDANA SARMATI;G. P. NOVELLI;PAOLA ROGLIANI;MASSIMO ANDREONI;AGOSTINO CHIARAVALLOTI;GIORGIO DI LORENZO;FRANCESCA SANTORI;LUCA BIANCHI;CINZIA NIOLU;VALERIA CAMMALLERI;SAVERIO MUSCOLI","23;19;18;16;12;10;8;8;7;7;7;7;7;7;7;7;6;6;6;6","GIANLUCA VANNI;ORESTE CLAUDIO BUONOMO;MARCO MATERAZZO;ALBERTO SIRACUSANO;MARCO PELLICCIARO;FLAVIA DI MICHELE;CHIARA ADRIANA PISTOLESE;PAOLA ROGLIANI;G. P. NOVELLI;CINZIA NIOLU;GIORGIO DI LORENZO;MARCO CIOTTI;MICHELE RIBOLSI;DORIANA LANDI;JONATHAN CASPI;GIROLAMA ALESSANDRA MARFIA;ENRICO FINAZZI AGRÒ;LUCA BIANCHI;VIVIANA MOSCHESE;LOREDANA SARMATI","2.49;1.99;1.64;1.61;1.3;1;0.88;0.79;0.78;0.78;0.78;0.77;0.75;0.73;0.72;0.7;0.66;0.66;0.61;0.55","ALBERTO SIRACUSANO;GIORGIO DI LORENZO;RODOLFO ROSSI;FRANCESCA PACITTI;ANTINISCA DI MARCO;VALENTINA SOCCI;ALESSANDRO ROSSI;PAOLA GUALTIERI;ALDA ATTINÀ;ANTONINO DE LORENZO;CLAUDIA LEGGERI;ERNESTO ESPOSITO;FRANCESCA PIVARI;FRANCESCO SCERBO;GIOVANNA CAPARELLO;GIULIA CINELLI;LAURA DI RENZO;LAURA SOLDATI;LUIGI BARREA;SONIA MENSI","2360;2329;2293;2282;2260;2260;2167;1881;1814;1814;1814;1814;1814;1814;1814;1814;1814;1814;1814;1368","ALBERTO SIRACUSANO;FRANCESCO SCERBO;CINZIA NIOLU;GIORGIO DI LORENZO;GIANLUCA VANNI;ORESTE CLAUDIO BUONOMO;MARCO MATERAZZO;MARCO PELLICCIARO;ADRIANO VENDITTI;CHIARA ADRIANA PISTOLESE;FRANCESCA SANTORI;JONATHAN CASPI;MARIA COTESTA;SARA INGALLINELLA;MASSIMO ANDREONI;VIVIANA MOSCHESE;MARK S. TALAMONTI;AGOSTINO CHIARAVALLOTI;MAURIZIO RHO;TOMMASO PERRETTA","2339;1814;1314;961;622;574;567;527;509;468;342;337;288;213;195;188;177;173;161;148","GIANLUCA VANNI;ORESTE CLAUDIO BUONOMO;MARCO MATERAZZO;MARCO PELLICCIARO;CHIARA ADRIANA PISTOLESE;ALBERTO SIRACUSANO;VIVIANA MOSCHESE;FRANCESCA SANTORI;G. P. NOVELLI;TOMMASO PERRETTA;ANNAMARIA TAVERNESE;MARIA COTESTA;LUCA BIANCHI;MARCELLO CHIOCCHI;MARCO CIOTTI;ALESSANDRA VITTORIA GRANAI;FELICIANA LAMACCHIA;GIORGIO DI LORENZO;JONATHAN CASPI;LOREDANA SARMATI","22;18;17;14;11;9;8;7;7;7;6;6;6;5;5;5;5;5;5;5","MEDICINE;BIOLOGY;PSYCHOLOGY;CHEMISTRY;PHYSICS;ECONOMICS;ENGINEERING;COMPUTER SCIENCE;POLITICAL SCIENCE;SOCIOLOGY;MATHEMATICS;BUSINESS;GEOGRAPHY;MATERIALS SCIENCE;PHILOSOPHY;ART","184;52;19;15;15;12;10;9;9;8;7;3;2;2;2;1","INTERNAL MEDICINE;SURGERY;PATHOLOGY;GENETICS;ENVIRONMENTAL HEALTH;RADIOLOGY;PSYCHIATRY;CARDIOLOGY;IMMUNOLOGY;INTENSIVE CARE MEDICINE;BIOCHEMISTRY;ONCOLOGY;VIROLOGY;GASTROENTEROLOGY;NURSING;PEDIATRICS;OBSTETRICS;OPTICS;CANCER RESEARCH;LAW;MICROBIOLOGY;PHYSICAL THERAPY","149;56;37;29;27;27;25;23;23;20;17;16;15;12;12;11;10;10;9;9;9;9","DISEASE;CANCER;GENE;POPULATION;RETROSPECTIVE COHORT STUDY;OUTBREAK;COHORT;ADVERSE EFFECT;CHEMOTHERAPY;PREGNANCY;HEART FAILURE;MYOCARDIAL INFARCTION;CONFIDENCE INTERVAL;HEMODYNAMICS;INCIDENCE (GEOMETRY);QUALITY OF LIFE (HEALTHCARE);ALTERNATIVE MEDICINE;ANXIETY;BIOPSY;HEALTH CARE;OBSERVATIONAL STUDY;ODDS RATIO;STROKE (ENGINE)","47;37;23;23;17;15;13;10;10;10;9;9;8;8;8;8;7;7;7;7;7;7;7","INFECTIOUS DISEASE (MEDICAL SPECIALTY);BREAST CANCER;2019-20 CORONAVIRUS OUTBREAK;COLORECTAL CANCER;CLINICAL ENDPOINT;CYCLOPHOSPHAMIDE;DEMENTIA;EJECTION FRACTION;FETUS;INFLAMMATORY BOWEL DISEASE;MUTATION;PERCUTANEOUS CORONARY INTERVENTION;PHENOTYPE;PSORIATIC ARTHRITIS;UNIVARIATE ANALYSIS;ADALIMUMAB;ALLELE;ALZHEIMER'S DISEASE;AORTIC VALVE REPLACEMENT;CARDIAC FUNCTION CURVE;CARDIAC OUTPUT;CHEMOTHERAPY REGIMEN;CONVENTIONAL PCI;ESCHERICHIA COLI;GESTATION;PARKINSON'S DISEASE;PLAQUE PSORIASIS;POLYMERASE CHAIN REACTION;PROSTATE;RITUXIMAB;THROMBOLYSIS;TOLERABILITY","28;20;13;7;5;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","CORONAVIRUS DISEASE 2019 (COVID-19);SECUKINUMAB;VINCRISTINE;FRONTOTEMPORAL DEMENTIA;MAMMOGRAPHY;ALLELE FREQUENCY;BREAST SURGERY;CARDIAC INDEX;CETUXIMAB;COLECTOMY;DIGITAL POLYMERASE CHAIN REACTION;INFLAMMATORY BOWEL DISEASES;IRINOTECAN;KLEBSIELLA PNEUMONIAE;LEVODOPA;LOWER URINARY TRACT SYMPTOMS;MASTECTOMY;MODIFIED RANKIN SCALE;NEOADJUVANT THERAPY;PROSTATE-SPECIFIC ANTIGEN;PROSTATECTOMY;USTEKINUMAB","28;4;4;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",";HUMANS;FEMALE;MALE;MIDDLE AGED;AGED;ITALY;ADULT;CORONAVIRUS INFECTIONS;PNEUMONIA, VIRAL;BREAST NEOPLASMS;AGED, 80 AND OVER;RETROSPECTIVE STUDIES;COVID-19;ADOLESCENT;PANDEMICS;YOUNG ADULT;STROKE;LYMPH NODES;TREATMENT OUTCOME","123;71;50;43;41;35;31;30;30;29;25;20;20;17;14;14;14;12;11;11","IMPACT OF COVID-19 ON CANCER PATIENTS AND CARE;EPIDEMIOLOGY AND MANAGEMENT OF STROKE;GENETIC BASIS OF PRIMARY IMMUNODEFICIENCY DISORDERS;IMPACT OF COVID-19 ON MENTAL HEALTH;PATHOPHYSIOLOGY AND MANAGEMENT OF PREECLAMPSIA;MANAGEMENT OF VALVULAR HEART DISEASE;RECIPROCAL DEVELOPMENT OF TH17 AND TREG CELLS;CORONAVIRUS DISEASE 2019;GLOBAL BURDEN OF CHRONIC PAIN;GLOBAL CANCER INCIDENCE AND MORTALITY PATTERNS;LYMPHOID NEOPLASMS;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;PELVIC FLOOR DISORDERS;ACUTE MYELOID LEUKEMIA;ADVANCEMENTS IN PROSTATE CANCER RESEARCH;ANORECTAL SURGICAL PROCEDURES;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;BREAST MAGNETIC RESONANCE IMAGING IN ONCOLOGY;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;CORONAVIRUS DISEASE 2019 RESEARCH","13;5;5;5;5;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2","PANDEMIC;2019-20 CORONAVIRUS OUTBREAK;TREATMENT;BREAST CANCER SCREENING;STROKE (ENGINE);CLINICAL ENDPOINT;INFARCTION TREATMENT;PSORIASIS;ABVD;DEPRESSION (ECONOMICS);PREGNANCY;REGIMEN;UNIVARIATE ANALYSIS;BREAST CANCER;CHEMOTHERAPY REGIMEN;CLINICAL CHARACTERISTICS;CORONAVIRUS;DISCONTINUATION;HEALTH CARE WORKERS;INTERQUARTILE RANGE","14;12;9;7;6;5;5;5;4;4;4;4;4;3;3;3;3;3;3;3","BREAST CANCER;CANCER PATIENTS;COLORECTAL CANCER;DISEASE PATIENTS;INFLAMMATORY BOWEL;CHRONIC HYPERTENSIVE;CORONAVIRUS DISEASE;COVID- PANDEMIC;HYPERTENSIVE PATIENTS;ISCHEMIC STROKE;MENTAL HEALTH;MULTIPLE SCLEROSIS;MYELOID LEUKEMIA;OBSERVATIONAL STUDY;PATIENTS RESULTS;PLAQUE PSORIASIS;PREGNANCY COMPLICATIONS;RETROSPECTIVE STUDY;ACUTE ISCHEMIC;ACUTE MYELOID;ADVANCED PARKINSONS;ALLOGENEIC STEM;ANAL FISTULA;ATTACHMENT STYLES;BIOLOGIC TREATMENTS;BOWEL DISEASE;BOWEL DISEASES;BRIDGING THERAPY;CANCER GC;CANCER SCREENING","14;5;5;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2","BREAST CANCER;MALDI-TOF MS;STATISTICALLY SIGNIFICANT;PHYLOGENETIC ANALYSIS;AORTIC VALVE;PNEUMONIAE STRAINS;CROSSREF MEDLINE;GA VERSUS;RISK FACTORS;AOR CI;PSYCHOLOGICAL DISTRESS;ADVERSE EVENTS;COHORT STUDY;PATIENTS RECEIVED;HAEMATOLOGICAL MALIGNANCIES;MEDIAN AGE;RESPONSE RATE;SIGNIFICANTLY REDUCED;SOCIAL DISTANCING;BLOOD CULTURES;CANCER BC;CAS GOOGLE;CONSECUTIVE PATIENTS;COVID- PANDEMIC;COVID- PATIENTS;MEDLINE CAS;MULTIVARIATE ANALYSIS;PATIENTS TREATED;POCKET HEMATOMA;ADULT PATIENTS","33;15;15;14;13;12;11;11;11;10;10;9;9;9;8;8;8;8;8;7;7;7;7;7;7;7;7;7;7;6",98,0.5,9,6,1.75,2,0,2,2.5,1,1,7,1,1,5,0,1,1,3.25,4,3,0,0,61.75,61.75,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,31,3.81,423.29,10.76,19,0.61,78.06,0,0,3,1,16,0,0,11,0,22,9,0,0,0,0,0,0,30,0,1,30,0,0,1,0,0,0,0,0,0,"United States;Italy;Japan;Germany;Switzerland","6;4;2;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3212 OPHTHALMOLOGY AND OPTOMETRY;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;3203 DENTISTRY;3210 NUTRITION AND DIETETICS","31;11;7;7;4;2;2;2;2;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;PATIENT SAFETY;EYE DISEASE AND DISORDERS OF VISION;HEMATOLOGY;RARE DISEASES;DIGESTIVE DISEASES;NEURODEGENERATIVE;AUTOIMMUNE DISEASE;NEUROSCIENCES;PREVENTION;AGING;LYMPHOMA;MACULAR DEGENERATION;BRAIN DISORDERS;COLO-RECTAL CANCER;CROHN'S DISEASE;INFECTIOUS DISEASES;INFLAMMATORY BOWEL DISEASE","30;19;11;11;7;7;6;5;5;4;4;4;3;3;3;2;2;2;2;2","CANCER;EYE;ORAL AND GASTROINTESTINAL;NEUROLOGICAL;RENAL AND UROGENITAL;SKIN","9;4;3;2;1;1","6.1 PHARMACEUTICALS;6.4 SURGERY;5.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;3.3 NUTRITION AND CHEMOPREVENTION;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.3 MEDICAL DEVICES;7.1 INDIVIDUAL CARE NEEDS;8.1 ORGANISATION AND DELIVERY OF SERVICES","22;3;2;2;1;1;1;1;1","LEUKEMIA / LEUKAEMIA;NON-HODGKIN'S LYMPHOMA;COLON AND RECTAL CANCER;BLADDER CANCER;PROSTATE CANCER","6;3;2;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES;4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING;5.2 LOCALIZED THERAPIES - CLINICAL APPLICATIONS;6.2 SURVEILLANCE","6;2;1;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"FRONTIERS","5","52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;32 BIOMEDICAL AND CLINICAL SCIENCES;42 HEALTH SCIENCES;3202 CLINICAL SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;4205 NURSING","6;3;2;2;1;1;1","BRAIN DISORDERS;BEHAVIORAL AND SOCIAL SCIENCE;CLINICAL RESEARCH;MENTAL HEALTH;RARE DISEASES;TUBEROUS SCLEROSIS;AUTISM;INTELLECTUAL AND DEVELOPMENTAL DISABILITIES (IDD);PEDIATRIC;NEUROSCIENCES;BASIC BEHAVIORAL AND SOCIAL SCIENCE;BIOENGINEERING;BIOMEDICAL IMAGING;CHRONIC PAIN;DEPRESSION;MIND AND BODY;PAIN RESEARCH;PATIENT SAFETY","5;4;4;4;4;4;3;3;3;2;1;1;1;1;1;1;1;1","MENTAL HEALTH","3","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;7.1 INDIVIDUAL CARE NEEDS","3;1","CLINICAL","5","CLINICAL MEDICINE AND SCIENCE","3","BRAIN TUMOR","1",NA,NA
"AOU_TORVERGATA",2021,218,15.3256880733945,2.9954128440367,0.334862385321101,0.311926605504587,0.376146788990826,1.92058823529412,1.35185185185185,1.58139534883721,1.43859649122807,0.660550458715596,0,73,50,31,19,0.33,0.23,0.14,0.09,10.76,0.697858066802728,7.07889908256882,0.284403669724771,0.912844036697248,0.46,0.455,0.39,0.443,"GIANLUCA VANNI;LOREDANA SARMATI;ORESTE CLAUDIO BUONOMO;MASSIMO ANDREONI;LUCA BIANCHI;MARCO MATERAZZO;MARCO PELLICCIARO;TOMMASO PERRETTA;FEDERICO TACCONI;MARK S. TALAMONTI;MARCO GALLUZZO;GIACOMO KOCH;KETTY PERIS;LUCA STINGENI;PAOLA ROGLIANI;UMBERTO TARANTINO;NICOLA BIAGIO MERCURI;FRANCESCO BUCCISANO;VINCENZO AMBROGI;GABRIELLA FABBROCINI","16;11;11;11;10;10;10;9;9;9;9;9;9;8;8;8;8;7;7;7","GIANLUCA VANNI;FEDERICO TACCONI;VINCENZO AMBROGI;MARCO MATERAZZO;MARCO PELLICCIARO;TOMMASO PERRETTA;ORESTE CLAUDIO BUONOMO;UMBERTO TARANTINO;MANUEL SCIMECA;ORAZIO SCHILLACI;MARCO GALLUZZO;PAOLA ROGLIANI;ELENA BONANNO;NICOLETTA URBANO;MARK S. TALAMONTI;SOFIA VIDALI;MASSIMO FEDERICI;NICOLA BIAGIO MERCURI;LOREDANA SARMATI;MASSIMO ANDREONI","1.86;1.6;1.35;1.19;1.16;1.14;1.11;1.11;1.06;1.03;0.98;0.97;0.89;0.89;0.87;0.86;0.85;0.85;0.84;0.79","GIANLUCA VANNI;LOREDANA SARMATI;ORESTE CLAUDIO BUONOMO;MASSIMO ANDREONI;LUCA BIANCHI;MARCO MATERAZZO;MARCO PELLICCIARO;TOMMASO PERRETTA;FEDERICO TACCONI;MARK S. TALAMONTI;MARCO GALLUZZO;GIACOMO KOCH;PAOLA ROGLIANI;UMBERTO TARANTINO;NICOLA BIAGIO MERCURI;FRANCESCO BUCCISANO;VINCENZO AMBROGI;MASSIMO FEDERICI;CHIARA ADRIANA PISTOLESE;MARCO CIOTTI","16;11;11;11;10;10;10;9;9;9;9;9;8;8;8;7;7;7;7;6","GIANLUCA VANNI;FEDERICO TACCONI;VINCENZO AMBROGI;MARCO MATERAZZO;MARCO PELLICCIARO;TOMMASO PERRETTA;ORESTE CLAUDIO BUONOMO;UMBERTO TARANTINO;MARCO GALLUZZO;PAOLA ROGLIANI;NICOLETTA URBANO;MARK S. TALAMONTI;SOFIA VIDALI;MASSIMO FEDERICI;NICOLA BIAGIO MERCURI;LOREDANA SARMATI;MASSIMO ANDREONI;ENRICO FINAZZI AGRÒ;MARCO CIOTTI;RENATO ARGIRÒ","1.86;1.6;1.35;1.19;1.16;1.14;1.11;1.11;0.98;0.97;0.89;0.87;0.86;0.85;0.85;0.84;0.79;0.77;0.75;0.72","MASSIMO ANDREONI;LOREDANA SARMATI;MARIA TERESA VOSO;ESTHER NATALIE OLÍVA;PIERRE FENAUX;UWE PLATZBECKER;VALERIA SANTINI;KETTY PERIS;MARCO IANNETTA;MARCO GALLUZZO;LUCA BIANCHI;MARK S. TALAMONTI;LUCA STINGENI;ALESSANDRO RAMBALDI;SERGIO BERNARDINI;BENEDETTO BRUNO;FABIO CICERI;FRANCESCA BONIFAZI;LUCIANO MILANESI;ALBERTO TERMANINI","290;242;227;218;218;218;218;198;195;192;186;177;173;166;164;163;163;163;162;159","MASSIMO ANDREONI;MARIA TERESA VOSO;MARCO IANNETTA;MARCO GALLUZZO;M. ANGÉLICO;MARK S. TALAMONTI;LOREDANA SARMATI;GIANLUCA VANNI;GIACOMO KOCH;VIVIANA MOSCHESE;MAYLA SGRULLETTI;VINCENZO MALAGNINO;ORESTE CLAUDIO BUONOMO;FABRIZIO SALLUSTIO;MARTA ZORDAN;PIETRO VITALE;SANDRO GRELLI;ANASTASIOS D. ASIMAKOPOULOS;LUCA BIANCHI;MARCO MATERAZZO","196;159;157;144;143;128;117;110;103;97;89;89;87;86;84;84;84;80;80;73","GIANLUCA VANNI;MARCO MATERAZZO;ORESTE CLAUDIO BUONOMO;FEDERICO TACCONI;MARCO PELLICCIARO;MARCO GALLUZZO;NICOLA BIAGIO MERCURI;TOMMASO PERRETTA;UMBERTO TARANTINO;LUCA BIANCHI;VINCENZO AMBROGI;MARK S. TALAMONTI;MASSIMO FEDERICI;MASSIMO ANDREONI;ANASTASIOS D. ASIMAKOPOULOS;CHIARA ADRIANA PISTOLESE;GIACOMO KOCH;MARIA CANTONETTI;NICOLETTA URBANO;SOFIA VIDALI","16;10;10;9;9;8;8;8;8;7;7;7;7;6;6;6;6;6;6;5","MEDICINE;BIOLOGY;PSYCHOLOGY;COMPUTER SCIENCE;PHYSICS;ENGINEERING;MATHEMATICS;CHEMISTRY;POLITICAL SCIENCE;ECONOMICS;SOCIOLOGY;ART;PHILOSOPHY;BUSINESS","211;59;23;16;16;14;14;13;8;7;5;2;2;1","INTERNAL MEDICINE;SURGERY;PATHOLOGY;IMMUNOLOGY;GENETICS;RADIOLOGY;CARDIOLOGY;ONCOLOGY;GASTROENTEROLOGY;BIOCHEMISTRY;PSYCHIATRY;INTENSIVE CARE MEDICINE;NURSING;PEDIATRICS;ENVIRONMENTAL HEALTH;VIROLOGY;PHYSICAL THERAPY;PALEONTOLOGY;BIOINFORMATICS;DERMATOLOGY;UROLOGY","160;64;43;33;32;27;25;24;21;19;17;16;16;16;15;15;14;12;10;10;10","DISEASE;CANCER;GENE;ALTERNATIVE MEDICINE;COHORT;POPULATION;RANDOMIZED CONTROLLED TRIAL;CONFIDENCE INTERVAL;LOGISTIC REGRESSION;TRANSPLANTATION;OBSERVATIONAL STUDY;PREGNANCY;ADVERSE EFFECT;OUTBREAK;COGNITION;INFLAMMATION;PSORIASIS;RETROSPECTIVE COHORT STUDY;CHEMOTHERAPY;IMMUNE SYSTEM;IN VITRO;LYMPHOMA","64;33;18;15;14;14;14;13;12;12;11;11;10;10;9;9;9;9;8;8;8;8","INFECTIOUS DISEASE (MEDICAL SPECIALTY);2019-20 CORONAVIRUS OUTBREAK;BREAST CANCER;CLINICAL ENDPOINT;DEMENTIA;ALZHEIMER'S DISEASE;COLORECTAL CANCER;PROSTATE;UNIVARIATE ANALYSIS;AUTOLOGOUS STEM-CELL TRANSPLANTATION;GENOTYPE;PHENOTYPE;PSORIATIC ARTHRITIS;EJECTION FRACTION;FETUS;HAZARD RATIO;HEPATITIS B VIRUS;OSTEOARTHRITIS;PLAQUE PSORIASIS;PROSTATE CANCER;PSORIASIS AREA AND SEVERITY INDEX;RITUXIMAB","30;10;10;7;7;6;6;6;6;5;5;5;5;4;4;4;4;4;4;4;4;4","CORONAVIRUS DISEASE 2019 (COVID-19);FRONTOTEMPORAL DEMENTIA;PROSTATECTOMY;BRENTUXIMAB VEDOTIN;FORMOTEROL;LYMPHOCYTE SUBSETS;OCRELIZUMAB;SECUKINUMAB;USTEKINUMAB;CARDIAC SKELETON;DEMENTIA WITH LEWY BODIES;HEART RATE VARIABILITY;KARYOTYPE;NEOADJUVANT THERAPY;ADIPONECTIN;ANDROGEN DEPRIVATION THERAPY;ANDROGEN RECEPTOR;ANTERIOR CEREBRAL ARTERY;ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY;ANTIVIRAL TREATMENT;ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA;ATHERECTOMY;AUTONOMIC NERVOUS SYSTEM;AXILLA;AXILLARY LYMPH NODES;BASDAI;BECLOMETASONE DIPROPIONATE;BENDAMUSTINE;BRAIN METASTASIS;BREAST RECONSTRUCTION;BREAST SURGERY;CAPECITABINE;CD3;CD52;CEFTAZIDIME;CERTOLIZUMAB PEGOL;CETUXIMAB;COGNITIVE DECLINE;COLD PRESSOR TEST;COPY-NUMBER VARIATION;DASATINIB;DIFFUSING CAPACITY;DIGITAL POLYMERASE CHAIN REACTION;DNA METHYLATION;EDINBURGH POSTNATAL DEPRESSION SCALE;FETAL GROWTH;FRAGILITY FRACTURE;GENE MUTATION;GENEXPERT MTB/RIF;GENOTYPING;GLOMERULOSCLEROSIS;GOLIMUMAB;HBSAG;HEPACIVIRUS;HEREDITARY SPASTIC PARAPLEGIA;HIGH-FUNCTIONING AUTISM;INTERNATIONAL PROGNOSTIC SCORING SYSTEM;KLEBSIELLA;KLEBSIELLA PNEUMONIAE;LAMIVUDINE;LIPOTOXICITY;LMNA;LNCAP;LOSS FUNCTION;LOWER URINARY TRACT SYMPTOMS;LYMPHEDEMA;LYMPHOVASCULAR INVASION;MAMMOGRAPHY;MANIA;MESANGIUM;METERED-DOSE INHALER;MODIFIED RANKIN SCALE;MOLECULAR MEDICINE;MONOCLONAL;MYELOPROLIFERATIVE NEOPLASM;MYH7;NILOTINIB;NIVOLUMAB;OMALIZUMAB;OXYCODONE;PHARMACOGENETICS;PLASMACYTOID DENDRITIC CELL;PNEUMOCYSTIS PNEUMONIA;PODOCYTE;PROBAND;PRODUCTS OF CONCEPTION;PSYCHOMETRIC TESTING;RANIBIZUMAB;RIBOSOME;ROTAVIRUS VACCINE;SENTINEL LYMPH NODE;SILENT PERIOD;SINGLE-NUCLEOTIDE POLYMORPHISM;SMALL FOR GESTATIONAL AGE;SOD1;SOD2;STEATOHEPATITIS;STEREOTACTIC RADIOTHERAPY;SUICIDE ATTEMPT;TAUOPATHY;THYMIDYLATE SYNTHASE;TILT TABLE TEST;TLR2;TRANSCRANIAL ALTERNATING CURRENT STIMULATION;TRANSCRIPTOME;TRANSLATION (BIOLOGY);TRANSURETHRAL RESECTION OF THE PROSTATE;VACCINE-PREVENTABLE DISEASES;VENTRAL TEGMENTAL AREA;VINCRISTINE","29;6;4;3;3;3;3;3;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;FEMALE;MALE;COVID-19;MIDDLE AGED;TREATMENT OUTCOME;ADULT;RETROSPECTIVE STUDIES;AGED;SARS-COV-2;BREAST NEOPLASMS;ITALY;PROSPECTIVE STUDIES;ANTIBODIES, MONOCLONAL, HUMANIZED;POSTOPERATIVE COMPLICATIONS;PSORIASIS;STROKE;DERMATITIS, ATOPIC;AGED, 80 AND OVER","118;98;43;36;32;29;26;25;24;21;16;15;14;13;12;12;12;11;10;9","CORONAVIRUS DISEASE 2019;RECIPROCAL DEVELOPMENT OF TH17 AND TREG CELLS;ACUTE MYELOID LEUKEMIA;CORONAVIRUS DISEASE 2019 RESEARCH;IMPACT OF COVID-19 ON CANCER PATIENTS AND CARE;LYMPHOID NEOPLASMS;HEPATITIS B INFECTION AND TREATMENT;STANDARDISATION OF LOWER URINARY TRACT FUNCTION;ANALYSIS OF BRAIN FUNCTIONAL CONNECTIVITY NETWORKS;ATOPIC DERMATITIS AND SKIN MICROBIOME;EFFECTS OF BRAIN STIMULATION ON MOTOR CORTEX;EPIDEMIOLOGY AND MANAGEMENT OF STROKE;MANAGEMENT AND EPIDEMIOLOGY OF INFECTIVE ENDOCARDITIS;POLYOMAVIRUS-ASSOCIATED CARCINOGENESIS AND CLINICAL MANIFESTATIONS;ROLE OF PENTRAXINS IN INNATE IMMUNITY AND INFLAMMATION;ADVANCEMENTS IN PROSTATE CANCER RESEARCH;AGE-RELATED MACULAR DEGENERATION RESEARCH;BREAST PATHOLOGY AND IMAGING TECHNIQUES;BREAST RECONSTRUCTION TECHNIQUES AND OUTCOMES;CHOLESTEROL-LOWERING TREATMENT","7;7;6;6;6;6;5;5;4;4;3;3;3;3;3;2;2;2;2;2","PANDEMIC;2019-20 CORONAVIRUS OUTBREAK;TREATMENT;CLINICAL ENDPOINT;UNIVARIATE ANALYSIS;AUTOLOGOUS STEM-CELL TRANSPLANTATION;DELPHI METHOD;PREGNANCY;PSORIASIS;STROKE (ENGINE);VACCINES;CARDIOTHORACIC SURGERY;CLINICAL CHARACTERISTICS;INFARCTION TREATMENT;PROSTATE CANCER;ACUTE MYELOID LEUKEMIA;BREAST RECONSTRUCTION;BRENTUXIMAB VEDOTIN;CARDIAC IMAGING;COMBINATION THERAPY","13;11;8;7;6;5;5;5;5;5;5;4;4;4;4;3;3;3;3;3","ACUTE MYELOID;BREAST CANCER;ITALIAN SOCIETY;MYELOID LEUKEMIA;COVID- PATIENTS;CANCER PATIENTS;CELL TRANSPLANTATION;COVID- PANDEMIC;HODGKIN LYMPHOMA;LONGITUDINAL STUDY;MULTIPLE SCLEROSIS;NURSING STUDENTS;STEM CELL;ATOPIC DERMATITIS;AUTOLOGOUS STEM;BRENTUXIMAB VEDOTIN;COVID- ERA;DE NOVO;EUROPEAN SOCIETY;HEMATOPOIETIC STEM;HOLMIUM LASER;INVASIVE SIMPLE;ITALIAN MULTICENTER;LASER ENUCLEATION;MARROW TRANSPLANTATION;MINIMALLY INVASIVE;ML PROSTATE;MULTICENTER RANDOMIZED;OBSERVATIONAL STUDY;PLAQUE PSORIASIS","6;6;6;6;5;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","PUBMED SCOPUS;COVID- PATIENTS;SPEAKERS BUREAU;DISEASE ACTIVITY;COVID- PANDEMIC;ADVERSE EVENTS;CD CD;LOGISTIC REGRESSION;NOVARTIS PFIZER;STATISTICALLY SIGNIFICANT;ADHESIVE CAPSULITIS;BUREAU ABBVIE;CORONAVIRUS DISEASE;CROSSREF PUBMED;DISEASE COVID-;FROZEN SHOULDERJ;MEDIAN AGE;PLAQUE PSORIASIS;ELBOW SURG;HR CI;PATIENTS AFFECTED;RESEARCH FUNDING;ROME ITALYSEARCH;SHOULDER ELBOW;ACUTE RESPIRATORY;ATOPIC DERMATITIS;BRISTOL-MYERS SQUIBB;CANCER PAIN;CLINICAL PRACTICE;CONSULTANCY HONORARIA","68;34;23;18;16;13;13;13;13;13;12;12;12;12;12;12;11;11;10;10;10;10;10;10;9;9;9;9;9;9",105,0.48,6.55,5,1.5,1,0,3.5,1,1,1,6,1.75,1,5,1,0,1,2,3,2.75,0,0,34,34,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,32,3.12,705.94,10.49,19,0.59,98.06,0,0,5,0,12,0,2,13,0,24,8,0,0,0,0,0,0,31,1,0,31,0,0,1,0,0,0,0,0,0,"United States;Italy;Japan;Belgium;Switzerland","7;4;3;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;3212 OPHTHALMOLOGY AND OPTOMETRY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;3203 DENTISTRY;3204 IMMUNOLOGY;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING","30;15;6;4;4;4;2;2;2;2;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;PATIENT SAFETY;RARE DISEASES;HEMATOLOGY;AUTOIMMUNE DISEASE;DIGESTIVE DISEASES;NEURODEGENERATIVE;BIOENGINEERING;BRAIN DISORDERS;PEDIATRIC;PREVENTION;LUNG;NEUROSCIENCES;PEDIATRIC CANCER;REGENERATIVE MEDICINE;STEM CELL RESEARCH;TRANSPLANTATION;AGING","29;22;11;11;11;8;7;5;5;4;4;4;4;3;3;3;3;3;3;2","CANCER;BLOOD;CARDIOVASCULAR;EYE;INFECTION;INFLAMMATORY AND IMMUNE SYSTEM;NEUROLOGICAL;ORAL AND GASTROINTESTINAL;RESPIRATORY;STROKE","8;2;2;2;2;2;1;1;1;1","6.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;2.2 FACTORS RELATING TO THE PHYSICAL ENVIRONMENT;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS;5.2 CELLULAR AND GENE THERAPIES;5.3 MEDICAL DEVICES;5.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES;6.2 CELLULAR AND GENE THERAPIES;6.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES;7.1 INDIVIDUAL CARE NEEDS","22;1;1;1;1;1;1;1;1;1;1;1","LEUKEMIA / LEUKAEMIA;NON-HODGKIN'S LYMPHOMA;LIVER CANCER;BLOOD CANCER;BREAST CANCER;COLON AND RECTAL CANCER;HODGKIN'S DISEASE;LUNG CANCER;NOT SITE-SPECIFIC CANCER","5;3;2;1;1;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;2.1 EXOGENOUS FACTORS IN THE ORIGIN AND CAUSE OF CANCER;4.1 TECHNOLOGY DEVELOPMENT AND/OR MARKER DISCOVERY;4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING;5.2 LOCALIZED THERAPIES - CLINICAL APPLICATIONS","5;1;1;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,9,"FRONTIERS;ZENODO","5;4","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3105 GENETICS;3204 IMMUNOLOGY;3212 OPHTHALMOLOGY AND OPTOMETRY;46 INFORMATION AND COMPUTING SCIENCES;3107 MICROBIOLOGY;3202 CLINICAL SCIENCES;3207 MEDICAL MICROBIOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;4607 GRAPHICS, AUGMENTED REALITY AND GAMES;4608 HUMAN-CENTRED COMPUTING","13;4;2;2;2;2;1;1;1;1;1;1","GENETICS;NEUROSCIENCES;PREVENTION;RARE DISEASES;AGING;BIOTECHNOLOGY;CLINICAL RESEARCH;EYE DISEASE AND DISORDERS OF VISION;MACULAR DEGENERATION;NEURODEGENERATIVE;NEUROFIBROMATOSIS;BEHAVIORAL AND SOCIAL SCIENCE;BIODEFENSE;CANCER;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;COLO-RECTAL CANCER;DIGESTIVE DISEASES;EMERGING INFECTIOUS DISEASES;INFECTIOUS DISEASES;VACCINE RELATED","4;4;4;4;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1","MUSCULOSKELETAL;CANCER;INFECTION;MENTAL HEALTH","2;1;1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;2.2 FACTORS RELATING TO THE PHYSICAL ENVIRONMENT;6.1 PHARMACEUTICALS","6;1;1;1","BIOMEDICAL;CLINICAL","5;2","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE","7;1","NERVOUS SYSTEM;COLON AND RECTAL CANCER;NOT SITE-SPECIFIC CANCER","2;1;1",NA,NA
"AOU_TORVERGATA",2022,258,15.5,2.83333333333333,0.317829457364341,0.337209302325581,0.341085271317829,1.77858880778589,1.22388059701493,1.42622950819672,1.3134328358209,0.697674418604651,0,76,64,36,18,0.29,0.25,0.14,0.07,5.72,0.641304921442306,6.19108826049698,0.368217054263566,0.934108527131783,0.457,0.441,0.399,0.399,"GIUSEPPE RIZZO;ILENIA MAPPA;MASSIMO ANDREONI;ENRICO FINAZZI AGRÒ;SAVERIO MUSCOLI;GIANLUCA VANNI;CIRO INDOLFI;ANASTASIOS D. ASIMAKOPOULOS;LUCA BIANCHI;MARCO CIOTTI;MARCO MATERAZZO;MARCO PELLICCIARO;PAOLA ROGLIANI;FRANCESCO ROMEO;ROSARIO FOTI;LOREDANA SARMATI;ANDREA FUSCHI;VIVIANA MOSCHESE;CARMEN SPACCAROTELLA;FLORENZO IANNONE","16;12;10;10;9;9;9;8;7;7;7;7;7;7;6;6;6;6;6;5","GIUSEPPE RIZZO;ILENIA MAPPA;ENRICO FINAZZI AGRÒ;ANASTASIOS D. ASIMAKOPOULOS;GIANLUCA VANNI;MARCO MATERAZZO;RICCARDO MORGAGNI;PAOLA ROGLIANI;MARCO PELLICCIARO;F. D’ANTONIO;LUIGINO CALZETTA;ANDREA GIOVANNI PARATO;ROBERTO GANDINI;MASSIMO ANDREONI;ROBERTO MIANO;SAVERIO MUSCOLI;DOMENICO SERGIO POGGI;MARIA ELENA PIETROLUCCI;ELEONORA PICCIRILLI;MASSIMO MASSARELLA","2.92;1.94;1.27;1.22;1.19;0.99;0.98;0.98;0.94;0.83;0.74;0.73;0.73;0.73;0.72;0.68;0.67;0.67;0.67;0.67","GIUSEPPE RIZZO;ILENIA MAPPA;MASSIMO ANDREONI;ENRICO FINAZZI AGRÒ;SAVERIO MUSCOLI;GIANLUCA VANNI;ANASTASIOS D. ASIMAKOPOULOS;LUCA BIANCHI;MARCO CIOTTI;MARCO MATERAZZO;MARCO PELLICCIARO;PAOLA ROGLIANI;FRANCESCO ROMEO;LOREDANA SARMATI;VIVIANA MOSCHESE;VALERIA GUGLIELMI;DAVIDE LAURO;PAOLO SBRACCIA;ROBERTO FLORIS;LUIGI MAZZONE","16;12;10;10;9;9;8;7;7;7;7;7;7;6;6;5;5;5;5;5","GIUSEPPE RIZZO;ILENIA MAPPA;ENRICO FINAZZI AGRÒ;ANASTASIOS D. ASIMAKOPOULOS;GIANLUCA VANNI;MARCO MATERAZZO;RICCARDO MORGAGNI;PAOLA ROGLIANI;MARCO PELLICCIARO;ANDREA GIOVANNI PARATO;ROBERTO GANDINI;MASSIMO ANDREONI;ROBERTO MIANO;SAVERIO MUSCOLI;DOMENICO SERGIO POGGI;MARIA ELENA PIETROLUCCI;ELEONORA PICCIRILLI;MASSIMO MASSARELLA;MARTINA SIRACUSANO;LUIGI MAZZONE","2.92;1.94;1.27;1.22;1.19;0.99;0.98;0.98;0.94;0.73;0.73;0.73;0.72;0.68;0.67;0.67;0.67;0.67;0.65;0.65","LUCA BIANCHI;ALESSANDRO PALMA;ANDREA SCALONI;ANDRÉS HIDALGO;ANNA CRESCENZI;ANTOINE A.F. DE VRIES;BEIYAN ZHOU;CHUAN LI;CLAUDIA FUOCO;DANIELE LETTIERI‐BARBATO;FARNAZ SHAMSI;FEDERICA RICCIO;FIORELLA FAIENZA;FLAVIA TORTOLICI;FRANCESCA SCIARRETTA;GIOVANNI RENZONE;GIUSEPPE FILOMENI;JONATHAN R. BRESTOFF;KATIA AQUILANO;KEATON KARLINSEY","162;133;133;133;133;133;133;133;133;133;133;133;133;133;133;133;133;133;133;133","LUCA BIANCHI;MARCO ROSINA;GIUSEPPE RIZZO;MARCO GALLUZZO;MARK S. TALAMONTI;MASSIMO ANDREONI;ELENA CAMPIONE;LORENZO TOFANI;RUSLANA GAETA SHUMAK;ILENIA MAPPA;SERGIO AMADORI;ARNALDO CIONI;VIRGINIA MAFFEI;VIVIANA MOSCHESE;PAOLA ROGLIANI;AMBRA STEFANI;ELISABETTA DEL DUCA;LAURA DILUVIO;FABIO PLACIDI;GIOVANNI MONTELEONE","162;133;93;73;73;70;62;58;58;43;41;40;40;40;39;38;38;36;35;35","GIUSEPPE RIZZO;ILENIA MAPPA;SAVERIO MUSCOLI;GIANLUCA VANNI;MASSIMO ANDREONI;ANASTASIOS D. ASIMAKOPOULOS;ENRICO FINAZZI AGRÒ;LUCA BIANCHI;VIVIANA MOSCHESE;JOSUEL ORA;MARCO MATERAZZO;MARCO PELLICCIARO;MARCO CIOTTI;FRANCESCO ROMEO;GIOVANNI MONTELEONE;PAOLA ROGLIANI;PAOLO SBRACCIA;ROBERTO PERRICONE;VALERIA GUGLIELMI;ALESSANDRO ANSELMO","16;10;9;8;8;7;7;7;6;6;6;6;6;5;5;5;5;5;5;4","MEDICINE;BIOLOGY;PSYCHOLOGY;CHEMISTRY;PHYSICS;COMPUTER SCIENCE;MATHEMATICS;POLITICAL SCIENCE;ECONOMICS;SOCIOLOGY;ENGINEERING;PHILOSOPHY;MATERIALS SCIENCE;BUSINESS;ENVIRONMENTAL SCIENCE;GEOGRAPHY;GEOLOGY;HISTORY","246;66;20;16;16;14;10;10;9;9;8;5;4;3;2;2;2;1","INTERNAL MEDICINE;SURGERY;RADIOLOGY;GENETICS;PATHOLOGY;CARDIOLOGY;IMMUNOLOGY;ONCOLOGY;BIOCHEMISTRY;GASTROENTEROLOGY;INTENSIVE CARE MEDICINE;ENVIRONMENTAL HEALTH;PEDIATRICS;PSYCHIATRY;NURSING;OBSTETRICS;UROLOGY;DERMATOLOGY;FAMILY MEDICINE;PHYSICAL THERAPY;VIROLOGY","179;73;42;41;38;37;26;24;23;22;21;20;19;19;18;15;14;13;13;13;13","CANCER;DISEASE;PREGNANCY;RETROSPECTIVE COHORT STUDY;POPULATION;GENE;COHORT;RANDOMIZED CONTROLLED TRIAL;CHEMOTHERAPY;ADVERSE EFFECT;HEALTH CARE;PROSPECTIVE COHORT STUDY;ALTERNATIVE MEDICINE;MAGNETIC RESONANCE IMAGING;CONFIDENCE INTERVAL;PSORIASIS;QUALITY OF LIFE (HEALTHCARE);HEART FAILURE;IMMUNE SYSTEM;STENOSIS;TRANSPLANTATION","42;40;21;21;17;15;14;14;13;11;11;11;10;10;9;9;9;8;8;8;8","INFECTIOUS DISEASE (MEDICAL SPECIALTY);FETUS;BREAST CANCER;PROSTATE;COLORECTAL CANCER;GESTATIONAL AGE;PROSTATE CANCER;2019-20 CORONAVIRUS OUTBREAK;PSORIATIC ARTHRITIS;TOLERABILITY;ADALIMUMAB;CLINICAL ENDPOINT;HAZARD RATIO;METASTASIS;PHENOTYPE;PSORIASIS AREA AND SEVERITY INDEX;AUTISM SPECTRUM DISORDER;CYCLOPHOSPHAMIDE;DEMENTIA;EJECTION FRACTION;HEMATOPOIETIC STEM CELL TRANSPLANTATION;TYPE 2 DIABETES;UNIVARIATE ANALYSIS;VASCULAR RESISTANCE","18;14;12;10;8;8;7;6;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4;4","CORONAVIRUS DISEASE 2019 (COVID-19);PRENATAL DIAGNOSIS;SECUKINUMAB;USTEKINUMAB;LOWER URINARY TRACT SYMPTOMS;ANDROGEN DEPRIVATION THERAPY;CYSTECTOMY;PROSTATECTOMY;ANTIRETROVIRAL THERAPY;BREAST SURGERY;BUSULFAN;CARDIAC SKELETON;CAREGIVER BURDEN;CERTOLIZUMAB PEGOL;CETUXIMAB;COLONOSCOPY;CXCR4;FETAL HEAD;FLUDARABINE;GOLIMUMAB;HAPLOINSUFFICIENCY;HERPESVIRIDAE;IDARUBICIN;INTERNATIONAL PROGNOSTIC SCORING SYSTEM;IRINOTECAN;KRAS;MAMMOGRAPHY;MASTECTOMY;SACUBITRIL;STEREOTACTIC RADIOTHERAPY;STROKE VOLUME;USUAL INTERSTITIAL PNEUMONIA;VINCRISTINE","18;5;5;5;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",";HUMANS;FEMALE;RETROSPECTIVE STUDIES;MALE;COVID-19;TREATMENT OUTCOME;PREGNANCY;ULTRASONOGRAPHY, PRENATAL;ADULT;AGED;MIDDLE AGED;MAGNETIC RESONANCE IMAGING;BIOMARKERS;BREAST NEOPLASMS;PROSPECTIVE STUDIES;AORTIC VALVE STENOSIS;OSTEOPOROTIC FRACTURES;PROSTATIC NEOPLASMS;SARS-COV-2","127;127;55;37;29;27;23;22;20;18;15;12;11;10;10;10;9;9;9;9","ACUTE MYELOID LEUKEMIA;RECIPROCAL DEVELOPMENT OF TH17 AND TREG CELLS;CORONAVIRUS DISEASE 2019;MANAGEMENT OF VALVULAR HEART DISEASE;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;ADVANCEMENTS IN PROSTATE CANCER RESEARCH;EPIDEMIOLOGY AND MANAGEMENT OF CONGENITAL HEART DISEASE;PELVIC FLOOR DISORDERS;AUTISM SPECTRUM DISORDERS;CLASSIFICATION AND TREATMENT OF SPONDYLOARTHRITIS;DIAGNOSIS AND TREATMENT OF BLADDER CANCER;DIAGNOSIS AND TREATMENT OF HEART FAILURE;MATERNAL AND NEONATAL OUTCOMES OF CESAREAN SECTION;MOLECULAR RESEARCH ON BREAST CANCER;STANDARDISATION OF LOWER URINARY TRACT FUNCTION;DIAGNOSIS AND MANAGEMENT OF CARDIAC TUMORS;EPIDEMIOLOGY AND MANAGEMENT OF CYTOMEGALOVIRUS INFECTION;LYMPHOID NEOPLASMS;NEUROLOGICAL MANIFESTATIONS OF COVID-19 INFECTION;PATHOPHYSIOLOGY AND MANAGEMENT OF PREECLAMPSIA","9;7;6;6;5;5;5;5;4;4;4;4;4;4;4;3;3;3;3;3","TREATMENT;CARDIAC IMAGING;TRANSCATHETER AORTIC-VALVE REPLACEMENT;CARDIOVASCULAR RISK ASSESSMENT;PRENATAL DIAGNOSIS;PROSTHETIC VALVES EVALUATION;TOLERABILITY;CLINICAL ENDPOINT;CONCOMITANT;METASTATIC COLORECTAL CANCER;PSORIASIS;USTEKINUMAB;2019-20 CORONAVIRUS OUTBREAK;FETAL CARDIAC DISEASE;FETAL MRI;FLT3 MUTATIONS;SPECIALTY;UNIVARIATE ANALYSIS;ACUTE MYELOID LEUKEMIA;AUTISM","10;9;7;6;6;6;6;5;5;5;5;5;4;4;4;4;4;4;3;3","ITALIAN SOCIETY;MAGNETIC RESONANCE;PATIENTS UNDERGOING;CLINICAL PRACTICE;HEART FAILURE;ACUTE MYELOID;BREAST CANCER;COLORECTAL CANCER;COVID- PATIENTS;MYELOID LEUKEMIA;POSITION PAPER;PSORIATIC ARTHRITIS;SARS-COV- INFECTION;BIOLOGIC TREATMENTS;MULTICENTER STUDY;MULTIPLE SCLEROSIS;PROSTATE CANCER;RETROSPECTIVE STUDY;RISK FACTORS;AORTIC VALVE;BARIATRIC SURGERY;CARDIAC MAGNETIC;CLINICAL OUTCOME;COHORT STUDY;CONGENITAL HEART;CONSENSUS DOCUMENT;DISEASE PATIENTS;FETAL BRAIN;HEART DISEASE;HEART DISEASES","8;7;7;6;6;5;5;5;5;5;5;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3","MEDIAN AGE;SARS-COV- INFECTION;BREAST CANCER;HR CI;ADVERSE EVENTS;PATIENTS UNDERGOING;RISK FACTORS;PROSTATE CANCER;SELF-CARE MANAGEMENT;COVID- PATIENTS;HEART FAILURE;ITALIAN SOCIETY;INCREASED RISK;RETROSPECTIVE STUDY;SIGNIFICANTLY LOWER;VIEW LARGEDOWNLOAD;AML PATIENTS;CEREBROVASCULAR EVENTS;CLINICAL PRACTICE;COHORT STUDY;CONTINUATION THERAPY;EASTERN EUROPEAN;FUNDING SOURCES;MAGNETIC RESONANCE;MANAGEMENT BEHAVIORS;PATIENTS AFFECTED;AORTIC VALVE;BREAST SURGERY;CONSECUTIVE PATIENTS;CORONAVIRUS DISEASE","17;16;14;14;13;13;13;12;12;11;11;11;10;10;10;10;9;9;9;9;9;9;9;9;9;9;8;8;8;8",121,0.47,5,4,1,1,0,1,1,1,0,5,0,0,4,1,0,1,2,4,3.75,0,0,16,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,24,2.75,2916.67,6.28,10,0.42,143.04,0,0,2,2,8,0,1,11,0,16,8,0,0,0,0,0,0,23,1,0,22,0,0,2,0,0,0,0,0,0,"United States;Italy;Japan;United Kingdom","9;8;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3204 IMMUNOLOGY;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;31 BIOLOGICAL SCIENCES;3107 MICROBIOLOGY;3203 DENTISTRY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;3215 REPRODUCTIVE MEDICINE;42 HEALTH SCIENCES","24;13;4;2;2;2;2;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;PATIENT SAFETY;DIGESTIVE DISEASES;LUNG;RARE DISEASES;AUTOIMMUNE DISEASE;CARDIOVASCULAR;ATHEROSCLEROSIS;BRAIN DISORDERS;COLO-RECTAL CANCER;DENTAL/ORAL AND CRANIOFACIAL DISEASE;HEART DISEASE;HEMATOLOGY;LUNG CANCER;PREVENTION;AGING;ARTHRITIS;AUTISM","22;16;6;6;5;4;4;3;3;2;2;2;2;2;2;2;2;1;1;1","CANCER;CARDIOVASCULAR;ORAL AND GASTROINTESTINAL;RESPIRATORY;BLOOD;INFLAMMATORY AND IMMUNE SYSTEM;MENTAL HEALTH;REPRODUCTIVE HEALTH AND CHILDBIRTH;SKIN","4;2;2;2;1;1;1;1;1","6.1 PHARMACEUTICALS;7.3 MANAGEMENT AND DECISION MAKING;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.4 SURGERY;7.1 INDIVIDUAL CARE NEEDS","14;3;1;1;1;1","COLON AND RECTAL CANCER;LUNG CANCER;BLOOD CANCER;BREAST CANCER;LEUKEMIA / LEUKAEMIA;LIVER CANCER;SARCOMA","2;2;1;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT;3.4 VACCINES;5.2 LOCALIZED THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","3;2;2;1;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,15,"FRONTIERS;PUBLIC LIBRARY OF SCIENCE;ZENODO;TAYLOR & FRANCIS GROUP","6;6;2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES;31 BIOLOGICAL SCIENCES;44 HUMAN SOCIETY;3204 IMMUNOLOGY;3101 BIOCHEMISTRY AND CELL BIOLOGY;3208 MEDICAL PHYSIOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;3213 PAEDIATRICS;4203 HEALTH SERVICES AND SYSTEMS;4205 NURSING;4206 PUBLIC HEALTH","24;9;4;3;3;2;1;1;1;1;1;1;1","CLINICAL RESEARCH;BIOMEDICAL IMAGING;CANCER;CARDIOVASCULAR;DIGESTIVE DISEASES;HEART DISEASE;LUNG;PATIENT SAFETY;PREVENTION;ASTHMA;BIODEFENSE;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DIABETES;EMERGING INFECTIOUS DISEASES;IMMUNIZATION;INFECTIOUS DISEASES;LIVER CANCER;LIVER DISEASE;NEURODEGENERATIVE;NUTRITION","6;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","CANCER;CARDIOVASCULAR;METABOLIC AND ENDOCRINE;RESPIRATORY;SKIN","2;2;1;1;1","6.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;3.4 VACCINES;7.1 INDIVIDUAL CARE NEEDS","3;2;1;1;1;1","CLINICAL;BIOMEDICAL","6;2","CLINICAL MEDICINE AND SCIENCE;PUBLIC HEALTH;BASIC SCIENCE","5;2;1","BREAST CANCER;COLON AND RECTAL CANCER;LIVER CANCER;LUNG CANCER","1;1;1;1","3 GOOD HEALTH AND WELL BEING","2"
"AOU_TORVERGATA",2023,271,15.380073800738,2.64206642066421,0.306273062730627,0.269372693726937,0.321033210332103,2.06936416184971,1.38333333333333,2.02777777777778,1.55357142857143,0.734317343173432,3,86,57,27,10,0.32,0.21,0.1,0.04,3.8,0.867978649366564,5.3614916286149,0.324723247232472,0.940959409594096,0.501,0.393,0.376,0.389,"LUCA BIANCHI;GIUSEPPE RIZZO;LOREDANA SARMATI;ANASTASIOS D. ASIMAKOPOULOS;MASSIMO ANDREONI;ADRIANO VENDITTI;MARCO MATERAZZO;ENRICO FINAZZI AGRÒ;FRANCESCO BUCCISANO;ORESTE CLAUDIO BUONOMO;MARCO VIGNETTI;MARCO IANNETTA;GIANLUCA VANNI;MARCO GALLUZZO;MARIA CONCETTA FARGNOLI;LUIGI MAZZONE;MONICA BOCCHIA;ROBERTO M. LEMOLI;ELISABETTA TETI;DAVIDE LAURO","18;15;11;11;11;11;10;10;9;9;9;8;8;8;8;8;7;7;7;7","GIUSEPPE RIZZO;ANASTASIOS D. ASIMAKOPOULOS;ENRICO FINAZZI AGRÒ;LUCA BIANCHI;CLAUDIA PAGANINI;GAIA COLALILLO;VINCENZO PANASITI;MARCO MATERAZZO;ALDO DI CARLO;ORESTE CLAUDIO BUONOMO;GIANLUCA VANNI;MARCO GALLUZZO;LUIGI MAZZONE;MARCO PELLICCIARO;ELENA CAMPIONE;JIA LI ANGELA LU;MARIA ELENA PIETROLUCCI;ILENIA MAPPA;LOREDANA SARMATI;DAVIDE LAURO","2.25;1.86;1.84;1.73;1.48;1.15;1.04;1.01;1;0.97;0.89;0.82;0.81;0.8;0.79;0.79;0.79;0.76;0.76;0.74","LUCA BIANCHI;GIUSEPPE RIZZO;LOREDANA SARMATI;ANASTASIOS D. ASIMAKOPOULOS;MASSIMO ANDREONI;ADRIANO VENDITTI;MARCO MATERAZZO;ENRICO FINAZZI AGRÒ;FRANCESCO BUCCISANO;ORESTE CLAUDIO BUONOMO;MARCO IANNETTA;GIANLUCA VANNI;MARCO GALLUZZO;LUIGI MAZZONE;ELISABETTA TETI;DAVIDE LAURO;MARCO PELLICCIARO;RAFFAELE PALMIERI;MARTINA SIRACUSANO;ASSIA RICCIONI","18;15;11;11;11;11;10;10;9;9;8;8;8;8;7;7;7;7;7;7","GIUSEPPE RIZZO;ANASTASIOS D. ASIMAKOPOULOS;ENRICO FINAZZI AGRÒ;LUCA BIANCHI;CLAUDIA PAGANINI;GAIA COLALILLO;VINCENZO PANASITI;MARCO MATERAZZO;ALDO DI CARLO;ORESTE CLAUDIO BUONOMO;GIANLUCA VANNI;MARCO GALLUZZO;LUIGI MAZZONE;MARCO PELLICCIARO;ELENA CAMPIONE;JIA LI ANGELA LU;MARIA ELENA PIETROLUCCI;ILENIA MAPPA;LOREDANA SARMATI;DAVIDE LAURO","2.25;1.86;1.84;1.73;1.48;1.15;1.04;1.01;1;0.97;0.89;0.82;0.81;0.8;0.79;0.79;0.79;0.76;0.76;0.74","ALEXANDER E. PERL;ARNAUD LESEGRETAIN;ELŻBIETA PATKOWSKA;HARRY P. ERBA;HEE‐JE KIM;HERVÉ DOMBRET;JIANXIANG WANG;JORGE E. CORTÉS;LI LIU;MARK J. LEVIS;MIKKAEL A. SEKERES;PAU MONTESINOS;PO‐NAN WANG;RICHARD F. SCHLENK;SERGIO AMADORI;YASSER MOSTAFA KAMEL;JAMES HANYOK;PAVEL ŽÁK;RADOVAN VRḪOVAC;AZIZ BENZOHRA","150;150;150;150;150;150;150;150;150;150;150;150;150;150;150;150;148;147;147;146","SERGIO AMADORI;GIULIO RUSSO;MARIA TERESA VOSO;LOREDANA SARMATI;GIUSEPPE RIZZO;LUCA BIANCHI;GIUSEPPE SANGIORGI;MASSIMO ANDREONI;VINCENZO FORMICA;CHIARA GIUSEPPINA BONOMI;ASSIA RICCIONI;MARCO GALLUZZO;MARTINA SIRACUSANO;ILENIA MAPPA;LUIGI MAZZONE;MARTINA GAIA DI DONNA;LUCREZIA ARTURI;TIZIANA MULAS;SANDRO GRELLI;ALESSANDRO MARTORANA","150;106;54;53;51;44;42;42;34;33;30;30;30;29;29;29;28;28;27;26","GIUSEPPE RIZZO;LUCA BIANCHI;ANASTASIOS D. ASIMAKOPOULOS;ENRICO FINAZZI AGRÒ;ADRIANO VENDITTI;MARCO MATERAZZO;MASSIMO ANDREONI;ORESTE CLAUDIO BUONOMO;LOREDANA SARMATI;MARCO GALLUZZO;GIANLUCA VANNI;ASSIA RICCIONI;LUIGI MAZZONE;MARTINA SIRACUSANO;VINCENZO MALAGNINO;RAFFAELE PALMIERI;SERGIO AMADORI;DAVIDE LAURO;ELISABETTA TETI;MARCO MELONI","15;14;11;10;9;8;8;8;8;8;7;7;7;7;6;6;6;6;6;6","MEDICINE;BIOLOGY;PSYCHOLOGY;COMPUTER SCIENCE;CHEMISTRY;PHYSICS;ECONOMICS;MATHEMATICS;POLITICAL SCIENCE;ENGINEERING;PHILOSOPHY;SOCIOLOGY;BUSINESS;GEOGRAPHY;HISTORY;ENVIRONMENTAL SCIENCE","257;75;29;25;20;19;11;11;8;7;6;6;5;3;2;1","INTERNAL MEDICINE;SURGERY;GENETICS;ONCOLOGY;PATHOLOGY;IMMUNOLOGY;GASTROENTEROLOGY;RADIOLOGY;BIOCHEMISTRY;CARDIOLOGY;DERMATOLOGY;ENVIRONMENTAL HEALTH;ENDOCRINOLOGY;PSYCHIATRY;NURSING;PEDIATRICS;CLINICAL PSYCHOLOGY;PALEONTOLOGY;OBSTETRICS;INTENSIVE CARE MEDICINE;NUCLEAR MEDICINE","192;92;46;44;42;30;29;29;26;23;23;23;21;21;18;18;16;16;14;12;12","CANCER;DISEASE;GENE;POPULATION;RETROSPECTIVE COHORT STUDY;PREGNANCY;CHEMOTHERAPY;COHORT;RANDOMIZED CONTROLLED TRIAL;ADVERSE EFFECT;CLINICAL TRIAL;LEUKEMIA;QUALITY OF LIFE (HEALTHCARE);TRANSPLANTATION;ALTERNATIVE MEDICINE;IMMUNE SYSTEM;PROSPECTIVE COHORT STUDY;HEART FAILURE;MYELOID LEUKEMIA;PSORIASIS;REGIMEN","43;42;28;23;23;21;20;18;18;15;15;14;14;14;13;13;12;11;11;11;11","INFECTIOUS DISEASE (MEDICAL SPECIALTY);CLINICAL ENDPOINT;BREAST CANCER;FETUS;CHRONIC LYMPHOCYTIC LEUKEMIA;COLORECTAL CANCER;GENE EXPRESSION;GESTATION;TOLERABILITY;CYTARABINE;MINIMAL RESIDUAL DISEASE;PROSTATE;CYCLOPHOSPHAMIDE;DUPILUMAB;GESTATIONAL AGE;HEMATOPOIETIC STEM CELL TRANSPLANTATION;IMMUNOTHERAPY;PLACEBO;PLAQUE PSORIASIS;VIRAL LOAD","16;14;13;12;8;8;8;8;8;7;7;7;6;6;6;6;6;6;6;6","CORONAVIRUS DISEASE 2019 (COVID-19);VENETOCLAX;DNA METHYLATION;ANTIRETROVIRAL THERAPY;PRENATAL DIAGNOSIS;FLUDARABINE;IDARUBICIN;INTERNATIONAL PROGNOSTIC SCORING SYSTEM;PROSTATECTOMY;SECUKINUMAB;AFLIBERCEPT;AMNIOTIC FLUID;APGAR SCORE;BREAST SURGERY;CEFTAZIDIME;CLINICAL PHENOTYPE;CRITICAL LIMB ISCHEMIA;ELTROMBOPAG;FEBRILE NEUTROPENIA;FETAL HEAD;KARYOTYPE;KLEBSIELLA PNEUMONIAE;KRAS;MASTECTOMY;MULTICENTER TRIAL;OXALIPLATIN;PEMBROLIZUMAB;SENTINEL LYMPH NODE","16;7;6;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",";HUMANS;FEMALE;RETROSPECTIVE STUDIES;TREATMENT OUTCOME;BREAST NEOPLASMS;MALE;AGED;PREGNANCY;PSORIASIS;ADULT;ANTIBODIES, MONOCLONAL;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;COVID-19;PROSPECTIVE STUDIES;ULTRASONOGRAPHY, PRENATAL;HIV INFECTIONS;PROSTATE;MIDDLE AGED;SEVERITY OF ILLNESS INDEX","150;114;33;25;24;23;17;16;14;14;13;12;11;11;11;11;10;10;9;9","ACUTE MYELOID LEUKEMIA;RECIPROCAL DEVELOPMENT OF TH17 AND TREG CELLS;ATOPIC DERMATITIS AND SKIN MICROBIOME;PATHOPHYSIOLOGY AND MANAGEMENT OF PREECLAMPSIA;MANAGEMENT OF VALVULAR HEART DISEASE;PELVIC FLOOR DISORDERS;PREVENTION AND MANAGEMENT OF DIABETIC FOOT ULCERS;STANDARDISATION OF LOWER URINARY TRACT FUNCTION;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;COLORECTAL CANCER RESEARCH AND TREATMENT;DEVELOPMENT AND DISORDERS OF FETAL BRAIN;EFFICACY AND SAFETY OF ANTIRETROVIRAL THERAPY FOR HIV;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;NEUROLOGICAL MANIFESTATIONS OF COVID-19 INFECTION;RADIOMICS IN MEDICAL IMAGING ANALYSIS;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;CANCER SURVIVORSHIP AND QUALITY OF LIFE;CORONAVIRUS DISEASE 2019;CORONAVIRUS DISEASE 2019 RESEARCH;DIAGNOSIS AND TREATMENT OF BLADDER CANCER","20;9;6;6;5;5;5;5;4;4;4;4;4;4;4;3;3;3;3;3","CLINICAL ENDPOINT;REGIMEN;TREATMENT;FETAL DNA ANALYSIS;PANDEMIC;TOLERABILITY;AML;MINIMAL RESIDUAL DISEASE;PRENATAL DIAGNOSIS;VENETOCLAX;ACUTE MYELOID LEUKEMIA;DUPILUMAB;FLT3 MUTATIONS;2019-20 CORONAVIRUS OUTBREAK;CARDIAC IMAGING;FETAL MRI;FOOT ULCERS;METASTATIC COLORECTAL CANCER;PSORIASIS;DECITABINE","13;12;10;8;8;8;7;7;7;7;6;6;6;5;5;5;5;5;5;4","ACUTE MYELOID;MYELOID LEUKEMIA;ALZHEIMERS DISEASE;PLAQUE PSORIASIS;BREAST CANCER;ATOPIC DERMATITIS;CELL TRANSPLANTATION;COLORECTAL CANCER;MULTICENTER STUDY;COMPLETE REMISSION;DIABETIC FOOT;GIMEMA AML;MEASURABLE RESIDUAL;METASTATIC COLORECTAL;MYELODYSPLASTIC SYNDROMES;OBSERVATIONAL STUDY;PILOT STUDY;PRELIMINARY RESULTS;PROSPECTIVE STUDY;QUANTUM-FIRST TRIAL;RESIDUAL DISEASE;RETROSPECTIVE STUDY;CELL CARCINOMA;CEREBROSPINAL FLUID;COHORT STUDY;DISEASE CONTINUUM;DISEASE MRD;ELDERLY PATIENTS;FOOT ULCERS;IMMUNE RESPONSE","14;12;8;7;6;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3","ADVERSE EVENTS;COMPLETE REMISSION;MEDIAN OS;ACUTE MYELOID;MEDIAN AGE;MYELOID LEUKEMIA;BREAST CANCER;HR CI;MONTHS CI;STEM CELL;MEDIAN FOLLOW-UP;SARS-COV- INFECTION;SURVIVAL OS;REMISSION CR;STABLE IMPROVED;WORSENED STABLE;ELDERLY PATIENTS;PATIENTS UNDERWENT;SIGNIFICANT DIFFERENCES;CELL TRANSPLANTATION;DISEASE PROGRESSION;PATIENTS RECEIVED;PATIENTS TREATED;RESPONSE RATE;ELN RISK;INTENSIVE CHEMOTHERAPY;LEUKEMIA AML;PATIENTS PTS;PRIMARY ENDPOINT;CLINICAL PRACTICE","23;22;22;18;18;18;17;17;17;17;16;16;16;15;15;15;14;13;13;12;12;12;12;12;11;11;11;11;11;10",111,0.41,6.07,6,1.5,1,0,3,0,1,1,6.5,1,0,6.5,1,1,2,3,5.25,3.5,0,0,8,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,16,2.38,873.75,5.05,4,0.25,121.06,0,0,4,1,6,0,1,4,0,14,2,0,0,0,0,0,0,15,0,1,16,0,0,0,0,0,0,0,0,0,"United States;Germany;Japan;Italy","5;3;3;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;42 HEALTH SCIENCES;52 PSYCHOLOGY;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3212 OPHTHALMOLOGY AND OPTOMETRY;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;4207 SPORTS SCIENCE AND EXERCISE;5202 BIOLOGICAL PSYCHOLOGY","15;10;3;2;2;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;PATIENT SAFETY;BRAIN DISORDERS;DIGESTIVE DISEASES;NEUROSCIENCES;AUTOIMMUNE DISEASE;AGING;BIOMEDICAL IMAGING;GENETICS;HEMATOLOGY;NEURODEGENERATIVE;STROKE;ARTHRITIS;BEHAVIORAL AND SOCIAL SCIENCE;BIOENGINEERING;CHILDHOOD LEUKEMIA;COLO-RECTAL CANCER;EYE DISEASE AND DISORDERS OF VISION","16;13;5;5;4;4;4;3;2;2;2;2;2;2;1;1;1;1;1;1","CANCER;CARDIOVASCULAR;ORAL AND GASTROINTESTINAL;STROKE;BLOOD;EYE;INFLAMMATORY AND IMMUNE SYSTEM;NEUROLOGICAL","4;3;2;2;1;1;1;1","6.1 PHARMACEUTICALS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.7 PHYSICAL","11;1;1;1","COLON AND RECTAL CANCER;LEUKEMIA / LEUKAEMIA;PROSTATE CANCER","2;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","2",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,22,"PUBLIC LIBRARY OF SCIENCE;FRONTIERS;TAYLOR & FRANCIS GROUP;FUTURE SCIENCE GROUP","12;5;3;2","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;49 MATHEMATICAL SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;3207 MEDICAL MICROBIOLOGY;4905 STATISTICS;31 BIOLOGICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3204 IMMUNOLOGY;3213 PAEDIATRICS;37 EARTH SCIENCES;52 PSYCHOLOGY","31;9;8;4;4;3;2;2;1;1;1;1;1;1","CLINICAL RESEARCH;PATIENT SAFETY;CANCER;PREVENTION;RARE DISEASES;INFECTIOUS DISEASES;PEDIATRIC;BRAIN DISORDERS;BREAST CANCER;CHILDHOOD LEUKEMIA;HEMATOLOGY;ORPHAN DRUG;PEDIATRIC CANCER;AGING;CHILD ABUSE AND NEGLECT RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;COMPARATIVE EFFECTIVENESS RESEARCH;DIABETES;DIGESTIVE DISEASES;EPILEPSY","7;6;5;5;5;4;3;2;2;2;2;2;2;1;1;1;1;1;1;1","INFECTION;CANCER;MUSCULOSKELETAL;NEUROLOGICAL","7;4;1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;6.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES","4;3;1","CLINICAL;BIOMEDICAL","4;3","CLINICAL MEDICINE AND SCIENCE;PUBLIC HEALTH;BASIC SCIENCE","9;5;2","BREAST CANCER;LEUKEMIA / LEUKAEMIA;NOT SITE-SPECIFIC CANCER","2;2;1","3 GOOD HEALTH AND WELL BEING","4"
"AOU_TORVERGATA",2024,246,16.1178861788618,2.52032520325203,0.349593495934959,0.317073170731707,0.382113821138211,1.8452380952381,1.36507936507937,1.69565217391304,1.56666666666667,0.646341463414634,0,89,60,24,11,0.36,0.24,0.1,0.04,0.81,0.850689836385718,4.18395155185466,0.321138211382114,0.967479674796748,0.495,0.433,0.416,0.436,"LUCA BIANCHI;ENRICO FINAZZI AGRÒ;LUCA FILIPPI;GIUSEPPE RIZZO;ANDREA ANTINORI;MARK S. TALAMONTI;MARCO GALLUZZO;ILENIA MAPPA;LOREDANA SARMATI;ANTONELLA D’ARMINIO MONFORTE;ANNALISA NOCE;GIANLUCA VANNI;ELEONORA ROSATO;UMBERTO TARANTINO;GIOVANNI MONTELEONE;MARCO MATERAZZO;ANTONELLA CASTAGNA;MARCO PELLICCIARO;ORESTE CLAUDIO BUONOMO;ENRICO GIRARDI","15;15;12;12;10;10;10;10;9;9;8;8;8;8;8;7;7;7;7;7","LUCA FILIPPI;ENRICO FINAZZI AGRÒ;GIUSEPPE RIZZO;ILENIA MAPPA;LUCA BIANCHI;MARK S. TALAMONTI;ELEONORA ROSATO;GIOVANNI MONTELEONE;MARCO GALLUZZO;GIANLUCA VANNI;UMBERTO TARANTINO;LUCA ORECCHIA;MARCO MATERAZZO;MARCO PELLICCIARO;ORESTE CLAUDIO BUONOMO;TUFAN TARCAN;ANNALISA NOCE;CONCETTA POTENZA;PAOLA ROGLIANI;ROBERTO MIANO","2.27;1.72;1.52;1.3;1.26;1.25;1.13;1.11;0.97;0.85;0.84;0.79;0.78;0.78;0.78;0.76;0.76;0.72;0.71;0.68","LUCA BIANCHI;ENRICO FINAZZI AGRÒ;LUCA FILIPPI;GIUSEPPE RIZZO;MARK S. TALAMONTI;MARCO GALLUZZO;ILENIA MAPPA;LOREDANA SARMATI;ANNALISA NOCE;GIANLUCA VANNI;ELEONORA ROSATO;UMBERTO TARANTINO;GIOVANNI MONTELEONE;MARCO MATERAZZO;MARCO PELLICCIARO;ORESTE CLAUDIO BUONOMO;CLAUDIA PAGANINI;VIVIANA MOSCHESE;NICOLA BIAGIO MERCURI;LUCA ORECCHIA","15;15;12;12;10;10;10;9;8;8;8;8;8;7;7;7;6;6;6;5","LUCA FILIPPI;ENRICO FINAZZI AGRÒ;GIUSEPPE RIZZO;ILENIA MAPPA;LUCA BIANCHI;MARK S. TALAMONTI;ELEONORA ROSATO;GIOVANNI MONTELEONE;MARCO GALLUZZO;GIANLUCA VANNI;UMBERTO TARANTINO;LUCA ORECCHIA;MARCO MATERAZZO;MARCO PELLICCIARO;ORESTE CLAUDIO BUONOMO;ANNALISA NOCE;PAOLA ROGLIANI;ROBERTO MIANO;JIA LI ANGELA LU;ANASTASIOS D. ASIMAKOPOULOS","2.27;1.72;1.52;1.3;1.26;1.25;1.13;1.11;0.97;0.85;0.84;0.79;0.78;0.78;0.78;0.76;0.71;0.68;0.67;0.65","GIUSEPPE RIZZO;ILENIA MAPPA;DENIS E. O’DONNELL;JEAN BOURBEAU;MIRANDA KIRBY;WAN C. TAN;DANIELA PEDICINO;FRANCESCO MAISANO;GIULIO RUSSO;MAURIZIO TARAMASSO;ALBERTO POZZOLI;AZEEM LATIB;DANIEL BRAUN;DANIEL KALBACHER;DOMINIQUE HIMBERT;EDITH LUBOS;FABIEN PRAZ;GEORG NICKENIG;GILBERT H.L. TANG;GIOVANNI PEDRAZZINI","21;20;18;18;18;18;17;17;17;17;16;16;16;16;16;16;16;16;16;16","ILENIA MAPPA;GIULIO RUSSO;GIUSEPPE RIZZO;JIA LI ANGELA LU;MARIA ELENA PIETROLUCCI;JOSUEL ORA;LUCA BIANCHI;ENRICO FINAZZI AGRÒ;MARIA CHIARA MARRA;ELENA CAMPIONE;LAURA DILUVIO;COSIMO DI RAIMONDO;FABIO ARTOSI;FLAVIA LOZZI;GIOVANNI MONTELEONE;MASSIMO FEDERICI;RUSLANA GAETA SHUMAK;SARA LAMBIASE;VIRGINIA GAROFALO;G. P. NOVELLI","18;17;15;15;15;11;11;9;9;8;8;7;7;7;7;7;7;7;7;6","ENRICO FINAZZI AGRÒ;LUCA BIANCHI;LUCA FILIPPI;GIUSEPPE RIZZO;MARCO GALLUZZO;MARK S. TALAMONTI;ILENIA MAPPA;UMBERTO TARANTINO;GIANLUCA VANNI;GIOVANNI MONTELEONE;MARCO MATERAZZO;MARCO PELLICCIARO;ORESTE CLAUDIO BUONOMO;ELEONORA ROSATO;VIVIANA MOSCHESE;LUCA ORECCHIA;ANNALISA NOCE;ELENA CAMPIONE;LAURA DILUVIO;MAURIZIO SALVATI","15;15;12;10;10;10;9;8;8;7;7;7;7;6;6;6;6;5;5;5","MEDICINE;BIOLOGY;COMPUTER SCIENCE;PSYCHOLOGY;PHYSICS;CHEMISTRY;MATHEMATICS;ENGINEERING;ECONOMICS;POLITICAL SCIENCE;SOCIOLOGY;GEOGRAPHY;PHILOSOPHY;MATERIALS SCIENCE;GEOLOGY;HISTORY","236;64;27;16;14;13;12;11;9;6;6;5;4;2;1;1","INTERNAL MEDICINE;SURGERY;PATHOLOGY;INTENSIVE CARE MEDICINE;IMMUNOLOGY;RADIOLOGY;CARDIOLOGY;DERMATOLOGY;GENETICS;ONCOLOGY;PSYCHIATRY;PEDIATRICS;BIOCHEMISTRY;ENDOCRINOLOGY;GASTROENTEROLOGY;UROLOGY;ENVIRONMENTAL HEALTH;CANCER RESEARCH;NURSING;BIOINFORMATICS;PHYSICAL THERAPY","169;60;33;32;31;29;24;24;23;21;20;19;17;17;15;15;13;12;12;11;11","DISEASE;CANCER;COHORT;RANDOMIZED CONTROLLED TRIAL;RETROSPECTIVE COHORT STUDY;CLINICAL TRIAL;PREGNANCY;ALTERNATIVE MEDICINE;DIABETES MELLITUS;INFLAMMATION;POPULATION;GENE;QUALITY OF LIFE (HEALTHCARE);HUMAN IMMUNODEFICIENCY VIRUS (HIV);PSORIASIS;RESECTION;ATOPIC DERMATITIS;CHEMOTHERAPY;HEART FAILURE;MAGNETIC RESONANCE IMAGING;ULTRASOUND","39;36;16;16;16;13;12;11;10;10;10;9;9;8;8;8;7;7;7;7;7","BREAST CANCER;FETUS;PROSTATE;CLINICAL ENDPOINT;DUPILUMAB;INFLAMMATORY BOWEL DISEASE;COLORECTAL CANCER;IMMUNOGLOBULIN E;PROSTATE CANCER;DIABETIC FOOT;MULTICENTER STUDY;OVERACTIVE BLADDER;AORTIC DISSECTION;DERMATOLOGY LIFE QUALITY INDEX;GESTATION;HAEMATOPOIESIS;HAZARD RATIO;IMMUNOTHERAPY;PROTOCOL (SCIENCE);PSORIASIS AREA AND SEVERITY INDEX;SURGICAL MARGIN;ULCERATIVE COLITIS;VIRAL LOAD;WEIGHT LOSS","11;11;7;6;6;6;5;5;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3","DUCTAL CARCINOMA;MASTECTOMY;SENTINEL LYMPH NODE;ANTIRETROVIRAL THERAPY;BROMODOMAIN;COLECTOMY;FETAL GROWTH;FLUDARABINE;LOWER URINARY TRACT SYMPTOMS;PRENATAL DIAGNOSIS;URINARY URGENCY;ABDOMINAL OBESITY;ACTIN CYTOSKELETON;ACUTE MIGRAINE;ACUTE PROMYELOCYTIC LEUKEMIA;AFLIBERCEPT;ARYL HYDROCARBON RECEPTOR;AXILLA;BLADDER OUTLET OBSTRUCTION;BREAST RECONSTRUCTION;BREAST SURGERY;BRENTUXIMAB VEDOTIN;BUSULFAN;CALCIFEDIOL;CALPROTECTIN;CARDIOTOCOGRAPHY;CASPASE;CETUXIMAB;CHIMERIC ANTIGEN RECEPTOR;CHRONIC INSOMNIA;CLASSICAL HODGKIN LYMPHOMA;COGNITIVE DECLINE;COLONOSCOPY;CONNECTIVE TISSUE DISEASE;CONTINUOUS GLUCOSE MONITORING;CORONAVIRUS DISEASE 2019 (COVID-19);CYSTECTOMY;DABIGATRAN;DISEASE MANAGEMENT;DNA METHYLATION;DYNAMIC HYPERINFLATION;ENHANCER;ENOS;ESTROGEN RECEPTOR;FETAL HEAD;GASTRIC BYPASS;GESTATIONAL DIABETES;GINI COEFFICIENT;GROWTH RESTRICTION;HEMATOPOIETIC CELL;HEPATITIS E;HERPESVIRIDAE;IN UTERO;INCREMENTAL COST-EFFECTIVENESS RATIO;INCRETIN;INFLAMMATORY BOWEL DISEASES;INHIBITOR OF APOPTOSIS;INSULITIS;INTERNATIONAL PROGNOSTIC SCORING SYSTEM;INTRAUTERINE GROWTH RESTRICTION;JANUS KINASE INHIBITOR;LATENT TUBERCULOSIS;LENVATINIB;MAMMOGRAPHY;MECHANISTIC TARGET OF RAPAMYCIN;MEPOLIZUMAB;METASTATIC BREAST CANCER;MITOPHAGY;MODIFIED RANKIN SCALE;MONOCHORIONIC TWINS;MYOCARDIAL PERFUSION SCINTIGRAPHY;OMALIZUMAB;OSTEOPOROTIC FRACTURE;OXALIPLATIN;P2Y12;PANCREATIC ISLETS;PEMBROLIZUMAB;POSTMENOPAUSAL OSTEOPOROSIS;PROSTATE BIOPSY;PROSTATECTOMY;QUANTITATIVE COMPUTED TOMOGRAPHY;RANIBIZUMAB;REGORAFENIB;RENAL MASS;RIVAROXABAN;SECUKINUMAB;SENTINEL NODE;SOD1;SUICIDAL IDEATION;SYSTEMIC THERAPY;TAUOPATHY;THORACIC AORTIC ANEURYSM;TRIPLE-NEGATIVE BREAST CANCER;TUBERCULOSIS DIAGNOSIS;UMBILICAL ARTERY;USTEKINUMAB;UTERINE ARTERY;VENETOCLAX;VO2 MAX;WEIGHT STIGMA","4;4;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;FEMALE;MALE;MIDDLE AGED;ADULT;AGED;ITALY;TREATMENT OUTCOME;RETROSPECTIVE STUDIES;YOUNG ADULT;ADOLESCENT;PROSPECTIVE STUDIES;PREGNANCY;CHILD;QUALITY OF LIFE;REGISTRIES;AGED, 80 AND OVER;ANIMALS;SURVEYS AND QUESTIONNAIRES","141;103;69;53;44;39;32;26;19;16;14;12;12;11;9;8;8;7;7;7","STANDARDISATION OF LOWER URINARY TRACT FUNCTION;ATOPIC DERMATITIS AND SKIN MICROBIOME;MANAGEMENT OF VALVULAR HEART DISEASE;RECIPROCAL DEVELOPMENT OF TH17 AND TREG CELLS;ACUTE MYELOID LEUKEMIA;MOLECULAR RESEARCH ON BREAST CANCER;PATHOPHYSIOLOGY AND MANAGEMENT OF PREECLAMPSIA;PROSTATE CANCER RESEARCH AND TREATMENT;CHOLESTEROL-LOWERING TREATMENT;PREVENTION AND MANAGEMENT OF DIABETIC FOOT ULCERS;REGULATION AND FUNCTION OF HAIR FOLLICLE STEM CELLS;ASTHMA;DIAGNOSIS AND MANAGEMENT OF AORTIC DISEASES;EPIDEMIOLOGY AND TREATMENT OF URINARY TRACT INFECTIONS;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;MALE CIRCUMCISION FOR HIV PREVENTION AND PENILE HEALTH;MIGRAINE PATHOPHYSIOLOGY AND TREATMENT;OSTEOPOROSIS;AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA;ANORECTAL SURGICAL PROCEDURES","9;7;7;7;6;5;5;5;4;4;4;3;3;3;3;3;3;3;2;2","TREATMENT;CLINICAL ENDPOINT;DUPILUMAB;FETAL GROWTH RESTRICTION;DIABETES;HIV;TRANSCATHETER AORTIC-VALVE REPLACEMENT;ACUTE MYELOID LEUKEMIA;ALOPECIA AREATA;CHOLESTEROL-LOWERING;CONCOMITANT;DISCONTINUATION;FETAL PROGRAMMING;LOWER URINARY TRACT SYMPTOMS;STROKE (ENGINE);TYPE B AORTIC DISSECTION;URODYNAMIC PRACTICES;ALZHEIMER'S DISEASE;AORTIC DISSECTION;AORTIC ROOT REPLACEMENT","13;6;6;6;5;5;5;4;4;4;4;4;4;4;4;4;4;3;3;3","ACUTE MYELOID;ITALIAN SOCIETY;FETAL GROWTH;MYELOID LEUKEMIA;URINARY TRACT;ALOPECIA AREATA;ATOPIC DERMATITIS;BREAST CANCER;COHORT STUDY;INFLAMMATORY BOWEL;ITALIAN STUDY;RETROSPECTIVE STUDY;RISK FACTORS;ACUTE STROKE;ALZHEIMERS DISEASE;BOWEL DISEASE;CLINICAL PRACTICE;COLORECTAL CANCER;CORTICAL DEVELOPMENT;DIABETIC FOOT;DUCTAL CARCINOMA;GROWTH RESTRICTION;HEART FAILURE;ITALIAN COHORT;LOWER URINARY;MACHINE LEARNING;PATIENTS TREATED;PHYSICAL ACTIVITY;PREDICTIVE MODEL;PROSTATE CANCER","7;6;5;5;5;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","CAVITY SHAVE;PROSTATE CANCER;RETROSPECTIVE STUDY;URINARY TRACT;WEEK WEEK;APOE Ε;INFORMED CONSENT;STATISTICALLY SIGNIFICANT;ADVERSE EVENTS;BONE MARROW;CLINICAL PRACTICE;CLINICAL TRIALS;DIABETIC FOOT;PATIENTS UNDERGOING;SINUS RHYTHM;SURGICAL TIME;SYSTEMATIC REVIEW;ADIPOSE TISSUE;INTRAOPERATIVE EVALUATION;MEDIAN AGE;PATIENTS SUBJECTED;PEDIATRIC PATIENTS;SIGNIFICANT DIFFERENCES;SIGNIFICANTLY LOWER;SURVIVAL OS;ADVERSE EFFECTS;CHRONIC INFLAMMATORY;COGNITIVE DECLINE;CONSECUTIVE PATIENTS;DETRUSOR UNDERACTIVITY","10;9;9;9;9;8;8;8;7;7;7;7;7;7;7;7;7;6;6;6;6;6;6;6;6;5;5;5;5;5",2,0.01,4.46,8.75,0,0,0,0,0,0,0,9.5,1,0,8.5,0,0,2,1.75,5,1,0,0,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,1.5,351,0.66,0,0,31,0,0,0,0,0,0,0,2,0,1,1,0,0,0,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;4205 NURSING","1;1;1;1;1;1","CANCER;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;HEMATOLOGY;LYMPHOMA;RARE DISEASES;BEHAVIORAL AND SOCIAL SCIENCE;DEPRESSION;MENTAL HEALTH;PREVENTION;REHABILITATION","2;2;2;2;2;2;1;1;1;1;1","GENERIC HEALTH RELEVANCE","1","6.1 PHARMACEUTICALS;7.1 INDIVIDUAL CARE NEEDS","1;1","NON-HODGKIN'S LYMPHOMA;COLON AND RECTAL CANCER","2;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,"FRONTIERS","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES","2;1","AUTOIMMUNE DISEASE;BIOTECHNOLOGY;DIABETES;PEDIATRIC","1;1;1;1","METABOLIC AND ENDOCRINE","1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.1 PHARMACEUTICALS","1;1","BIOMEDICAL","1","BASIC SCIENCE","1",NA,NA,NA,NA
